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ABSTRACT 
Smoking, Anemia, and Risk of Oral Clefts in Utah 
by 
Melinda Michelle Moss, Master of Science 
Utah State University, 2006 
Major Professor: Dr. Ronald G. Munger 
Department: Nutrition and Food Sciences 
Cigarette smoke contains sufficient carbon monoxide to induce maternal and fetal 
hypoxia. Hypoxia is a known teratogen, and consequently maternal smoking has been 
the focus of many studies on adverse birth outcomes, including cleft lip and palate. 
Current literature of epidemiological studies on smoking and clefts suggests a modest but 
statistically significant increase in risk of clefting associated with maternal smoking. A 
biological condition that may also contribute to hypoxia is anemia. Data from the Utah 
Child and Family Health Study was used to assess the effects of hypoxia-inducing 
conditions, maternal smoking, anemia, and their interaction, on the risk of having a child 
with a cleft. Smoking during the first trimester and hemoglobin levels ofless than 12.0 
g/dL were the defined risk exposures and logistic regression modeling was used to test 
the hypotheses. Smoking during the first trimester of pregnancy was associated with 
increased risk of clefting; however, anemia did not appear to be associated with clefting 
lV 
in this population, and there was also no apparent additional increase in risk for those 
mothers who both smoked and were anemic. Prospects for future studies include using 
populations that have higher rates of anemia and smoking to gain more statistical power, 
and using more sensitive measures of red blood cell health other than hemoglobin. From 
a public health perspective, evidence from this study would suggest that efforts to 
promote smoking cessation in women of child-bearing years is of considerable 
importance. 
(196 pages) 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
Abstract 
IdentifYing risk factors associated with cleft lip and palate abnormalities may help 
reduce the incidence of these conditions, thus eliminating a tremendous medical burden 
for many families worldwide. Data from the Utah Child and Family Health study will be 
used to determine the risk of clefting associated with smoking and anemia, two 
conditions that contribute to hypoxia, a known teratogen. General data collection 
procedures, analysis techniques and hypothesis are set forth herein. 
Introduction 
Despite an increased understanding of disease etiology in recent years, cleft lip 
and cleft palate abnormalities continue to be a burden on society. The World Health 
Organization estimates that 1 out of every 500 to 700 live births involves a cleft of the lip 
or palate, making cleft defects one of the most prevalent birth defects, not only in the 
U.S., but also across the globe (1). Based on both environmental and genetic factors, 
cleft palate rates differ across geographic regions and within ethnic groups (2, 3). 
Reported rates range from a low of 0.18 to 1.67 per 1,000 live births among blacks, to a 
high of 1.45 to 4.04 per 1,000 live births among Chinese populations (2). Unfortunately, 
it is developing countries with populations of low socioeconomic status that seem to 
suffer most from increased risk of cleft lip and cleft palate ( 4 ). For example, in the 
Philippines where the GDP is less than 5,000 U.S. dollars per year, the rate of cleft lip 
and cleft palate is 1.94 per 1,000 live births ( 4, 5). 
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Children born with cleft lip and palate have increased difficulty in feeding, 
speaking, and social development. One Vietnamese mother laments, "It is impossible for 
my baby to eat. She only drinks milk and porridge and vomits frequently. Social norms 
dictate that many of these children enter adulthood without having experienced many of 
the societal benefits that many of us take for granted: education, marriage and friendship 
for example. In some cultures, children with cleft lip and palate are thought to be 
"cursed" (5). Economic studies estimated that in 1992 cleft palate birth defects cost the 
U.S. over 697 million dollars (6). Part of that estimate is related to direct medical costs, 
while a significant portion is loss due to decreased productivity, special education and 
other considerations (6). In places where access to medical technology is limited and 
funds for medical care are scarce, at any cost, there is little hope that these birth defects 
can be corrected. While the cost of corrective surgery in these countries is comparatively 
low, as little as$ 750 per patient, many people still cannot afford medical treatment (5). 
Background 
Morphology 
Palate formation in the human fetus begins around day 45 when mesenchymal 
cells migrate from the neural crest to the oral cavity (7). Rapid cell proliferation occurs 
and two shelves are formed at the surface of the maxillary processes (7). The palate 
shelves are composed of mesechymal cells surrounded by a matrix of extracellular 
gycosaminoglycans and collagen and encompassed by two to tluee layers of epithelial 
cells (7, 8). Due in part to the relatively fast growth of the palate shelves in relation to 
the growth rate of the headspace, as well as the hydration and electrostatic repulsion of 
the gycosaminoglycans, as the shelves form they move from a vertical position on either 
side of the tongue to a horizontal position above the tongue (7). Once the shelves come 
in contact above the tongue, surface epithelial cells from the opposing shelves adhere to 
each other via surface carbohydrates and proteins (7, 8). The epithelial cells then 
undergo an epithelial to mesenchyme transition and mesenchymal continuity is achieved 
across the seam (7, 9). 
Ferguson et al. categorizes the mechanisms that may be responsible for incorrect 
palate formation into five basic groups: 1) inhibition of cell division or migration 2) 
failure of palate shelf to elevate at the correct time 3) excessive head width 4) failure of 
shelf fusion and 5) post fusion rupture (7). Gene expression, hormone levels and 
environmental factors, such as toxins, can affect one or more of these processes causing 
the formation of a cleft (7, 1 0). The most common form of oro facial clefts is cleft lip 
with or without cleft palate CL(P), and is categorized by a cleft in the lip with or without 
a cleft in the primary or hard palate. CL(P) is further classified by the site of the lip cleft: 
left, right, or midline unilateral lip clefts are possible, as well as bilateral clefts. 
Several syndromes can be associated with clefting, including those associated 
with chromosomal syndromes, teratogens and other uncategorized syndromes (11, 12). 
In studying cleft deformities, a distinction needs to be made between the different types 
in order to account for their different pathologies. The difference between CL(P) and 
cleft of the soft palate alone, CP, needs particular consideration (12). Epidemiological 
data would suggest a different mechanism for clefts of the soft, or secondary palate alone 
3 
and accordingly, statistical analysis are typically performed looking at CL(P) and CP 
separately (13). 
Genetics 
Recently a great deal of research has focused on genetic factors and their 
contribution to palate malformation. Loci scanning projects in humans have found some 
30 genes that appear to be associated with palate formation (14). Genes for extracellular 
matrix proteins, transcription factors and cell signaling molecules have been linked to 
cleft palate phenotypes (14). While these studies show an increased risk for cleft palate 
with certain genetic variation, many studies also focus on how genes and environment 
interact to induce clefting ( 10, 12, 15). 
Environment 
4 
Migrant studies are an excellent example of how the environment can interact 
with, or over-ride genetics to induce clefting. For example, hospitals in Manila report 
different rates of clefting dependant on the socioeconomic status of the patient population 
(16). Other studies show that Philippine people who have immigrated to the United 
States, either to California or Hawaii, have cleft rates similar to other people in those 
areas and not their home countries (14, 17, 18). These patterns would suggest that 
altering environmental factors could help reduce the incidence of cleft lip and cleft palate 
birth defects. 
Animal Models 
Animal models have shown that cleft palate formation can be induced in several 
species by altering various environmental factors (19-23). Folate antagonists, 
corticosteroid, and anticonvulsive drugs are among the known teratogens that cause oral 
clefts in animals (24, 25). Some plant based poisons are also suspect (23). Several 
nutritional deficiencies or toxicities have likewise been shown to induce clefts in animal 
models, including vitamin A, riboflavin, folic acid, pantothenic acid, vitamins B-12 and 
B-6 and zinc (24, 26-28). 
Hypoxia 
5 
Blood oxygen levels are one particular environmental factor of interest that has 
been associated with cleft lip and palate in mice (21 ). Oxygen is essential in virtually all 
metabolic processes and hypoxia has been shown to be a powerful, nonspecific teratogen 
(21, 29). Induced hypoxia in mice studies have conclusively shown that reduced levels of 
blood oxygen can increase the risk and severity of cleft palate (20, 21 ). A study done by 
Millicovsky and published in the Proceeding of the National Academy of Science, goes 
even further to show a dose response relationship between hypoxia and incidence of cleft 
lip in mice (19). While there is not a complete understanding of how oxygen, or a lack 
thereof affects palate formation, one specific mechanism of interest is the inhibition of 
the enzyme lysyl oxidase. Lysyl oxidase is responsible for oxidizing lysine residues in 
collagen thus forming stabilized crosslinks (30). While teratogens can inhibit this 
enzyme, basic bioenergetics also dictate that low levels of 0 2 will retard enzyme 
function. Regardless of the specific mechanism involved, oxygen is essential for proper 
6 
fetal growth and development and two significant environmental factors that can alter the 
availability of oxygen are maternal smoking and anemia. 
Smoking 
The World Health Organization lists smoking as one of the major risks to public 
health (31 ). Smoking has been associated with a myriad of health concerns such as 
coronary heart failure, cancer, emphysema, stroke, etc (31 ). Due in large part to targeted 
advertising by tobacco companies, tobacco use among developing nations has been 
steadily increasing, and while developed nations show a decrease in smoking rates 
amongst males, smoking rates for females continue to rise (32, 33). According to the 
CDC, Utah has one of the lowest reported smoking rates in the nation, with only 
approximately 13% ofwomen smoking (34), which is good news in terms ofpublic 
health as smoking may account for a higher incidence of certain diseases including cleft 
lip and palate, especially in areas where tobacco use is wide spread and on the increase. 
In fact, an ever-increasing body of research has implicated cigarette smoke as a 
risk factor for spontaneous abortions and certain birth complications including orofacial 
clefts (35). While the epidemiological data are not conclusive, a significant number of 
studies show that maternal smoking can influence cleft palate rates (15, 36-48). There 
have been two meta-analysis published in recent years and both show an overall 
increased risk of cleft palate formation in association with maternal smoking. Wyszynski 
et al. ( 49) looked at 9 different studies in 1997 and Little et al. (50) looked at 15 studies 
in 2004. Both studies show an over-all increase in risk for clefts in conjunction with 
smoking. For those studies that reported the number of cigarettes smoked, Little et al. 
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(50) indicates a marginal, though not significant, dose-response relationship. Studies that 
failed to show such an association had very little statistical power due to small sample 
sizes, which may explain an apparent lack of association. It is also unclear as of yet, 
exactly what components of tobacco smoke contribute to the physiological effects of 
smoking on the fetus. Certainly, more work needs to be done in order to verify or refute 
an association between maternal smoking and cleft palate rates, and identify the many 
pathways by which tobacco smoke could be a contributor to palate malformation. 
Anemia 
Anemia is defined by the World Health Organization as, "a condition in which 
the hemoglobin content of the blood is lower than normal as a result of a deficiency of 
one or more essential nutrients regardless of the cause of such deficiency" (51). As this 
statement indicates, a number of different nutritional factors can contribute to anemia, 
including vitamin A, vitamin B 12, riboflavin, zinc and iron (52-55). In fact, iron 
deficiency anemia is the most prevalent source of anemia worldwide (55). UNICEF 
estimates that globally 4-5 billion people have some level of iron deficiency and two 
billion are anemic (56). Iron deficiency anemia rates in developed countries are lower 
than those in developing nations, but pregnant women are more at risk than the general 
population irrespective of geography. 
Anemia can be diagnosed based on the World Health Organization standards of 
hemoglobin levels greater than or equal to llg/dL (57). Hemoglobin levels correspond 
with long-term dietary iron intake and are usually a good indicator of late stage anemia 
(29). However, some concern has been expressed over the universal application of the 
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WHO standard of diagnosis because of inherent differences in hemoglobin levels in 
various populations (57). For example, one study that focused on anemia in pregnant 
Philippina women suggests that a standard of I 0.4 g/dL for determining anemia status 
would be more appropriate for that population (57). Certain factors can also artificially 
elevate hemoglobin levels without actually increasing oxygen availability in the body. 
This may inhibit proper screening of anemia using hemoglobin values. Smoking is a 
particular concern because smoking can raise hemoglobin levels significantly without any 
reduction in tissue hypoxia (58). The increase is in fact just a reflection of increased 
levels of hemoglobin bound with carbon monoxide. 
The Utah Child and Family Health Study 
Study Objectives 
Anemia and smoking have been independently suspected as risk factors for 
adverse birth outcomes, however, the combined effect of smoking and anemia on cleft 
rates have not been thoroughly explored. Based on the animal models for hypoxia and 
the propensity of anemia and smoking to decrease oxygen availability in the body, it 
seems likely that there is an interaction between the two that may be responsible for an 
increased risk of cleft lip and cleft palate birth defects. Consequently, the objectives of 
this study are to: 
1. Ascertain the prevalence of anemia and smoking in the Utah Child and Family 
Health Study, and the associated odds ratio for each in relation to cleft risk, 
and, 
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2. Detetmine the combined effect of smoking and anemia on the risk (OR) of 
having a child with CL(P) independent of other confounding factors including 
the mother's age, weight, height, alcohol use and parity. 
Hypothesis 
Women who smoke and are anemic are subject to a combined physiological 
reduction in oxygen transport that can synergistically increase the risk of cleft lip and 
palate in their offspring. 
Study Design 
The low incidence of cleft lip and palate dictates that the design for this study 
must be of the case-control nature. Data from the Utah Family and Child Health Study 
used to test this hypothesis included over 800 cases with both interview and lab data, and 
were collected thanks to funding from the NIH. All of the study methods and materials 
for this particular study have been reviewed and approved by the Utah State University 
IRB. 
Data Collection 
All study subjects, including both cases and controls, were identified and 
informed of the purposes and procedures involved with the study through the Utah 
Department of Health (UDOH), which monitors the Utah Birth Defect Network. UDOH 
officials issued letters of invitation to qualified families to participate in the study, and 
then actively pursued a response from each household if necessary. Once written 
consents were obtained, participant information was released to researchers at Utah State 
University. Trained staff at the center for epidemiological studies at USU were 
responsible for providing participating mothers with information regarding the study, 
including providing materials to help the mothers prepare for the interviews, and 
conducting the phone interviews. These interviews lasted for approximately one hour 
and consisted of questions regarding demographic, anthropometric, diet and other 
lifestyle characteristics of the mothers, as well as specific information about the site and 
classification of the cleft for case children. Case classification was verified by official 
department of health records. 
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A 20 ml blood sample was later collected from each mother that consented to 
donate a biological sample. Hemoglobin levels were determined on site using the 
Hemocue System, produced by the HemoCue corporation in Sweden. Blood analyzed 
with the HemoCue machine must be used within 24 hours and use EDT A as an 
anticoagulant. It is recommended that samples be mixed for at least ten minutes and be at 
room temperature before using. Accordingly, during the course of data collection for this 
study the exact time of blood draw was recorded as well as the centrifuge time in order to 
ensure that no spurious results were generated due to differences in processing time. 
The chemical basis on which the HemoCue operates is as follows: A small drop 
of blood is placed in a HemoCue cuvette and inserted into the machine. Inside the 
machine, sodium deoxycholate hemolyzes the erythrocytes and hemoglobin is released. 
Sodium nitrite then converts hemoglobin to methemogobin, which reacts with sodium 
azide to produce axide methemoglobin. Azide methemoglobin can be detected 
photometrically at 570nm and 880nm. The HemoCue has an optimal range of0.0-23.5 
g/dL and expected values from 11.0-16.0 g/dL. The HemoCue has its own control 
cuvette that should be used daily, and the acceptable deviance from the control cuvette 
value is± 0.3 g/dL. 
Data Management 
Data management for this project was multifaceted. The consent forms and 
questionnaire data were obtained prior to collection of biological samples. All forms 
were subjected to quality assurance checks, including coding for variables, followed by 
data entry. A double entry method was used as a measure of data entry quality control. 
All data was stored as Microsoft Access files. 
Statistical Analysis 
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SPSS 12.0 statistical analysis software will be used for exploratory analysis, 
followed by SAS 9.1 software for generation of logistic regression models. Hemoglobin 
levels and smoking status will be looked at as individual risk factors and then 
associations will be explored. Separate analysis will be conducted for cleft palate alone 
CP and cleft lip with or without cleft palate CL(P). Confounding factors that need to be 
controlled for include: mother's age, height and weight, parity, and alcohol usage. 
Summary 
In order to reduce the incidence of cleft lip and cleft palate birth defects there 
needs to be a greater understanding of the risk factors involved in the disease etiology. 
Based on animal models, there is strong evidence that hypoxia could be a major risk 
factor. Because smoking and anemia both reduce oxygen availability in the body, it 
needs to be determined what effect, if any, those risk factors have on cleft rates. While 
12 
there is already a large push for pregnant women to stop smoking, further evidence of 
adverse pregnancy outcomes may help to boost anti-tobacco efforts. A greater 
understanding of maternal nutrition and its importance in birth outcomes is also desirable. 
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CHAPTER2 
SMOKING, ANEMIA, AND ORAL CLEFTS: A REVIEW 
Abstract 
Oral clefts engender economic, health and social burdens for a substantial number 
of children and their families worldwide. Genetic and environmental risk factors are 
thought to play a role in cleft malformation, a process that is biologically complex and 
not completely understood. Maternal smoking is one of the most widely studied 
exposures associated with clefting and despite considerable amounts of data, there is not 
a consensus among researchers as to how much of a risk maternal smoking truly imposes. 
Animal models target carbonmonoxide-induced hypoxia as the mechanism by which 
cigarette smoke might alter fetal development of the palate. Maternal anemia is also a 
widely researched as a risk factor for poor birth outcomes, although not necessarily clefts. 
Since both conditions, smoking and anemia, have the capacity to exacerbate hypoxia in 
the developing fetus it is reasonable to consider that there may be an association between 
the two conditions and oral clefts. Current health recommendations are for anyone, but 
particularly women of childbearing age, to quite smoking. Several programs in this 
country and worldwide are designed to increase the overall nutritional health of women 
and children. Hopefully, progress in these endeavors will have an impact on the rate of 
clefting globally. Further research regarding smoking and nutrition and their relationship 
to palate formation will help resolve some of the many questions left unanswered by the 
current literature. 
Introduction 
Despite an increased understanding of disease etiology in recent years, cleft lip 
and cleft palate abnormalities continue to be a burden on society. The worldwide 
incidence of clefting is 1 out of every 500 to 700 live births, making it one of the most 
prevalent forms ofbirth defects not only in the US, but also across the globe (1, 2). 
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Based on both environmental and genetic factors, cleft palate rates differ across 
geographic regions and within ethnic groups (3 , 4). Reported rates range from a low of 
0.18 to 1.67 per 1,000 live births among blacks, to a high of 1.45 to 4.04 per 1,000 live 
births among Chinese populations (3) . In the US, it is estimated that there is a child born 
with a cleft lip or palate every two minutes (5). 
The physical and emotional burden of cleft palate birth defects is immeasurable. 
Children born with cleft lip and palate have increased difficulty in feeding, speaking and 
social development. One Vietnamese mother laments, "It is impossible for my baby to 
eat. She only drinks milk and porridge and vomits frequently (6)." In excess of physical 
restraints, social norms dictate that many of these children enter adulthood without 
having experienced many of the societal benefits that many of us take for granted 
including education, marriage and friendship. One father in Iraq, whose daughter had a 
severe cleft defect, was told not to let her come back to school because she frightened the 
other children. In some cultures, children with cleft lip and palate are even thought to be 
"cursed" (6). In places where access to medical technology is limited and funds for 
medical care are scarce, there is little hope that these birth defects can be corrected. 
While the cost of corrective surgery in these countries is comparatively low, as little as 
$750 per patient, many people still cannot afford medical treatment (6). 
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In the United States where more advanced medical options exist, the lifetime cost 
of treating a cleft can be monumental. Economic studies estimated that in 1992 cleft 
palate birth defects cost the US over 697 million dollars (7, 8), which is nearly 101,000 
US dollars for each child born with a cleft (5). Part of that estimate is related to direct 
medical costs, while a significant portion is loss due to decreased productivity, special 
education and other considerations (7). Congenital malformations, especially those 
clearly exposed like cleft lip and palate, are also not exempt from social stigma in the U.S 
and other developed countries. 
For several decades now, researchers have sought to understand the complex 
developmental processes that contribute to the formation of the human palate in hopes of 
finding a way to prohibit its malformation and consequently eliminate a measure of 
human suffering. There is in existence a large body of knowledge to draw from, and yet 
there is no shortage of questions for which to find answers. Data for the Utah Family and 
Child Health Study used to test the hypothesis set forth in this manuscript was generated 
thanks to funding from the NIH and collected by the Center for Epidemiological Studies 
at Utah State University, with Dr. Ronald Munger as the center director and principal 
investigator. 
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Background 
Morphology 
Palate formation in the human fetus begins around day 45 when mesenchymal 
cells migrate from the neural crest to the oral cavity (9). Rapid cell proliferation occurs 
and two shelves are formed at the surface of the maxillary processes (9). The palate 
shelves are composed of mesenchymal cells surrounded by a matrix of extracellular 
glycosaminoglycans and collagen and encompassed by two to three layers of epithelial 
cells (9, 10). Due in part to the relatively fast growth of the palate shelves in relation to 
the growth rate of the head space, as well as the hydration and electrostatic repulsion of 
the glycosaminoglycans, as the shelves form they move from a vertical position on either 
side of the tongue to a horizontal position above the tongue (9). Once the shelves come 
in contact above the tongue, surface epithelial cells from the opposing shelves adhere to 
each other via surface carbohydrates and proteins (9, 1 0). The epithelial cells then 
undergo an epithelial-mesenchymal transition and mesenchymal continuity is achieved 
across the seam (11 , 12). Figure 2-1 is a series of time-lapse pictures of in vitro mice 
palates that clearly illustrate the process of cell adhesion and fusion. 
The palate forming process is complicated at best and requires the timely 
participation of a number of hormones and other signaling molecules; utilizing a myriad 
of signaling pathways that are not yet completely undisclosed (11 ). Some of the 
hormones that are purportedly involved in the adhesion of opposing shelves and the 
conversion of midline epithelial cells into mesenchyme include epidermal growth factor 
(EGF) and transforming growth factor beta (TFG-b) (13-16). EGF regulates "cellular 
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Figure 2-1: Palate formation in mice. (t)tongue, (p)palatal shelf, (n)nasal septum, (me) 
midline epithelium, (ne)nasal epithelium, (oe) oral epithelium, (m)palatal mesenchyme, 
(ma)maxilla, (mb)mandible 
Source: (14) 
proliferation, extracellular matrix synthesis and cellular differentiation" (13). Increased 
EGF corresponds with the phosphorylation of extracellular receptor kinases 1 and 2 
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(ERK1/2) indicating a very common method of cell signaling (13). TFG-b3 is crucial to 
palate formation as shown by cell culture methods with mice, and may work by 
activating matrix metaloproteinases that play a role in altering the extracellular matrix 
(16-18). TGF-b also inhibits nuclear DNA synthesis and promulgates the synthesis of 
gelatinase enzymes, which are key to palate formation (13, 17). Some researchers have 
demonstrated that the phosphorylation of SMAD proteins via TGF -b is responsible for 
the inhibition of DNA synthesis in epithelial cells during palate fusion (14). 
Improper hormone balance can likewise inhibit proper palate fusion. A few 
retinoic acid derivatives including trans-retinoic acid and 13-cis-retinoic acid, have been 
shown to reverse the process of normal palate fusion ( 19). They block the programmed 
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cell death of midline epithelials and can, in some combination with EGF, persuade some 
epithelial cells to even acquire nasal cell characteristics ( 19). These results have been 
confirmed in both animal and human organ culture models (20). The compound effects 
of these and other regulatory molecules are clearly very complex, and as of yet have not 
been extremely well charted. Fortunately, there is a great deal of active research in this 
area and more complete information will likely aide in uncovering exactly how these 
compounds work conjointly to influence embryonic development. 
Ferguson et al. (9) categorizes the mechanisms that may be responsible for 
incorrect palate formation into five basic groups: 1) inhibition of cell division or 
migration 2) failure of palate shelf to elevate at the correct time 3) excessive head width 
4) failure of shelf fusion and 5) post fusion rupture. Gene expression, hormone levels 
and environmental factors, such as toxins, can affect one or more of these processes 
causing the formation of a cleft (9, 21 ). 
Types of clefts 
The most common form of orofacial clefts is cleft lip with or without cleft palate 
CL(P), or more specifically, a cleft in the lip with or without a cleft in the primary or hard 
palate. CL(P) is further classified by the site of the lip cleft: left, right, or midline 
unilateral lip clefts are possible, as well as bilateral clefts. A graphic graciously provided 
by the Cleft Lip and Palate Association illustrates these different cleft types. See figure 
2-2. 
,...._-up 
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--..:-..:- Soft palate 
=l--- Uvula 
C e: Palnte 
Figure 2-2. Types and positions of oral clefts. 
Source: (22) 
Right Unilateral 
Cleft Up & Palate 
Bilateral 
Cleft Lip & Palate 
The morphology and pathology of clefts other than CL(P) are less well 
understood. Median, oblique, versal, nasoocular and oroocular clefts, while less 
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frequent, are also known to occur and several syndromes can be associated with clefting, 
including those associated with chromosomal syndromes, teratogens and other 
uncategorized syndromes, the most well studied of which is probably the VanderWoude 
syndrome (23, 24). In studying cleft deformities, a distinction needs to be made between 
the different types in order to account for their different etiologies. The difference 
between CL(P) and cleft of the soft palate alone, CP, needs particular consideration (24). 
Epidemiological data would suggest a different mechanism for clefts of the soft, or 
secondary palate alone and accordingly, statistical analysis are typically performed 
looking at CL(P) and CP separately (25-27). 
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Cleft Rates 
Descriptive analyses of clefting among the world's populations are not in short 
supply. In fact, they are so numerous as to become almost daunting. One journal 
reviewer made the comment, "I must confess that when this manuscript came to my 
attention for review and comment, my first reaction was, 'Oh no! Not another 
epidemiological study of clefts!"' (28). Indeed, defining even the vary most basic 
epidemiological parameters for cleft lip and cleft palate has proven to be easier said than 
done. Consequently, many studies have been published throughout the literature and 
reported incidence and prevalence rates for similar populations vary considerably. 
Tremendous effort has been put forth by researchers in order to compile and make sense 
of these data, and several others have recently published reviews of clefting rates, 
including Tolarova, Vanderas and the WHO (3 , 29). In fact, it has been estimated that a 
review article on cleft rates appears about every five years (30). For example, the 
comprehensive book Cleft Lip and Palate edited by Diego Wysyzyski, contains 12 pages 
of charts that summarize cleft rates around the world (31)! Two are presented herein: one 
to illustrate the considerable length of time that cleft research has been going on, and the 
other to provide a visual representation of how drastically cleft rates vary across the 
globe. The first summary, presented as Figure 2-3, is a portion of a table from Tolarova 
et al . (29) and catalogs over 70 studies starting from 1864. Figure 2-4 (page 28) is a 
series of maps found in the WHO's 2002 publication on craniofacial anamolies and 
presents average clefting rates for several nations where data is available. According to 
the WHO, rates per 10,000 range from 1.35 to 25.31, although it seems that after only 4 
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years there is a considerable amount of new data that needs to be added to the maps (32-
35). 
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Figure 2-3: Reported clefting rates staring in 1864. 
Source: (29) 
While rate discrepancies may be due to real differences between populations, they 
are also due, at least in part, to differences in study design. Some of these descriptive 
studies rely solely on birth certificate data to ascertain cleft cases (30). This may lead to 
certain types of bias based on incomplete data medical geneticist or similar form of 
verification. Some studies include fetal deaths and abortions in calculating incidence 
rates, although this does not seem to be the standard (3, 30). Earlier studies fail to 
recognize the difference between varied types of clefts or the now known genetic 
disorders that exhibit cleft phenotypes (30). That being said, it is easy to understand why 
there is difficulty comparing separate studies, and the subsequently urgent need to update 
and standardize methodologies. Dr. Oka of the Plastic and Reconstructive Surgery 
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Department at Penn State reports that only 4 things have remained consistent with each 
review of the epidemiology of clefts: 1) a distinct racial gradient exists 
(asians>whites>blacks) 2) difference in the incidence of congenital defects by sex 3) a 
higher incidence of isolated cleft lip or cleft lip and palate occurs on the left side and, 4) 
clefts are often associated with other congenital anomalies and are frequently a part of a 
distinct syndrome (30). One thing that Tolarova notes rather or misclassification (30). 
Other studies have more active methods of discovery and diagnosis, including 
certification of all cases by a unfortunately, is that despite the vast amount of data that 
has been collected and analyzed, as well as the many important advances in medical care 
and changes in public health policy in recent decades, cleft rates "remain largely 
unchanged since 1942" (29). 
Genetics 
Clefting shows strong patterns of familial inheritance and fairly consistent rates 
within races, early indicators of a genetic component of this disease (36, 37). For 
instance, in a study conducted in the United States comparing the risk for clefts in 
offspring of mixed racial couples, it was found that even with controlling for fathers race, 
white women were more at risk for having a child with a cleft than their black 
counterparts (OR=2.33, p=O.OOOI) (4). Some environmental exposures have also been 
shown to be modified dependent on certain genoptypes, such as in the case of maternal 
smoking and transforming growth factor alpha (TGFa) where the rare C2 geneotype and 
light smoking (less than 10 cigarettes per day) together raised the risk of having a child 
with cleft palate (CP) over six fold, (OR=6.16) and the same allele with heavy smoking 
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(greater than 10 cigarettes per day) raised the risk of CP by over eight fold (OR=8.69) 
(38). With the advent and development of molecular biological technologies, the amount 
of genetic available in conjunction to cleft lip and cleft palate research has burgeoned as 
oflate and these studies are barely the tip of the iceberg. Certainly the wealth of 
accumulated data in that area is well beyond the scope of review for this study. However, 
there are a few crucial aspects of cleft genetics worth mentioning here. 
Like many other aspects of cleft research, animal models have proven an 
invaluable tool for genetic explorations. Martyn Cobourne, a researcher with Division of 
Orthodontics and Craniofacial Development at the Dental Institute in London, 
summarizes the contributions that animal models have made in identifying the roles of 
certain genes in cleft formation in his 2004 publication. These include several 
transcription factors, signaling pep tides, vasoactive peptides and the like. Many of the 
knock-out studies performed using mice models have helped to solidify the idea that one 
or a few genes of interest may lead to cleft phenotypes (24). 
As a preliminary step in identifying genes of interest related to cleft formation in 
humans, several gene-scanning projects have been performed using samples from a 
number of different populations. These scans have located some thirty genes that seem to 
warrant further investigation (5, 24, 39) (Table 2-1). Genes for extracellular matrix 
proteins, transcription factors and cell signaling molecules have been linked to cleft 
palate phenotypes ( 40). While some genes are identified based on parametric parameters, 
such as LOD scores greater than 1, others have been singled out based on biological 
plausibility (38, 40-42). TGFa has been the focus of a good deal of genetic research in 
various populations, so much so that there is even a meta-analyses of gene-environment 
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interaction studies TGF and smoking in relation to clefting (18, 38, 43, 44). Because of 
the interest in maternal folic acid metabolism and the risk of birth defects, most 
especially neural tube defects, genes involved with folate transport and function have also 
been extensively investigated candidate genes. Included in these studies are genes for 
methylenetetrahydrafolate reductase (MTHFR) (15, 45), reduced folate carrier gene 
(RFCl) (46), methionine synthase reductase (MTRR), cystathionine 3-synthase (CBS), and 
methionine synthase (MS) (47). Members ofthe folate receptor family, FOLRl and 
FOLR2, have also been studied and appear to have no association with clefting ( 48). As 
pointed out by Marazita and others, these studies show that susceptible loci differ from 
population to population, making it difficult to come to any concrete conclusions about 
the role of any particular loci or genes ( 49). Particularly, it seems that there is a 
difference between Asian populations and the more widely studied Caucasian populations 
(50). 
Table 2-1 : Genes regulating the development of the head, in particular of the lip and 
palate 
Gene Type' Featureb Mouse< Human~ Key references 
TGFA OF UP LD 23,24 
END I SF M KO Linkage 88 
RARA SF P/M TG/EXP LD.Iinkage 27 
TGFB OF UP KO, EXP LD 26,28 
SKI OF UPIM KO, EXP 89 
MSXI HD UP KO,EXP LD,Iinkage 26 
DLX 1/2 HD P/M EXP 90 
PITX2 HD P/M KO,EXP Rieger 91 
PAX9 HD P/M KO,EXP 92 
AP2 TF LIP/M KO,EXP Linkage 42 
ITF2 TF p KO Thyroid dysgenesis 93,94 
'GF, growth factor; HD, homeodomain; SF, signaling factor; TF, transcription factor. 
bL, lip; P, palate; M, maxilla and/or mandible. · 
<KO, knockout; TG, transgene; EXP, expression. 
dLD, linkage disequilibrium. 
Source: (39) 
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Despite a lack of consistent results, one overall result of these studies has been to 
help narrow down on the most probable model of inheritance for cleft lip and palate. At 
one point, the genetic model of preference was the multifactorial threshold model that 
supported the idea that there were several genes, each of miniscule importance 
individually, that that when taken together resulted in palate malformation (49). 
Increasingly however, it seems more likely that a single loci model, or major loci with as 
few as four susceptible sites is more likely the case ( 49, 51). In reviewing three separate 
scanning projects with populations in China, England, and Denmark, Marazita et al. (50) 
concluded that: 1) there is insufficient evidence to support the previously popular 
multifactorial threshold model, 2) based on data currently available, a single autosomal 
recessive gene is most likely the major gene responsible for cleft phenotypes, and 3) 
there may not be genetic homogeneity for CLP as English, Chinese and Danish 
populations do not support the same probable inheritance model (50). The most 
promising candidate genes under consideration include: TGF-a, RARA, BCL3, 6p23, 
MSXI , MTHFR and TGF-b3 (24, 43). "Is there a major gene determination of liability 
to cleft lip with or without cleft palate?" asks Marazita et al, " we would answer an 
unqualified 'Probably (50)."' Obviously there will be more work done in this area. 
Environmental Risk Factors 
Several different study designs have been used to show that environmental factors 
can interact with genetic factors to induce clefting and may even be the predominant risk 
type associated with clefting. Maternal exposure to toxins like cigarette smoke and 
pesticides, as well as diet deficiencies have profound effects on pregnancy outcomes. For 
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example, migrant studies report that Philippinos and Japanese who have immigrated to 
the United States, either to California or Hawaii, have cleft rates similar to other people 
in those areas and not their home countries, a clear indication of environmental impact on 
cleft rates (39, 52-54). Hospitals in Manila have different rates of clefting dependant on 
the socioeconomic status of the patient population. Animal models have shown that cleft 
palate formation can be induced in several species by altering various external factors 
(55-59). Folate antagonists, corticosteroids, and anticonvulsive drugs are among the 
known teratogens that cause oral clefts in animals (60-62). Some plant based poisons are 
also suspect (59). Several nutritional deficiencies or toxicities have likewise been shown 
to induce clefts in animal models, including vitamin A, riboflavin, folic acid, vitamins 
B-12 and B-6 and zinc (63-65). 
Maternal Nutrition 
Maternal nutrition has been a focal point of birth defect studies since the early 
1940's and the first animal models that showed that vitamin deficiencies could induce 
clefting were reported as early as 1914 (66). JosefWarkany was instrumental in 
pioneering these animal models, and his studies confirmed that riboflavin and other B 
vitamin deficiencies are teratogenic in rats (66). Since then, work done by various 
research groups has also established that vitamin B-6, zinc, and folate deficiencies, as 
well as vitamin A toxicity, cause clefting in a variety of animals including rats, mice, 
chickens, rabbits, dogs, sheep, pigs and primates. An concise overview of animal models 
related to nutrition and clefts is available in the chapter authored by Ronald Munger in 
the text edited by Diego Wyszynski (66). 
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Hwnan studies in nutrition have largely been limited to observational methods, as 
clinical trials have proven economically and ethically cwnbersome. The early attempts at 
vitamin supplementation trials for clefting have been subject to a nwnber of 
methodological follies and the results are therefore un-interpretable (29, 67). There is 
however an impressive amount of data available in the form of case- control and cohort 
studies that show reduction in fetal abnormalities including cleft lip and palate with 
maternal vitamin supplementation ( 68-71 ). A nwn ber of specific nutrients have been 
singled out for their biological roles in fetal development, however interactions between 
different nutrients have also become increasingly important. 
Folic acid 
Folic acid is a nutrient found in abundance in many leafy green vegetables, grains, 
legumes and liver (72). Folic acid is used biologically in different forms of 
tetrahydrofolate, which facilitates the metabolism of 1- carbon units in various metabolic 
pathways, most particularly to facilitate methylation of DNA and signaling proteins (70). 
Additionally, folate is used to methylate homocysteine in order to form the amino acid 
methionine. Folate levels therefore are directly related to homocysteine concentrations in 
the body and excess homocystiene has been associated with increased risk for cleft lip 
and palate. Hyperhomocystemia may cause apoptosis in cells and disrupt the normal 
course of palatogenesis (73). 
The history of folic acid and birth defect studies started with the publication of 
the 194 7 edition of the Proceedings of the Society for Experimental Biology and 
Medicine, in which Nelson reported that the folate antagonist succinylsulfathiazole was 
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teratogenic to developing fetal rats (66). Shortly afterwards she also published the results 
of other rat models regarding folate deficient diets in relation to congenital abnormalities. 
Studies with dogs, chickens and mice confirmed this relationship (66). 
Folic acid has been the most extensively considered nutrient in birth defects 
studies due mainly to its relation to neural tube defects. In 1997 the United States started 
supplementing processed cereal grains with folic acid because there was convincing 
evidence that pregnant woman who are folate deficient are at increased risk for having 
children with neural tube defects. In fact, prenatal supplementation with 400 ug of folic 
acid per day can significantly reduce neural tube defects (74). Because neural crest cells 
give rise to most craniofacial structures during fetal development, it has been 
hypothesized that folic acid may also be a factor dictating the incidence of orofacial 
clefts. Animal models have also confirm this relationship and show that folate 
supplementation in mice can reduce the risk of clefting from 40% to 10% (75). There 
are some observational studies that have detected an association with maternal folate 
levels. As recently as 2004 researchers in the Netherlands found that women who 
reported using even low levels of folate have a decreased risk ofhaving children with 
clefts- as much as a 4 7% less chance (76) . For one California population, a case control 
study showed that taking multivitamins periconceptually did in fact produce a protective 
defense against clefts (OR=0.5-0.7) (71). ltikala et al. (68) found a protective effect of 
folic acid supplementation for CLP (OR= 0.52, 95% CI=0.34 -0.80) corresponding to 
48% reduction in risk ( 68), and Loffredo (77) likewise found a significant rate of folate 
supplementation for CP cases and controls (RR=0.60) (77). 
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Vitamin B-6 
Otherwise known as pyridoxal phosphate, or PLP, vitamin B-6 is linked to many 
of the same biological processes as folate. Also a contributor of carbon units during 
metabolism, PLP is needed for transamination reactions, decarboxylation reactions, 
steroid hormone action and as a coenzyme for other reactions (5, 78). Like folate, a lack 
ofB-6 can cause a build up of homocysteine in the tissue. Vitamin B-6 is found in whole 
grains, and meat products as well as fruits and vegetables and soybeans (72). 
The protective effects of B-6 have been confirmed using a number of different 
study designs. Animal models have shown that B-6 supplementation can protect against 
corticosteroid, valproic acid, B-amino-proprionitrile, and vitamin A induced clefts (65). 
In a recently published article, vitamin B-6 was linked to folate levels and risk of cleft lip 
in humans as well. Munger et al. (79) found that case mothers in the Philippines who 
were both B-6 deficient and had low blood folate levels had a significantly increased risk 
of having children with cleft palate. Trend data was also significant over quartiles of 
consumption for B-6 (p=0.003) in a population in Europe (80). 
Riboflavin Vitamin B-2 
Riboflavin is also one of the B vitamins. In the body it contributes the flavin 
portion of flavin adenine dinucleotide, F ADH, which is a reducing agent imperative to 
central metabolism (78). By accepting electrons from metabolites in the citric acid cycle, 
it facilitates the catabolism of sugars and provides reducing equivalents for the 
production of A TP (78). Like other B vitamins, it is found naturally in meat and dairy 
products and in the US it is also found in fortified cereal products (72). 
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Aside from the initial studies done by Warkany and others in the early 40's, work 
done with riboflavin and orofacial clefts has been limited. A 2004 study looking at B 
vitamins and clefts did report a difference in dietary intake of B-12 between cases and 
controls, but that did not hold true for riboflavin (81 ). Interestingly enough, the rat study 
done by Warkany was very specific in showing that pregnant rats on a deficient diet that 
were supplemented with only riboflavin before day 13 of gestation gave birth to normal 
babies (82). This is certainly supportive evidence that more work should be done with 
this particular nutrient. 
Vitamin B-12 
Vitamin B-12 is involved largely for DNA synthesis (70, 78). B-12 is mostly 
available from animal sources, including dairy products (72). B-12 deficiencies are most 
often associated with impairment of neural function (70). Supplementing with folate can 
often mask a B-12 deficiency, so it is important to ascertain the status of both in the event 
of clinical or observational studies (83). One study did find a significant difference in B-
12 between smokers and nonsmokers (84), however that Wong et al. (85) did not find a 
significant difference in B-12 between cases and controls. 
Vitamin A 
As one of the fat-soluble vitamins, vitamin A has the capacity to be stored in the 
body more readily than the water soluble vitamins and consequently it exhibits 
teratogenic effects with both dietary insufficiencies and toxicities. Retinoid compounds 
like beta carotene are the dietary precursors for vitamin A and are found abundantly in 
colorful vegetables: carrots, broccoli, liver, and leafy greens. Vitamin A plays a role in 
both cell differentiation and maintenance of epithelial tissue- both important factors in 
palatogenesis. Endocrinology studies confirm that retinoic acid alters the efficacy of 
other signaling molecules like EGF during palate formation. Animal studies show that 
supplementing with folic acid can prevent clefts caused by retinoic acid toxicity (63). 
Zinc 
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Zinc is a metal ion found almost exclusively in red meat products (72). In the 
nucleus of living cells, intercellular receptors that regulate DNA translation attach to both 
DNA and steroid hormones by means of a "zinc finger" (78). Thus, zinc can directly 
affect the binding capacity ofhormones and regulation of DNA expression. This is 
critical in rapidly developing cells such as fetal cells. Another venue that zinc levels may 
influence the development of the palate is in conjunction with matrix metaloproteinases 
(17). This family of enzymes includes nine proteins each with a highly conserved zinc-
binding site (86). These enzymes are responsible for the degradation and alteration of 
many proteins in the extracellular matrix including collagen, elastin, and fibrin during 
many developmental phases, in many parts of the body (86). Some studies have shown 
that production of different matrix metaloproteinases can be induced by hormones like 
TGF, EGF and others, many of which are also hormones known to play a part in 
palatogenesis. Certain genetic polymorphisms of those hormones have also been 
associated with clefting ( 18). A study by Laurence Blavier links metaloproteinases, 
induced by TGF-b3 expression, with palate formation by showing that metaloproteinases 
were expressed both in midline epithelial and adjacent mesenchymal cells during regular 
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fusion and that inhibition of the MMP resulted in the failure of opposing shelf palates to 
fuse (17). 
New methods of handling blood samples in order to preserve the integrity of the 
micronutrient profile are very important. This includes holding blood samples on dry ice 
immediately after collection until analysis can be completed, which proves difficult in the 
field where sampling conditions are not always optimal (87). Utilizing these techniques, 
and recent case-control study conducted in the Philippines showed that higher plasma 
zinc was indeed associated with reduced risk of oral clefts (88). 
Food Frequency Questionnaires (FFQ) and dietary recall 
There are many tools used by researchers to determine nutritional status in human 
populations. Clinical lab data is often considered the gold standard for such information, 
and there is certainly no scarcity of available assays for generating such data (89). Many 
would argue that relying heavily on lab data is both expensive and nai"ve (90). Biological 
samples, while not subject to recall biases, are not exempt from other types of downfalls. 
Blood samples alone for instance do not shed light on the differences between nutrients 
consumed and nutrients absorbed and blood samples are rarely if ever collected during 
the critical time period- typically blood samples are not even collected until many years 
after the birth of an affected child. Often times, cheaper, less appropriate lab data is used 
as an indicator of disease rather than a more expensive but more accurate disease marker 
such as is the case of always using hemoglobin values to assess anemia instead of serum 
ferritin or cobalamin levels (83). Lab work is also subject to human error. Some 
alternative methods of determining nutrient status and food consumption patterns are 
cheaper and have been shown to render precise, validated results (89). These methods 
include 24 hour recall, food record, diet history and FFQ's. 
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It is not unusual for epidemiological studies to rely on FFQ's to assess a mother's 
diet before or during a pregnancy (91). FFQ's have several distinct advantages over 
other assessment methods for these types of studies. First, they are relatively inexpensive 
to perform. Usually FFQ's can be filled out without the help of trained dieticians or 
nurses. This is a useful feature for any assessment method when considering the large 
numbers of participants in most studies, as more complex methods may be cumbersome 
financially, as well as logistically inconvenient. Two, FFQ' s are versatile. Many 
previously developed FFQ's from studies like the Nurses' Health Study can be modified 
to fit a certain population. Third, food frequency questionaries can be developed to focus 
on relevant time periods (91) and still report dietary patterns with acceptable accuracy. 
This is an essential element ofFFQ' s in that it can match more closely the proper 
exposure time for nutrition related diseases (92). In the Utah Child and Family Health 
Study for instance, the mother is provided with a pregnancy calendar that references her 
to the index pregnancy in order to help increase the accuracy of her dietary recall. FFQ's 
show correlation rates with actually dietary intake (as determined by other dietary 
assessment methods) of up to 0. 70 (89), a correlation that parallels other measures of 
biological functions including blood pressure, physical activity and skinfold tests (93). 
Oxygen Transport 
The concept for this particular study was initially conceived after reviewing some 
intriguing animal models that clearly show that the offspring of genetically susceptible 
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mice will be born with clefts palates if there is a lack of available oxygen during the 
critical embryonic period. Environmental factors that decrease the availability of oxygen 
or impede its transport then become suspect as risk factors for cleft palate formation. In 
human studies this translates into two major factors that effect blood oxygen levels and 
distribution efficiency -smoking and anemia. While both of these conditions have been 
studied extensively as risk factors for undesirable birth outcomes, the combination of the 
two, and their relationship with palate formation, is left largely undefined. Therefore, the 
goal of this study is to determine what relationship exists, if any, between oxygen 
depletion via smoking and nutritional anemia, and cleft palate formation. 
Oxygen is transported through the body by means of hemoglobin proteins (94-
96). Hemeoglobin is a tetrameric protein composed of two alpha and two beta subgroups 
(96). Each subgroup is associated with one heme group, and each heme group has the 
capacity to bond with one molecule of oxygen, for a total of four oxygen molecules per 
hemoglobin protein (78). Hemoglobin is particularly well designed to deliver oxygen to 
the tissues for several reasons. First, hemoglobin is an allosteric protein that exhibits a 
sigmoidal bonding curve (96). When one oxygen molecule attaches to a heme group the 
protein undergoes a conformational change that makes it successively easier for the other 
heme groups on that protein to bind with oxygen molecules. This type of cooperative 
binding makes hemoglobin very sensitive to differences in the concentration of oxygen 
available in the lungs and in the tissues. Secondly, in the tissues where the pH is lower 
than in the lungs, hemoglobin has a much lower affinity for oxygen and will readily 
release the oxygen into the tissue (96). In order to facilitate the removal of waste from 
the tissues, hemoglobin will also bind to carbon dioxide at physiological pH a."ld release it 
in the higher pH of the lungs conversely to the binding and releasing of oxygen in 
peripheral tissues. In patients that smoke it is estimated that nearly 10% of their blood 
hemoglobin is saturated with carbon dioxide- significantly more than that of non-
smokers, the effects of which will be discussed more fully in a later section. 
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It is interesting to note that hemoglobin is again well suited to transport oxygen in 
fetal tissue. Hemoglobin in fetal tissue is composed of two alpha and two gamma 
subunits. This increases its affinity for oxygen above that of the hemoglobin in the 
mother's blood and thus allows the fetus to extract oxygen from the mother. Blood 
oxygen levels in fetal tissue are proportionly related to the blood oxygen of the mother, 
and smoking likewise effects oxygen transport and availability in fetal tissue (97). In 
fact, fetal tissue in pregnant women who smoke exhibits as much as 1.8 times more 
carboxy hemoglobin than in those that don't smoke (98). 
Hypoxia 
In studies of mice, it has been fairly straightforward to produce evidence linking 
blood oxygen availability and cleft palate formation (57). Oxygen is essential in virtually 
all metabolic processes and hypoxia has been shown to be a powerful, nonspecific 
teratogen (57, 96). Induced hypoxia in mice studies have conclusively shown that 
reduced levels of blood oxygen can increase the risk and severity of cleft palate (56, 57). 
A study done by Millicovsky and published in the Proceeding of the National Academy 
of Science, goes even further to show a dose response relationship between hypoxia and 
incidence of cleft lip in mice (55). A 1972 study in Denmark showed that as little as 8% 
carboxyhemoglobin in rabbits adversely affected fetal development and which correlated 
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well with their concurrent findings of decreased birth weight of children born to mother's 
who smoked (99). While not directly related to clefting, a study in Colorado lends 
support to hypoxia as a risk factor for adverse decreased birth weight (100). 
While there is not a complete understanding of how oxygen, or a lack thereof 
affects palate formation, one specific mechanism of interest is the inhibition of the 
enzyme lysyl oxidase (LO). Lysal oxidase is an enzyme that has been isolated from a 
number of different animal and human tissues. While some of the important enzymatic 
functions of LO have been uncovered, there is still a great deal of information about the 
enzyme that is unknown. The basic role of LO is the oxidation of lysine residues during 
the formation of cross-links between collagen and elastin fibrils in extra cellular matrix 
proteins (101). New evidence suggests that LO may also act intracellularly to oxidize 
other enzymes, including certain growth factors (TGF-b), a hormone previously 
identified as having a role in palatogenesis (101). Because the catalytic activity of the 
enzyme is dependant on the availability of molecular oxygen, it is reasonable to assume 
that a lack of oxygen would impair the LO efficiency. 
Smoking 
The correlation between smoking and disease has been a widely studied 
controversy in the public health arena for decades. Smoking has been associated with a 
myriad ofhealth concerns such as coronary heart failure, cancer, emphysema, stroke, etc. 
( 1 02). The World Health Organization lists smoking as one of the major risks to public 
health (1 02). The May 2002 World Health Organization Factsheet on smoking sites a 
number of starteling statistics that help illuminate the extent of tobacco damage: 
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More than 4,000 toxic or carcinogenic chemicals have been found in tobacco 
smoke. 
Smoking related-diseases kill one in 10 adults globally, or cause four million 
deaths. 
Smoking is the single largest preventable cause of disease and premature 
death. It is a prime factor in heart disease, stroke, and chronic lung disease. It 
can cause cancer of the lungs, larynx, esophagus, mouth and bladder and 
contributes to cancer of the cervix, pancreas and kidneys. 
Cigarettes cause more than one in five American deaths 
A full one third of smokers in the United States and other developed countries are women 
(1 03). Social and psychological factors contribute to women's smoking status and their 
success rates with cessation (1 03). Smoking can significantly alter economic status of 
women, as smoking is expensive and often cigarette purchasing is a priority over 
adequate nutrition (1 03). Politics, of course, always plays a significant role in health 
and economic matters, and as quickly as lawmakers pass new regulations, tobacco 
companies have managed to avert many of those political boundaries. 
Besides the normal health concerns, cigarette smoke is of particular concern for 
pregnant women because it has also been associated with birth defects like coronary heart 
disease, spontaneous abortions, and low birth weight, as well as post-birth complications 
like Sudden Infant Death Syndrome ( 42, 1 04). This is not surprising considering the 
chemical make-up of cigarette smoke, which includes physiologically detrimental levels 
of nicotine, tar and carbon monoxide and a host of other toxic chemicals, the most toxic 
of which are most likely the combustib1e toxins ( 1 04 ). This may account for a higher 
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incidence of certain diseases including cleft lip and palate, especially in countries where 
tobacco use is wide spread and on the increase. Carbon monoxide intoxications in 
pregnant women have been shown to cause deformities in children as well as increase 
still births (1 04). 
Epidemiological Studies of Smoking and Clefts 
Nearly forty years ago, Senator Walter Mondale expressed the following concern 
regarding the state of research in the field of education, " . .. For every study, statistical or 
theoretical, that contains a proposed solution or recommendation, there is always another 
equally well-documented study, challenging the assumptions or conclusions of the first. 
No one seems to agree with anyone else's approach. But more distressing: no one seems 
to know what works" ( 1 05). Such is the case in many fields of research and Senator 
Mondale may as well have been referring to the many studies regarding clefts and 
smoking. An ever-increasing body of research has implicated cigarette smoke as a risk 
factor for spontaneous abortions and certain birth complications, including orofacial 
clefts (I 06). However, the epidemiological data are not entirely conclusive: a significant 
number of the studies show that maternal smoking can influence cleft palate rates (1 07) 
(27, 1 08-119), and a number found no association at all (38, 108, 118). Table 2-2 is a 
summary of those studies. 
Table 2-2: Review of studies on smoking and clefts 
Author Year Place Data Case Control Control 
T_ype 
Kullander 1971 Malmo Total NA NA (106) Malformations 
~rew Prospective 1972 UK- Cardiff birth survey 30 18,63 1 (26) Cardiff Prospective 
Sax en 1974 Finland Finnish Registry of 599 Matched (110) Congenital (time/place 
Malformations birth) 
Kelsey 1978 Conneticut Hospitals/Private 1370 2968 Birth date (Ill) Clinics malformed ±._!year 
Ericson 1979 Sweden National Board of 66 130 Matched (I 12) Health Records (place/time 
birth, 
Maternal 
age, parity) 
Christianso 1980 San Child Health and 2~ 14.735 Cohort 
n (120) Francisco Devel~ment Study 
jHemminki 1983 Finland Finnish Registry of 3300 total NR Previous 
114) Congenital malformati birth in 
Malformations ons district 
Shiono 1986 Maryland Kaiser Permanente KP- KP Prospectiv 
(108) &Collaborative 32CLP 33,536 e 
Perinatal Project 24 CP CPP 
53512 
Khoury 1987 USA Maryland Birth CLP(28) 198 Controls 
(116) Detects Reporting CP(26) are other 
&Info Systems malformed 
births 
L--. 
Cleft Categories Point Estimate 95%CI 
Any malformation X2-17 p=0.7- NA 
0.5 
Cleft palate X2 5.36 
and/or hair lip p=0.05-00I NA 
CP All clefts VS NA 
CL(P) controls 
Clefts mult. P<0.05 
X2 
(N=40) Cleft 1-20-1 0 NA 
palate and cleft lip 20+=17 
CLP ( desc Chart X2-13.1 p<O.OI NA 
includes CP, CL, 
and CLP) X2 is 
all together 
Anomalies of ear, X2-NS 
face and neck 
Oral clefts I )1.28 (124) Smoking: 
2) 1.28 ( 1.25) lSporadica 
3)1.25 (1.48) lly 
adjusted (crude) 2Regularly 
3>5 
cig/day 
CP 0.7 0.3-1.8 
CLP 1.1 0.5-2.4 
NS 
CLP 2.56 1.13-5 .78 
CP 2.39 1.04-5.45 
Other (cont) 
Confounding 
I year 
survival 
Trends 
considered 
Not stated 
Non-smoking 
<10 cig/day 
10-19 
20+ 
(13)Age, 
parity ,alcohol 
coffee,abortio 
n rooms in 
house occup 
pregnancy 
conditions, 
medical 
treatments etc 
Smoking 
0,10,20,30 
trend is 
considered=fi 
ndings not 
corroborated 
inCPP 
Smoking 
groups 
0,1-10,11-
20,21+ Odds 
ratios 
Notes 
No association 
between smoking and 
malformations 
Study notes sig. 
Anemia•smoking 
interaction 
Anemia 
4.4(%) 
control 
5.7(%) 
cases NS 
Smoking assessed 
during Third month 
ofpr~ancy 
Non-smoking 
includes a few cig a 
week 
Bad des ign 
First tri exposures 
CPP used to 
corroborate KP 
findings 
+:>. 
0\ 
Koury 1989 USA Atlanta Birth CLP (238) 2809 Matched All cases CP (I Hi) Defects CP(I07) race, birth All cases CLP 
area, Isolated CP 
hospital Isolated CLP 
MultipleCP 
Multiple CLP 
Malloy 1989 Missouri Missouri Center for 451 288,067 Matched CLP (I 17) Health Statistics time/place 
birth, 
child ' s sex, 
race 
VanDenEe 1990 Washingto Washington State 173 total 4500 Random CLP(N-105) den(121) n Birth Records clefts CLP mult(N=22) 
CP (N=37) 
CP mult (N=I5 
All Cleft 
Werler 1990 Boston Sloan Epi Birth CP 2710 Other CP(N-136) (118) (Multiple Defects Study 215 malformed CP mult(N=79) 
Centers) CLP births CLP(N=292) 
400 CLP mult(N=I 08) 
McDonald 1992 Montreal Survey 96 89317 Cleft of Lip or (122) Palate 
Zhang 1992 Shanghai, Random, 29 CLP(48) 419 Birth CLP (123) China hospitals in CP(lO) before or CP 
Shanghai after case 
Hwang 1995 Maryland Maryland Birth 69 (CP) 284 Malformed CLP (38} Defects Reporting 114 (CLP) controls CP 
and Information matched 
System time& 
place of 
birth, 
maternal 
age 
Shaw 1996 California California Birth 731 734 CLP (N 348) (107) Defects Monitoring CP(N=l41) 
System CLP mult(N=99) 
CP mult(N=74) 
1.39 (1.50) (0 .97-2 32) 
1.48( 1.4 7) (1.09-1.97) 
1.87(1.96) (1.10-3 .50) 
1.59(1.55) (1.10-2.18) 
0.88(1.01) (0.45-2.26) 
1.17( 1.30) (0.69-2.44) 
(aclj_ust~ (adjustel!2_ 
0.84 0.68-1 .05 
1.5 1.0-2.3 
1.1 0.4-2.9 
1.2 0.6-2.5 
1.9 0.6-5 .6 
1.4 1.0-2.0 
Non significant Never 
across all smoked, 
smoking exsmoker, 
categories 1-14, 15-
24,25+ 
Non smoking, All odds 
1-9, 10-19, 20+ ratios non-
sig for 
each 
smoking 
_gi"Ol!I'_ 
0.79 0.49-1.29 
0.75 0.42-1.33 
CLP(l-19cig) Smoking 
1.2-2.3 groups:O,I 
CLP(20+cig) 
-19, 20+ 
1.3-3.6 Paternal 
CP (20+cig) smoke-sig 
1.1-4.5 forCp and 
CLPat 
reported (see 
article) 
Smoking:< 14, 
15-24,25+ 
Trend not sig 
across any 
groups 
Parity, marital 
status, edu, 
age 
Maternal age 
Parity 
Age, Edu, 
race, alcohol, 
vitA suppl 
Maternal age, 
education, 
ethn ic 
No 
adjustments 
made 
Cig/day 
<10,>10 
significant 
association 
with smoking 
and Taql 
(TFGa) 
polymorphis 
m 
Age, race, 
edu, 
gravidity, 
alcohol, 
diabetes, 
folate 
TFGa 
Population based 
First reference to 
Pierre Robin no 
syndromic cases 
Large # cases 
First three months 
pregnancy 
Dose 
Paternal Smoke 
exposure (based on 
mother's reports) 
TFGA, family history 
Good review of what 
is wrong with the 
other studies 
HYPOXIA 
~ 
-...) 
Beaty 1997 Maryland Maryland Health 121 86 Random Bilateral CUP (124) Dept Birth Defects Hospital (15) 
Registry Based Unilateral CL 
(22) 
Unilateral CLP 
(38) 
CP(46) 
All 
All 
Wyszynski 1997 NA See references NA NA Meta- CUP (125) Analysis CP 
Kallen 1997 Sweden Swedish Registry of 1834 1,002,7 Population CLP (1 09) Malformations & 42 based- CP 
Power Medical Birth same data PR 
analysis Registries as Keels All clefts 
'91 but CLPmult 
more data CPmult 
PRmult 
All clefts mult 
Christense 1999 Denmark Population based 302 567 Hospital, CLP 
n (126) Centralized preceding CP 
treatment centers 2 births CLP(I0-19 cig) 
CLP(I0-19 
cig)adj 
Lietf(l27) 1999 USA Slone Epi Unit 1479 (total 2295 Malformed CL(N- 334) 
Boston Birth Defects Study clefts) controls CLP(N=494) 
Philli Iowa CP(N=244) 
CL mult (N=58) 
CLP(N=l40) 
CP mult (N=209) 
Chung 2000 USA 1996 US Natality 2207 4414 Healthy CLP: (128) Database controls (Smoking) 
And 1-10 1.32 
malformed 11-20 1.28 
controls- 21+ 1.69 
results not adjusted 
different 
between 
control 
20+cig 
2.67 0.78-9.17 
1.58 0.49-5.07 
1.51 0.57-6.03 
1.73 0.71-2.46 
1.75 1.02-3.02 
X2=4.09 
(p=0.04) 
1.29 1.18-1.42 
1.32 110-1.62 
1.13 0.99-1.29 
1.35 1.12-1.63 
0.79 0.47-1.33 
118 1.06-1.31 
1.43 0.98-2.09 
0.88 0.51-1.54 
0.94 0.28-3 .19 
119 0.88-1.62 
1.4 0.99-2.0 
0.87 0.50-1.52 
1.56 1.07-2.27 
1.62 1.06-2.49 
Analysis ]-{Jut of Smoking: I 
32 OR's only 7 
-14, 15-24, 
had Cl that do 25+ 
not include I 
Analysis 2- not Dose 
enough smokers Response 
to divide into sig for 
catagories CLP mult 
Exposure 
from I month 
before 
conception & 
I~ tri 
Family 
History 
This is the 
same data as 
Keels (1991) 
but more data 
SEI (socioeco 
status based 
on edu and 
'workers' 
Smoking:> I 0 
or < IO 
Infant TGFA, 
alcohol, 
vitamin: 
cig/day 
0, 1-9,10-
19,>20 
Analysis 2-
has more 
precise data 
on smoking 
time and dose 
Smoking: 0,1-
10,11-20,21+ 
ANEMIA, 
edu, race, 
diabetes, 
hypertension, 
Sex, age, 
birth weight, 
TGFa 
In Trimester 
Exposure 
Maternal age, parity, 
year of birth 
First trimester 
exposure 
Dose non sig 
Whites only, 
geographic area, sex, 
age, edu, family 
history, miscarriage, 
abortion folate etc. 
Dose response 
positive 
~ 
00 
groups 
Lorente 2000 France, European 16 1 1134 Hospital (129) UK, Italy, Registration of Based-
Netherland Congenital &birth 
s Anomalies records 
Beaty 2001 Maryland Treatment Centers/ 171 182 Random (130) Craniofacial Clinic Hospital 
ofWashington DC/ Based 
BORIS 
Honein 2001 USA45 National Vital 2,632 3 mill Cohort (131) States Statistics system (1997) (1997) 
NYC, Dist 2,606 3.1 mill 
COlumbia (1998) (1998) 
Woods 2001 Cincinnati TriHealth Hospitals 75 18,076 Retrospecti (132) 
ve Cohort 
Wyszynski 2002 USA 1997 US Natality 2029 4050 Matched (133) Database race, sex, 
time& 
place birth 
DeRoo 2003 Washingto Birth Cerificates 298,138 608 Matched (95) n State (W A state birth time birth ; 
defects registry) healthy 
Little (69) 2004 Meta -Analysis 15 studies 
Meyer 2004 Sweden Swedish Medical 128,688 CP Control (134) Birth Registry (678) births 
CLP restricted 
(1175) to at least 
2 births 
Zeiger(44) 2004 Meta- TGFa and Smoking 5 Studies 
Analysis 
Lam mer 2005 CA, USA CA Birth defects 423 294 Non-(135) monitoring syatem malformed 
controls 
CL(P) (N-1 09) 1.79 1.07-3.04 
CP (N=52) 0.86 0.40-1.87 
CUP 1.36 0.68-2 .72 
CUP(adj ) 1.04 0.44-2.43 
CP 1.74 0. 75-4.02 
CP (adj) 1.05 0.23-2.92 
Oral Clefts (1997) I 1.32 119-1.46 
Oral Clefts (1998) I 1.38 1.24-1 .53 
Oral Clefts (97- 1.35 1.25-1.45 
98) I 
Head,ear,nose, 0.7 0.30-1 .63 
and throat 
anomalies 
CLP 1.16 1.01-1 .33 
Isolated CLP 11 0.8-1.5 
Isolated CP 1.4 0.9-2.3 
Non Iso-CLP 1.2 0.7-2.1 
Non lsoCP 11 0.7-1.5 
CLP 1.34 1.25-1 .44 
CP 1.22 11-1.35 
CP All combined 
CLP 1.1(1.0-1.3) 
1.3(11-1.5) 1-9 cig/day 
10+ 
cig/day 
Smoking alone 1.64 1.33-2.02 
Smoking+ Cs 1.1.95 1.22-3.10 
allele 
Matched by Genotype 
county dependent OR' s 
2.9 
6.3 1.2-7.2 
1.3-42 
Alcohol use 
Socio-
economic 
Maternal Age 
& 
Education 
Maternal age, 
education,rac 
e Cig/day: 1-
5,6-10,11-
21,21+ 
Age, race, 
diabetes 
Alcohol 
Maternal age, 
ethnicity, 
marital status, 
infant sex 
No evidence 
of publication 
bias 
age, year of 
birth, 
diabetes, 
marital status, 
history, parity 
GSTil (-/-) 
GSTil&GST 
Ml (-/-) 
Dose 
No dose response 
0-3 month 
critical time 
DoseNS 
Not cleft-
Analysis for head, 
ear, nose and throat 
Dose-slightly sig 
CLP (7 of 1 0 studies 
have sig dose-
response) 
CP (3 of8 studies 
have sig dose-
resoonse) 
Case crossover, case 
control, case-time 
crossover, bi-
directional study 
design 
These genes are for 
enzymes that detox 
tobacco chemicals 
~ 
\0 
50 
Included in the summary table are the principle investigators, the publication date 
and reference as well as a number of specifics about the study design. Table 1 is similar 
in design with the review published as part of a recent meta-analysis by Julian Little (69), 
but includes a number of addition pieces of information not in that review that are helpful 
for the current author! By considering the epidemiological data on smoking and clefts 
chronologically it is possible to see the evolution of study design that has served to 
eliminate some of the methodological shortcomings of earlier studies. These 
shortcomings are diverse and generate various difficulties when trying to interpret any 
inferential statistics. They include everything from case misclassification, to limited 
sample size and everything in between. In fact, it has only been in the last few decades, a 
short fraction of the history of cleft research, that studies have been shaped t<? eliminate 
some of these research flaws. 
One of the problems with the earliest studies regards the classification of cases. 
Kullander et al's paper published in 1971 is a good representative study where clefts are 
considered only as a minor subgroup of birth defects if considered separately at all (I 06). 
The fact that many of these studies fail to find any significant association between 
smoking and malformations is no surprise considering the wide variety of malformations 
clumped together in the study. Everything from diseases of the central nervous system to 
minor defects like club foot are considered with little or no regard to differences in 
disease etiology. Such gross classification of malformations overlooks disease specific 
exposures not to mention genetic components of certain birth defects. Even in the studies 
where clefts are separated from other malformations, there is no separate analysis of CLP 
and CP, not to mention multiple rnalfom1ations that include cleft phenotjpes that are of 
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known genetic etiology. One illustration that clearly shows how this type of general 
grouping of malformations limits research productivity has been previously mentioned-
that of neural tube defects and clefts. Due to the fact that the human palate is 
morphologically derived from the same tissue as the neural tube, it has been hypothesized 
that the two malformations may have similar etiologies. However, supplementation trials 
with folic acid in both the US and China that have significantly reduced NTD's have 
failed to elicit similar reductions in cleft rates (136). Considering clefts and cleft sub-
groups independently from other malformations has been a tremendous help in accurately 
estimating attributable risk for disease specific risk factors. 
A shift in focus from malformations in general to individual birth defects has 
necessitated a significant change in study design. Cohort studies rely on birth registries 
for data and can include information from millions oflive births. However, while cleft 
rates are high enough to procure a steady and significant public health burden, they are 
not great enough to produce case numbers sufficient enough to provide the statistical 
power needed for analysis, unless large population sizes are considered. A power 
analysis conducted by Karin Kallen (1 09) estimated that in order to identify any 
significant risk difference due to smoking between cases and controls there would need to 
be at least 1 ,000 cases- and that is an estimate based on having a 40 % smoking rate and 
with a 20% true risk increase, not a very conservative estimate for some populations, like 
Utah where smoking rates are lowest in the nation (109, 137). Early studies did not have 
the kinds of numbers needed to produce meaningful analyses. Kallen et al. (1 09) had to 
track data for over a million live births in Sweden over the course of nine years in order 
to get a total of 1834 cleft cases, a sufficient arnount, but the time and resources required 
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to establish such extensive registries is tremendous (1 09). Case control studies can elicit 
similar numbers of study participants much quicker while significantly decreasing the 
burden of data collection and effectively providing data from afflicted children. For 
example, Susan Lieff et al. (127) had only to collect data from a total of 3774 
participants, 14 79 cases and 2295 controls, in order to get enough data to effectively test 
the same hypotheses as Kallen. 
Case control studies offer additional benefits over other designs for studies of low 
frequency diseases like clefts. Cohort studies that rely on birth registries are limited to 
retrospective data that often do not have data specific enough to pinpoint certain 
exposures. Palate formation is completed before the end of the first trimester and 
smoking exposure during that critical time-period is difficult to determine when birth 
registry data on smoking is limited to a simple yes or no question without regard to the 
time frame or degree of exposure. Case-control studies also rely on retrospective data for 
information, but these studies also utilize data collected via interviews with 
questionnaires carefully designed to precisely determine a temporal relationship between 
exposure and disease status. The questionnaires include vast amounts of information-
enough to test numerous hypotheses within each population while also providing much 
needed information about specific confounding factors that may not be taken into 
consideration with birth registries. The Hungarian Case-Control Surveillance of 
Congenital Anomoalies recently published a paper supporting their position that 
retrospective, self reported smoking status is highly unreliable ( 13 8). While that may be 
the case, randomized controlled trials for smoking will never be an option, and though 
retrospective reporting falls short of providing any concrete causation, using 
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questionnaires specific to cleft research and relevant exposure times undoubtedly adds a 
measure of decisive information over general registry data. Population based case and 
control studies, where controls are randomly picked as representative samples of a larger 
population, can still be used to define prevalence rates within the population and thus 
serve dually as descriptive studies as well. Case crossover, case-time-control and bi-
directional studies have been investigated as optional study designs for cleft research. By 
utilizing the same mother at two or more different times with differing levels of 
exposures, they eliminate sources of bias in traditional case control designs and can be an 
increased source for risk assessment (134). 
Another important piece of information that has not been routinely collected for 
cleft studies over the years is the number of cigarettes smoked. Some of the birth 
registries do include this information irrespective of the date of publication - it appears to 
be based solely on registry specifications. For studies that do include this data, trend tests 
for dose-response relationships have varied results. Each researcher has a different way 
to categorize the number of cigarettes smoked, which makes between study comparisons 
somewhat. A further limitation to some studies is that while active smoking on the part 
of the mother is recorded, any exposure to second hand smoke is not jointly considered. 
Those studies that scrutinize exposure to second hand smoke do not concurrently assess 
active smoking. The fashionable design for current studies is to look at some measure of 
both active and passive smoking as a better indicator of degree of exposure. 
The criteria used to identifY acceptable controls for each case-control study are 
another area where each study maintains its own priori. Hospital controls are a popular 
choice, as well as healthy, population-based controls obtained from various sources such 
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as drivers license information. Controls are frequently matched for place and time of 
birth. Other matching criteria differ from one study to the next. One frequent complaint 
about case-control studies is their propensity for recall bias. It is not unusual for study 
participants to underreport exposures, but it is also not unusual for there to be a greater 
measure of under-reporting exposures for mothers with affected children versus mother's 
with unaffected children. One method used to remedy this problem is to use children 
with malformations other than clefts as controls. A few of the studies listed in table 1 
opted to utilized malformed controls for their analysis. Chung et al. (128) computed odds 
ratios for their data twice - once with healthy controls and once with malformed controls. 
The results were fairly similar, enough so to warrant the continued use of healthy controls 
in cleft research. 
Taken together these studies look like a patchwork quilt with nearly every 
possible idea and combination of ideas represented in some form or another. 
Consequently, it is difficult to interpret the collective results embodied by the years of 
dedicated research and untold amounts of financial investment represented here. This is 
not an uncommon problem in research today and as such meta-analyses are taking more 
of a spotlight role in interpreting data. Meta analyses utilize odds ratios and other 
inferential statistics from numerous studies and combine them to generate an overall odds 
ratio and confidence intervals for the accumulated data. To date there have been two 
meta-analyses for clefts and smoking. 
Published in 1997 Wyszynski et al. (125) looked at 9 different studies for their 
meta-analysis. The group odds ratio represented by this group of studies is 1.29 with a 
confidence interval of 1.18-142 for CLP and ] .32 and 1.10-1.62 for CP. Wyszynski 
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cautiously summarizes that there is a higher risk associated with smoking. In 2004 Little 
et al. (69) looked at over 15 different studies and also concluded that there is an increased 
risk of cleft lip and cleft palate associated with maternal smoking based on a combined 
relative risk of 1.34 and confidence interval of 1.25-1.44 for CLP and a relative risk of 
1.22 with a confidence interval of 1.1-1.3 5 for CP ( 69). The authors were very thorough 
and also included formal tests for publication bias (results were not significant) and 
analysis of dose- response relationships where possible (69). Four ofthe studies that 
provided dose response data had positive, but not significant dose effects, while four did 
not support a dose response pattern. Certainly, more work needs to be done in order to 
substantiate these findings and help estimate the impact of smoking on fetal palate 
formation. The data as it currently stands suggests that 11 to 12% of all clefts could be 
avoided if women of reproductive age quite smoking (43). 
Andrews and McGarry published an interesting finding that links both smoking 
exposure and anemia in human populations (27). In 1972 they analyzed data from the 
Cardiffbirth survey, which included 18,631 births. While their primary goal was not to 
asses.s risk factors for clefts, they were looking at "the habit of smoking during pregnancy 
in relation to maternal and fetal well being," the implications for the study currently at 
hand are remarkable. In their report they found that for the parameters of premature birth 
and infant weight, not only were the chi-square values for both anemia and smoking 
significant, so was the interaction between the two. This is further evidence that these 
two conditions may work conjointly to effect fetal growth, and possibly cleft 
malformation (27). Saxen also investigated anemia in a study published two years later 
in 1974 (11 0). They reported a small difference in anemic status between cases and 
controls, but this difference did not reach significance (11 0). 
Anemia 
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Anemia is defined by the World Health Organization as "a condition in which the 
hemoglobin content of the blood is lower than normal as a result of a deficiency of one or 
more essential nutrients regardless of the cause of such deficiency" (139). As this 
statement indicates, a number of different nutritional factors can contribute to anemia, 
including many of the same nutrients that are already under investigation in relation to 
oral clefts: vitamin A, folate, vitamin B-12, riboflavin, and zinc (140-144). However, 
different nutrient deficiencies that lead to anemia are not physiologically equivalent. 
While iron deficiency leads to a reduction in red blood cell production; untimely 
destruction of red cells and swelling of red cells due to other nutrient insufficiencies are 
also of significant health consequence (141 ). Many researchers use instead a broader 
definition of anemia, "a decrease in the oxygen carrying capacity of the blood," to 
incorporate anemias that do not directly relate to hemoglobin levels, but nonetheless alter 
oxygen transport through the blood (144). Studies have supported the idea that maternal 
anemia may in fact decrease oxygen transfer to the fetus (145). 
Iron deficiency anemia, or microcytic anemia is the most prevalent source of 
anemia worldwide, due quite heavily to iron deficiencies in developing nations (143). 
And, like other risk factors, anemia has been associated with clefts in mice (36) and some 
evidence suggests association in humans (81 ). UNICEF estimates that globally 4-5 
billion people have some level of iron deficiency and two billion are anemic (146). This 
translates into a significant risk for women of reproductive age and children as iron 
deficiency has been shown to extensively increase mortality and illness. Those high 
rates for iron deficiency anemia do not seem to hold true for more developed nations 
however where studies like NHANES attribute as few as 2% of anemia to iron 
deficiency, and instead attribute other factors for the anemia (147). 
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Anemia is typically diagnosed based on the World Health Organization standards 
ofhemoglobin levels less than llg/dL (148). Hemoglobin levels correspond with long-
term dietary iron intake and are usually a good indicator of late stage microcytic anemia 
(96). However, hemoglobin only accounts for 65% of total iron stores and so a more 
complete account of iron stores includes ferritin and hemosiderin (94). Iron deficiency 
develops in stages. The first stage is characterized by a depletion of iron stores and a 
subsequent decrease in serum ferritin. The second stage is transient, and accounts for a 
decrease in transport iron and continued decreases in serum iron. The final stage, or 
anemic stage, results when iron stores are depleted enough to cause a marked decrease in 
hemoglobin production (94). 
Anemia due to vitamin B-12 and folate deficiencies, megoblastic or macrocytic 
anemia, occurs when red blood cells grow too large inhibiting the transport of oxygen in 
the body (144). Megoblastic and macrocytic anemia can not diagnosed based on 
hemoglobin alone, but instead are determined by mean corpuscular volume (MCV), and 
mean corpuscular hemoglobin (MCH) values (83, 144, 149). An alternative lab test, the 
mean corpuscular hemoglobin concentration (MCHC), can also be used to determine the 
concentration of hemoglobin proteins within red cells (150). In developed countries it 
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has been observed that folate and B-12 responsive anemias are more prevalent than iron 
deficiency anemia. 
Some concern has been expressed over the universal application of the WHO 
standard of diagnosis for anemia because of inherent differences in hemoglobin levels in 
various populations (141, 148). For instance, one study that focused on anemia in 
pregnant Philippina women (141) suggests that a standard of I 0.4 g/dL for determining 
anemia status would be more appropriate for that population (148). The CDC uses 
12g/dL as a cutoff point for anemia in the Unjted States. Hemoglobin and hematocrit 
levels are also very insensitive measures of total iron. Other more accurate measures of 
iron status include, "serum ferritin, mean corpuscular volume (MCV), transferrin 
saturation, free erythrocyte protoporphyrin, and hemoglobin response to therapeutic trial 
with iron" ( 14 7). Certain factors can also artificially elevate hemoglobin levels without 
actually increasing oxygen availability in the body (37). This may inhibit proper 
screening of anemia using hemoglobin values. Smoking is of particular concern because 
smoking can raise hemoglobin levels significantly without any reduction in tissue 
hypoxia (3 7). The increase is in fact just a reflection of increased levels of hemoglobin 
bound with carbon monoxide. 
During the course of a normal pregnancy it is typical for hemoglobin levels to 
fluctuate, and many women develop anemia due to decreased blood iron levels before 
delivery ( 1 51). Third term development of anemia is considered a normal result of the 
necessary increase in blood volume and the subsequent dilution of blood proteins (151 ). 
Scholl (152)also reports that women who showed poor nutritional status earlier in 
pregnancy not only had higher rates of iron deficiency anemia, but also had serum ferritin 
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and red cell folate were also lower (14 7). A current meta analysis has linked maternal 
anemia during early pregnancy with poor pregnancy outcomes including low birth 
weight, perinatal mortality and preterm birth (153-156). These findings hold true in a 
number of independent studies. Even after controlling for age, ethnicity, education, 
marital status, and smoking, a study from the Kaiser-Permanete Birth Defects Study 
Cohort showed that anemia diagnosed during the second and third trimester using 
hemoglobin concentrations, was a statistically significant risk factor for preterm birth 
(OR=l.9). Populations from Tanzania and India also both showed that low birth weights 
are attributable to iron deficiency anemia (149, 155). And again with a population from 
Camden New Jersey, a statistically significant odds ratio of3. 10 for low birth rates was 
seen for those mothers starting prenatal care with iron deficiency anemia (147). Using 
an energy adjusted FFQ, researchers in the Netherlands found significant a differences in 
iron consumption between cleft cases and controls (80). Just like other research fields 
however, these studies cannot conclusively prove causality and there are plenty of 
observational studies that found no association between iron deficiency and or anemia 
and birth outcomes. 
The Utah Child and Family Health Study 
Utah 
Although exposure to low iron levels and nutritional anemias are limited in the 
United States, NHANES data attribute as few as 2% of anemia to iron deficiency in the 
US, (152) Utah has several other demographic and cultural features that make it a good 
option for conducting population based studies on birth defects. Utah is situated in the 
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Great Basin in the northwestern part of the country. The landscape is diverse and ranges 
from the arid, minimalistic beauty of the red rock canyons in the south, to the bitter cold 
snow lands and rocky-mountains in the north. Utah was home to several Native 
Americans, including Ute, Shoshone, Anasazi and Navajo tribes, long before any western 
settlers came to the area. The first European settlers to make the trek across the plains to 
settle in the area were religious refugees from The Church of Jesus of Christ of Latter-
Day Saints, LDS or Mormons, who had been driven from Missouri and Illinois by mobs 
on account of their religious convictions. A good portion of the population in Utah today 
are descendants of the early Mormons 
Members of the LDS church are counseled by their leaders to observe strict health 
standards, which include not drinking or smoking, and abstaining from coffee and tea 
consumption. The large numbers of faithful observers ofthese religious ethics provide a 
large, very clean, non-smoking group for analysis. CDC data list Utah as the state with 
the smallest proportion of active smokers, 13.7% as compared with the national average 
of23.3% (41). Conveniently, the majority ofthose who have had neither active nor 
passive smoking exposure also do not drink alcohol, which is usually considered a 
confounding variable in cleft research. Access to such a discrete control group with very 
limited exposure to tobacco and alcohol should help make more exact distinctions 
between risk exposure groups and result in more precise odds ratios. 
Like other religious groups, members of the church of Jesus Christ of Latter Day 
Saints cherish family relationships and many tend to have large families. It is not unusual 
to find families with 10 or more children in fact. Preliminary looks at the Utah Child and 
Family Health Data show women with up to14 children. Women who have had 
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numerous live births provide much needed information about the role of nutrient 
depletion due to excessive parity and short pregnancy intervals (95, 157). The LDS 
church also fosters a deep interest and respect for their ancestry, and most Mormon 
families have access to family genealogical records for several generations. This can be a 
great resource for determining family history of a disease and the Utah State University 
Center for Epidemiological Research hopes to join their databases with the other genetic 
data available in the state, which will likely prove to be a tremendous asset for research. 
Conclusion 
"Assuming 15,000 children are born per hour worldwide (United States Bureau 
of the Census, 2001 ), a child is born with a cleft somewhere in the world approximately 
every 2 minutes (5)." This is indeed motivation enough to drive researchers to look for 
some insight into the intricate process of palate formation and search for ways to preclude 
developmental shortcomings. Perhaps at this juncture in time it is most advisable, while 
not disregarding the historical data on hand, to do as Dr. Bixler suggests and shift the 
focus of research from descriptive analyses to testable hypotheses (28). 
On that note, a panel of cleft experts has established some guidelines to help 
streamline cleft research and make independent research efforts more valuable to the 
collective research efforts. Published in 2002, they make the following recommendations 
to maximize data collection for hypotheses testing: 
1) Description of the cleft. At a minimum, the side and extent of the cleft should 
be documented as should palatal involvement. 
2) Pregnancy history. The results of prenatal testing, identification of maternal 
illness, medication (e.g., anticonvulsants and retinoic acid derivatives), vitamin (before 
and after conception) and tobacco use, ethanol intake, and other maternal exposures 
should be documented. 
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3) Birth history. Birth weight and length and the need for any additional medical 
services not related to the cleft should also be documented. Specific attention should be 
given to a history of feeding disorders (beyond early cleft feeding difficulties) and 
infections. Additional information, such as Apgar scores, may be helpful but is not 
essential. 
4) Developmental hjstory. The identification of developmental disabilities, 
including learning disabilities and attention deficits, hearing impairment, and speech 
deficits or abnormalities may be the first indication of an underlying genetic disorder. 
5) Family history. At a minimum, a three-generation pedigree should be 
obtained. The family history should emphasize orofacial clefts and related conditions, 
including any additional major associated anomalies (e.g., cardiac defects and eye and 
brain anomalies). The family history should also identify spontaneous abortions, 
stillbirths, and infant deaths. There should be special attention to identification of 
developmental disabilities because theses may indicate the presence of specific 
predisposing disorders(25). 
Other study design recommendations have also been set forth by the World 
Health Organization. They call for a "standardization of research" that includes universal 
data collection methods for: nutrition, lifestyle, occupational, medical, obstetric, drug, 
genetic, biochemical, and family history factors, as well as classification for cases and 
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controls (1 ). Field experts across the globe are pushing in particular for the creation of a 
centralized registry for all craniofacial anomalies worldwide (1 ). Successful 
reorganization of existing cleft research and standardizing of future studies will greatly 
facilitate the application of any public health initiatives that may arise from such a 
collaborative effort. For a detailed set of universal guidelines, see the Global Registry and 
Database on Craniofacial Anomalies, Chapter 5 (1 ). 
The Utah Child and Family Health Study follows quite closely these guidelines 
and is a prime example of the direction in which cleft research is headed. With access to 
both biological samples for DNA and nutritional biomarker data and detailed interview 
data including a food frequency questionaire, the Utah study has a wealth of information 
and an excellent database from which to draw some conclusions about the role of 
smoking and anemia in palatogenesis. 
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CHAPTER3 
MATERNAL SMOKING AND ANEMIA AND THE RISK OF 
ORAL CLEFTS IN UTAH 
Abstract 
81 
Hypoxia is a known teratogen, and animal models have shown that maternal 
hypoxia can in fact contribute to oral clefting (1 , 2). In humans, maternal smoking and 
anemia are likely the two biggest factors that can lead to hypoxia during pregnancy. Data 
from the Utah Child and Family Health Study were used to test the hypothesis that 
maternal smoking and anemia may synergistically increase the risk of oral facial clefting. 
In this population-based study there was a total of 838 women who completed both 
detailed interviews and donated biological samples for analysis. Overall, 12.7% of the 
mothers smoked during the periconceptional period and 17% were anemic based on CDC 
standards of 12 g/dL for non-smokers and 12.3g/dL for smokers (3). There was a strong 
pattern of smoking cessation over the course of pregnancy for both cases and controls, 
but there was a significantly larger portion of case mother's who reported smoking at 
each time point as compared to the percentage of control mother's who were smoking. 
There was an increased risk of clefting associated with smoking across all cleft subgroups 
(N=358) that remained significant after adjusting for education, income, race, alcohol 
consumption, vitamin supplementation, mother's age, parity, hemoglobin quartile and 
child's gender (OR=1.82, 95% CI=1.02-3.24). The impact of maternal anemia, as 
determined by hemoglobin levels, did not contribute any additional risk itself, nor as an 
interactive term with smoking. Based on the current findings and other published 
literature, it is reasonable to single out smoking as a public health concern of 
consequence in relation to maternal health and oral clefting (4). 
Introduction 
Oral clefts affect one out of every five to seven hundred births worldwide (5). 
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Years of research have yielded significant amounts of data regarding possible causes for 
clefting, which include a large range of genetic factors and environmental factors 
including diet, drug and behavioral exposures ( 4-12). Some syndromic conditions with 
known genetic origins include cleft lip or palate (13), but thus far no single exposure, 
genetic or otherwise, has been identified as the principal exposure responsible for the 
majority of isolated clefts, although, there has been an increased understanding ofthe 
disease in recent decades. It is now known that the etiology of cleft lip with or without 
cleft palate (CLP) is somewhat different than that of cleft palate only (CP) (14) and that 
the formation of the palate occurs in early embryogenesis, around day 45 in humans and 
entails a complex sequence of cell signaling and morphological changes in the facial 
tissue (15-18). Clefting rates differ between ethnic groups, with Asians and Native 
Americans consistently having the highest rates, and blacks the lowest (19, 20). Among 
the numerous environmental exposures that have been shown in animal and human 
studies to be associated with clefting are: plant toxins(6), epileptic drugs (11 ), nutritional 
factors such as folate, B 12, B6, and zinc deficiencies and vitamin A toxicities (7), alcohol 
consumption (21, 22), and smoking (4, 21, 23-44). 
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The detrimental effects of smoking on fetal growth are most largely attributed to 
the development of hypoxia (45, 46). In smokers, a portion ofhemoglobin in the blood is 
bound to carbon monoxide and the consequential increase in carboxyhemoglobin in the 
blood decreases the oxygen carrying capacity of the blood (1, 4 7, 48). The decrease in 
available oxygen is even more pronounced in fetal tissue and in animal models a dose-
dependant effect has been confirmed between blood carboxyhemoglobin levels and 
clefting ( 46). Human epidemiological studies have produced inconsistent results with 
regard to smoking and clefts, however, much of the inconsistency may be due to 
insufficient study designs, including small sample sizes, and insufficient detail about 
case-status and exposure levels. A recently published review in the form of a meta-
analyses did show a marginal increase in clefting in cases over controls, an indication that 
smoking does indeed contribute to a portion of isolated clefts ( 4). 
The purpose of this study is to investigate the effects of smoking in addition to 
another factor that contributes to hypoxia , anemia, and their relationship to oral facial 
clefting. Iron deficiency anemia is clinically diagnosed as hemoglobin values less than 
llg/dl according to WHO standards (49) or 12 g/dL for non-smokers and 12.3g/dL for 
smokers based on CDC standards (3). Iron deficiency is common throughout the world 
although iron deficiency, or microcytic anemia, is more common in developing nations 
(49, 50). Anemia in general is characterized by a decrease in oxygen transport in the 
body, a condition undoubtedly found when hemoglobin production decreases due to iron 
deficiency (51), however other nutritional deficiencies can also induce anemia (52, 53). 
These other types of anemia also inhibit the efficiency of oxygen transport in the body, 
but without affecting hemoglobin level (54). They include folate and vitamin B 12 
responsive anemia, or macrocytic anemia, and these are characterized by a swelling of 
red bloods and a decreased in red blood cell transport through capillaries (55). 
Materials and Methods 
Participants 
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All study procedures for were reviewed and approved by the institutional review 
boards at Utah State University, University ofUtah and the Utah Department of Health. 
Participants for the Utah Child and Family Health Study were identified with the help of 
the Utah Department of Health (UDOH), which oversees the Utah Birth Defect Network. 
Mothers of children with clefts born in Utah between 1996 -2005 were contacted by the 
UDOH via a letter explaining the study objectives. UDOH workers used telephone 
follow-ups to confirm or elicit a response to the initial introductory letter. Every possible 
option was exhausted in recruiting participants by the UDOH, including field tracing and 
home visits if necessary. This active method of recruitment ensured the highest possible 
participation rates, thus eliminating participation bias. 560 case mothers and 630 control 
mothers agreed to participate in the study after being contacted by the Utah Department 
of Health, for participation rates of 79.4% and 58.9% respectively. After the 1190 
mothers who consented to participate in the study returned a consent form to the health 
department, their information was then released to the Center for Epidemilogical studies 
at Utah State University. Eligibility for the study was determined for cases based on the 
following criteria: 1) the mother was English or Spanish speaking, and 2) there was a 
confirmed cleft birth. Those not included in the study were those mothers who had died 
previous to the study, did not speak English and were therefore unable to complete an 
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interview, the address of the potential participant was unknown or was outside ofUtah, 
and refusals. Controls were also identified through the UDOH birth certificate 
information and were matched to cases by month of birth and gender of the child. 
Interviews 
After release of participant information to USU, an initial phone contact was 
carried out by trained interviewers from the Center for Epidemiological Studies to assess 
the eligibility of participants. Verification was obtained for contact information as well 
as the date of birth for the index child, the child's gender and the corroboration of cleft 
status for case participants. Information was also obtained regarding the timing of the 
pregnancy in question, including whether or not the pregnancy ended early. At this time, 
as well as throughout the entire study, mothers were given the opportunity to refuse 
participation in the study. At the conclusion of the initial phone contact, a future 
appointment was made to conduct the full telephone interview. 
Before the full telephone interview commenced, each mother was mailed a packet 
of information to help them prepare for the interview, including another summary of the 
study for their consideration. Central to the preparation materials provided were 
pregnancy calendars constructed by the USU team from UDOH birth records and 
corroborated pregnancy information from the previous phone contact. The calendar was 
specific for each participant, and supplied a referent time frame to help them more readily 
and accurately recall any relevant exposures during the pregnancy in question. In 
addition to the pregnancy calendar, an example of which can be found in appendix A, all 
participating mothers were given a list of helpful items to collect and have on hand to 
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help them during their phone interview, including the index child's birth certificate, 
health records and scrapbook and the mother's prenatal health records, nutritional 
supplement bottles and medication bottles. Diet interview cards were also supplied. 
They provided information on how respondents were to answer the food frequency 
questionnaire- including what time periods they were to focus on, and how to determine 
the average amount of each food consumed. The phone interviews lasted approximately 
I hour. Data collection included information for demographic variables, self-reported 
anthropometric data, cigarette, alcohol and drug exposure and dietary assessment via a 
food frequency questionnaire. Relevant paternal exposures were also determined as 
reported by the mothers. See appendix A for a complete copy of the Utah Child and 
Family Health Questionnaire (Appendix A). 
Particulars about the type and site of cleft for each case child were self-reported 
by the mothers during the phone interviews. Mothers were probed for specific 
information as to whether the cleft was bilateral or unilateral, and on what side of the 
face, or if the child had a cleft of the soft palate only. Questions regarding any further 
malformations of the index child were also addressed. This data was later corroborated 
by UDOH health records, and the official UDOH coding was used to classify cleft 
subgroups for further analysis. 
Blood Samples 
Mother's who consented to donate biological samples during the phone interview 
were visited at a later date by a staff phlebotomist. Besides collecting blood samples 
from the mothers and buccal swabs from the children and fathers, the phlebotomists also 
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collected additional information on currently used, and measured the mother's height and 
weight. At the time ofbiological sample collection, written consent was obtained for 
each facet of the study individually: the interview, height and weight measurements, 
blood sample collection, storage ofblood samples, labeling of the blood samples, and 
future contact. Similar consents were obtained for the collection and storage of cheek 
swabs for the children and fathers. Hemoglobin assays were done as part of the 
preparation and analysis ofthe blood samples following the recommendations and 
procedures for the HemoCue system, (HemoCue, Sweden). A total of 835 women, 70% 
of those that consented to participate in the study, had donated blood samples at the time 
this data was analyzed. 
Statistical Analysis 
As described in the literature, factors that may be associated with clefting were 
compared between cases and controls from the Utah Child and Family Health Study 
using statistical software SPSS 12.0 (SPSS,Chicago, IL,USA) and SAS 9.1 (SAS 
Institute, Cary, NC, USA). For the continuous variables, differences in the means were 
evaluated using t-tests, after appropriately applying transformations to meet the 
assumptions of normality, however the non-transformed means are reported in Table 1 
for ease of analysis. All categorical variables were collapsed from the interview data into 
groups appropriate for analysis based on their individual distributions, and associations 
between them were assessed using chi-squared tests. 
Height and weight information was collected both during the phone interview as 
self-reported data, and during the phlebotomist visit as a measured parameter. Because 
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there were several participants who volunteered interview data but did not consent to 
giving blood, there was more data available from the self- reported questionnaire. 
Correlation rates between the self-reported and measured data showed consistent results 
and in order to be more consistent with the retrospective nature of other exposure 
variables considered in the study, the self reported data was used to calculate body mass 
index (BMI, kg/M2). 
BMI, hemoglobin, and parity showed non-linear risk association with clefts and 
so they were included in adjusted models as categorical variables, as quartiles ofBMI 
and hemoglobin, and parity from I through 5 (Appendix C). This is consistent with 
available literature that indicates higher risk for low infant birth weight with extremely 
high and extremely low BMI (56, 57). Maternal age did show a linear risk relationship 
and was kept as a continuous variable in the models. Normality of maternal age at birth 
ofthe index child was not particularly improved with the application of transformations, 
and so the data was used in modeling without any (Appendix C). Comparisons of log 
likelihood values for models with and without quadratic terms for maternal age showed 
no indication of a quadratic effect. 
Early exploratory analyses included six measures of smoking exposure for 
consideration. Active smoking during the preconception period and during first 
trimester, passive smoking during the preconception period and during the first trimester, 
and both active and passive smoking during the preconception period and during the first 
trimester. Exposure to passive smoke was highly correlated to active smoking. Out of 
the I 09 subjects who reported exposure to second hand smoke pre-conceptually, 97 or 
88.9% of those also actively smoked. During the first trimester that dropped to 82%, still 
a substantial amount. All of the participants who reported smoking during the first 
trimester had also smoked pre-conceptionally, and so subsequent analyses were 
conducted classifying smokers only based on first trimester, or periconceptional 
exposure. 
Results 
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Characteristics of the study population are listed in Table 3-1. EducatiOJ?., alcohol 
consumption, vitamin supplementation, religion, smoking, and child's gender all showed 
significant differences between some subgroups of cases and controls, although active 
smoking is the only variable that shows an association with all clefts grouped together 
(Table 3-1 ). Many of the variables were also associated with smoking, as evidenced by 
highly significant chi-squared values or ANOV A p-values. These differences between 
smokers and non-smokers are highlighted in Table 3-2. Marital status and religion were 
not included as covariates in adjusted models because marital status showed no 
association with clefting and religion only showed association with clefting in two of the 
smallest subgroups. Any risk associated with these two descriptors is most likely due to 
their relationship to smoking and other lifestyle factors, like alcohol consumption, 
ethnicity, education and income with which they are also highly correlated. (Appendix 
B). 
Self-reported smoking data from the Utah Child and Family Health study shows 
that 152 out of 1189 participants that had completed interviews as of September of 2005 
Table 3-1: Characteristics of Cases and Controls for the Utah Child and Famil~ Health Stud 
Covariates Controls CLPiso CPiso Alllso CLPmult CPmult Allmult All Clefts 
1N""637 N=306 N=98 N=405 N=59 N=89 N= 149 N=552 Mean ~SD) 
26.23 (5 .2) 26.29 (5.6) 26.67 (5.6) 26.38 (5.6) 26.42 (6.0) 
Age 
26.98 (6.2) 26 77 (6.1) 26.48 (5. 7) Height' 65. 19 (2.6) 65 .15 (2.64) 64.68 (2.57) 65 04 (2.83) 64.92 (2.90) 65.14 (2.64) 65.05 (2.7) 65.04 (2.81) We;ght' 146.46 (32.67) 147.83 (34.09) 145.96 (35.41) 147.38 (34.38) 145.53 (33.32) 142.9 1 (25.71) 143.96 (28.93) 146.46 (33 .02) BMI ' 24.3 (5.32) 24.45 (4.89) 24.62 (5.88) 24.49 (5.15) 24.31 (5 .31) 23 .74 (4.32) 23.97 (4.74) 24.35 (5.04) Hemoglobin 13 .04 (1.26) 13.08 (1.31) 13.29 (0.88) 13 .13 (1.22) 13 .17(1.10) 13.23 (1.03) 13.20 (1.05) 13 .148 (1.18) No.(%) 
Education 
0-11 years 38 (6.0) 32 (10.4)** 3 (3.1) 35 (8.6)** 2 (3.4)* 6 (6.7) 8 (5.4) * 43 (7.8)** HS grad!votec 137 (21.5) 87 (28.3) 29 (29.6) 116 (28.6) 23 (39.0) 26 (29.2) 49 (33.1) 165 (29.8) Some College 265 (41.6) 115 (37.5) 33 (33.7) 148 (36.5) 16 (27.1) 30 (33. 7) 46 (31.1) 194 (35 .1) BSIBA!MS 197 (30.9) 73 (23.8) 33 (33. 7) 106 (26.2) 18 (30.5) 27 (30.3) 45 (30.4) 151 (27.3) Ethnic Group 
White 572 (89.8) 267 (87) 87 (88 .8) 354 (87.4) 49 (83.1) 81 (91.0) 130 (87.8) 484 (87.5) Hispanic 33 (5.2) 24 (7.8) 4 (4.1) 28 (6.9) 7 (11.9) 3 (3.4) 10 (6.8) 38 (6.9) Other 32 (5 .0) 16 (5.2) 7 (7.1) 23 (5.7) 3 (5. 1) 5 (5.6) 8 (5.4) 3 1 (5 .6) lncvme 
S0-20,000 122 (19.6) 79 (26.7) 18(19.0) 97 (24.01) II (19.6) 18 (21.4) 29 (20.7) 126 (23 .7) $20-30,000 155 (24.9) 73 (24. 7) 18 (19.0) 91 (22.52) 17 (30.4) 17 (20.2) 34 (24.3) 125 (23.5) $30-40,000 115 (18.5) 46 (15.5) 20 (21.1) 66 (16.34) 10 (17.9) 18 (21.4) 28 (20.0) 94 (17.7) $40-50,000 78 (12.5) 32 (10.8) 17 (17.9) 49 (12. 13) 6(10.71) 9(10.7) 15 (10.7) 64(12.1) $50,000+ 153 (24.6) 66 (22.3) 22 (23.2) 88(21.78) 12 (21.4) 22 (26.2) 34 (24.3) 122 (23.0) Alcohol Exposure 6 
Yes 40(6.3) 19 (6.2) 7 (7.1) 26 (6.4) 4 (6.8) 12 (13.5)* 16 (10.8)* 42 (7.6) No 597 (93.7) 287 (93 .8) 91 (92.9) 378 (93 .6) 55 (93.2) 77 (86.5) 132 (89.2) 510 (92.4) Active Smoking 7 49 (8.4) 40 (14.3)** 13 (13. 7) 53 (14.1)** 9 ( 17.6)* 12 (14 .8) 21 (15.9)** 74 (14.6)••• Passive Smoking 1 69(11.4) 45 (15.8) II (11.8) 56 (14.8) 10(19.2) 12 (14.8) 22 (16.5) 78 (15.3) Religion 
LDS 508 (79.7) 237 (77.2) 80 (81.6) 317 (78.3) 41 (69.5) 65 (73)** 106 (71.6)*• 423 (76.5) Other 76(11.9) 47 (15.3) 10 (10.2) 19 (4.69) 8 (13.6) 9(10.1) 17 (11.5) 74 (13 .4) None 53 (8.3) 23 (7.5) 8 (8.2) 31 (7.7) 10 (16.9) 14 ( 15.7) 24 (16.2) 55 (9.9) Marital Status 
MIITTied!Live In 603 (94.7) 282 (91.9) 93 (94.9) 375 (92 .6) 54 (91.5) 82 (92.1) 136 (91.9) 511 (92.4) Other 34 (5.3) 25 (8.1) 5 (5.1) 30(7.4) 5 (8.5) 7 (7.9) 12 (8.1) 42 (7.6) Vitamin Supplementation 1 
Yes 578 (90.7) 278 (90.8) 90(91.8) 36 (8.9) 55 (93 .2) 87 (97.8)* 142 (95.9)* 510 (92.4) N~ 59 (9.3) 28 (9.2) 8 (8.2) 368 (91.1) 4(6.8) 2 (2.2) 6(4.1) 42 (7.6) Child's gender 
Male 391 (61.4) 194 (63.2) 45 (45.9)•• 239 (59.0) 44 (74.6)••• 50 (56.2) 94 (63.5) 333 (60.2) Fenale 246 (38.6) 113 (36.8) 53 (54.1) 166(41.0) 14 (23.7) 39 (43 .8) 53 (35.8) 219 (39.6) Parity' 
I 198 (31.1) 
2 136 {21.4) 
3 138 {21.7) 
4 76(11.9) 
5+ 89(14.0 
*~0.05 ••p:::;O.Ol •••p:::;O.OOI 
6. Any alcohol exposure during the first trimester I. N may differ slightly due to missing data; percentages may not add to I 00 due to rounding 2. Maternal age at time of birth of index child 7. Periconceptional smoke exposure 3. Self-reported height 
8. Multivitamin and/or folate use during pregnancy 4. Self-reported weight at birth of the index child (p-values calculated with inverse log transformation) 9. Parity at birth of the index child 5. BMI calculated from self-reported height/weight data (p-values calculated with inverse transformation) 
\0 
0 
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Table 3-2: Characteristics of active smokers vs. non-smokers separate by case and 
control status1 
All Clefts Controls 
Smoker Non-smoker Smoker Non-Smoker 
Mean (SD) 
Age 2 22.97 (5 .88)••• 27.32 (5.38) 22.43 (4 .21)••• 26.83 (5 .07) 
Height 3 64.65 (2.83) 65 .18 (2 .72) 64.5 (2 .47)* 65.34 (2 .67) 
Weight' 143.69 (30.4) 148.19 (33 .68) 147.83 (35 .73) 145.57 (30.58) 
BMij 24.23 (5.03) 24 .53 (5 .13) 25 .09 (6.38) 24.04 (4.96) 
Hemoglobin 13.42 (1.22)** 13 .09 (1.18) 13.49 (1.23)•• 13.01 (1.21) 
(%) 
Education 
0-11 years 25 .7••• 3.2 28.6··· 3.0 
HS gradlvotec 56.8* .. 23.1 49.0 ... 17.0 
Some College 16.2··· 40.0 16.3••• 44.1 
BS/BNMS 1.4··· 33.7 6.1 *** 35 .9 
Ethnic Group 
White 85.1 89.8 83 .7 90.8 
Hispanic 5.4 5.5 6.1 4.7 
Other 9.5 4.6 10.2 4.5 
Income 
$0-20,000 45 .16··· 19.16 44.68··· 16.35 
$20-30,000 30.65··· 21.73 40.43*** 24.33 
$30-40,000 9.68••• 19.16 6.38··· 19.01 
$40-50,000 6.45••• 13.08 4.26··· 13.30 
$50,000+ 8.06··· 26.87 4.26··· 26.81 
Alcohol Exposure 6 
Yes 29.7••• 3.07 38.8••• 2.6 
No 70.3··· 97.0 61.2••• 97.4 
Religion 
LOS 48.6••• 84.3 38 .8••• 86.4 
Other 16.2··· 11.1 34.7••• 8.8 
None 35 .1 ... 4.6 26.5••• 4.9 
Marital Status 
Married/Live In 75 .7••• 97.9 73 .5••• 97.9 
Other 24.3••• 2.1 26.5*** 2.1 
Vitamin 
Supplementation 7 
Yes 91.9 93 .1 83.7 91.4 
No 8.1 6.9 16.3 8.6 
Child 's gender 
Male 47.3* 61.8 55 .1 62.2 
Female 52.7* 38.2 44.9 37.8 
Pari~ 8 2.0 2.0 2.0 2.0 
•p_:::0 .05 ••p_:::O.OI •••p_:::O.OOI 
I. Active smoking exposure during the periconceptional period 
2. Age of the mother at the birth of the index child 
3. Self reported height data 
4. Self reported weight data at the time of the birth of the index child (p-values calculated with inverse log transformation) 
5. BMI calculated from self-repo~d height/weight data (p-values calculated with inverse transformation) 
6. Any alcohol exposure during the first trimester 
7. Multivitamin and/or folate use during pregnancy 
8. Median parity at birth of the index child 
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reported smoking. That is 12.7% of the study population and corresponds well with the 
CDC's reported smoking rates for Utah of 13% (58). Fortunately, the data also show a 
strong pattern of smoking cessation over the course of pregnancy. This is true of the 
study population as a whole, as smoking rates declining from 12.7 pre-conceptually, to 
1 0.5%, 5.03%, and 4.61% during the first, second, and third trimesters respectively. 
Interestingly enough, the biggest decline in smokjng rates among the participants is 
between the first and second trimesters. Unfortunately since the relevant exposure period 
for cleft formation is during the early period of fetal development, well before the second 
trimester, the huge decline in smoking rates between months 3 and 4 may be too late 
during the pregnancy to effectively protect against the physiological effects of smoking. 
Figure 3-1 illuminates an even more impmtant finding regarding smoking exposure 
among participants, namely that there is a difference in smokjng rates between cases and 
control. For all cleft cases considered together the smokjng rates were: 15.2% pre-
conceptually, 13.4% during the first semester, 6.52% for the second trimester and 5.79% 
for the third trimester. This pattern can also be seen when comparing controls to all the 
subgroups of clefts (Figure 3-1 ). 
Table 3-3 shows the unadjusted and adjusted odds ratios for active, passive, and 
both active and passive smokjng during the first trimester by oral cleft subgroups. Odds 
ratios ranged from 1.73 for isolated CP to 2.34 for CLP multiple. For active smokers, all 
of the lower bounds of the 95% confidence intervals are well above 1.0, except in the 
cases of isolated and multiple CP, indicating that the increased risk from smoking before 
adjustment is significant. IQsk attribuTable to passive smoking was insignificant, and for 
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those with both active and passive exposure, the odds ratios changed little from the active 
smoking exposure alone, however, the confidence intervals did change slightly. 
Percent smokers for controls and All 
clefts 
:~ . :c§ 
1
- Control ·1 
1a - All Clefts I 
%-
Figure 3-1. Percentages of case mothers (all cleft types) and control mother's who 
reported smoking over the course of pregnancy, Utah Child and Family Health Study. 
After adjusting for mother' s age, BMI, race, education, income, alcohol 
consumption, vitamin supplementation, hemoglobin quartiles and child's gender, the 
odds ratios did change slightly, but the overall risk trends were the same as for the 
unadjusted risk estimates. These results are also found in Table 3-3 (page 94). Some 
caution should be used when comparing the two sets of odds ratios however, as 
controlling for hemoglobin, the only model parameter to come from the lab data, reduced 
the sample size considerably, approximately 30% for cases overall. Nonetheless, active 
smoking during the periconceptional period is significantly associated with all cleft 
groups combined with an odds ratio of 1.82 and confidence interval 1.02 to 3.24. 
Literature exploring the dangers of smoking during pregnancy clearly indicates 
that smokers have elevated hemoglobin levels. This is a physiological response on part 
of the body to compensate for the decreased oxygen transport due to the build up of 
Table 3-3: Adjusted1 and unadjusted odds ratios for cleft type b~ first trimester smoking 
Unadjusted Odds Ratios Adjusted Odds Ratios 
Active Smoking Passive Smoking Active and Passive Active Smoking Passive Smoking 
Smoking 
N OR 95%CI N OR 95%CI N OR 95%CI N OR 95%CI N OR 95%CI 
CLP 280 1.82 1.17-2.8 285 1.45 0.97-2 .18 267 1.82 1.07-3.1 203 1.75 0.88-3 .47 206 1.07 0.58-1.97 
CP 95 1.73 0.90-3 .3 93 1.04 0.53-2 .05 91 1.78 0.82-3 .9 67 2.23 0.77-6.46 65 1.14 0.397-3.28 
Isolated 375 1.79 1.19-2.7 378 1.35 0.92-1.9 358 1.81 1.1-2.9 270 1.71 0.915-3 .21 271 1.05 0.595-1.85 
CLPmulr 51 2.34 1.08-5.09 52 1.85 0.89-3 .8 48 2.32 0.92-5 .8 33 5.33 1.31-21.62 31 1.31 0.34-4.49 
CPmult 81 1.89 0.96-3 .7 81 1.35 0.69-2 .6 76 1.65 0.7-3 .9 55 2.13 0.64-7 .14 53 0.85 0.256-2 .82 
Multiple 716 2.06 1.2-3 .6 133 1.54 0.91-2 .6 124 1.89 0.97-3 .7 88 2.65 1.04-6.78 84 1.04 .415-2.59 
All Clefts 507 1.86 1.27-2.7 511 1.39 0.99-1.98 482 1.84 1.16-2.9 358 1.82 1.02-3.24 355 1.04 .6 11-1 .76 
1- Adjusted for maternal BMI, education, ethnicity, alcohol consumption, income, vitamin supplementation, parity and gender of child. 
2- Mult refers to non-isolated clefts cases or cases with multiple birth defects 
N 
194 
64 
258 
30 
51 
81 
339 
Active and Passive 
Smoking 
OR 95%CI 
1.13 0.75-1.7 
1.47 0.78-2.8 
1.15 0.79-1.7 
1.828 0.76-4.4 
1.034 0 .47-2.3 
1.23 0.68-2.2 
1.15 0.81-1.6 
\0 
~ 
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carboxyhemoglobin in the blood. This phenomenon can be seeri in the present data as 
well. Table 3-2 clearly shows that there is a substantial and significant association 
between smoking and hemoglobin levels and that relationship holds true for both cases 
and controls. Table 3-1 does show an increase in hemoglobin among cases versus 
controls, although not enough of a difference is detected to obtain statistical significance. 
Table 3-4 shows the percentage of study participants who were clinically anemic based 
on the CDC standards of anemia with cutoffs at 12.0g/dl for non-smokers, and 12.3 g/dl 
for smokers. As would be expected for a population in a developed country, anemia 
levels are low, with approximately 7 to 10 percent of women with clinical anemia. The 
difference in anemia rates between cases and controls was not significant. After 
controlling for anemia status, smoking still produced an increased risk of clefting as 
shown in Table 3-5, and Breslow-Day statistics show no significant difference between 
odds ratios for smoking and clefts after stratification for anemia. 
Table 3-4: Percentaye of smokers and non-smokers by cases and control status, 
stratified by anemia · 
Anemic Non-Anemic 
Control Case Control Case 
Non-Smoker 67 (93.06%) 53 (89.83%) 306 (90.8%) 265 (84.9%) 
Smoker 5 (6.94%) 6 (10.17%) 31 (9.2%%) 47 (15.06%i 
I Anemia is defined according to the CDC criteria of 12 g/dL for non-smokers and 12.3 g/dL for smokers 
2 Chi square p-value <0.05 between cases and controls within anemia 
Table 3-5: Risk of Clefts (all types combined) associated with smoking, stratified by 
. I 
anemta status 
Anemic 
Non-Anemic 
Cases 
59 
312 
Controls 
72 
337 
Odds Ratios (95% Cl) 
1.5 (0.44-5.24) 
1.75 (1.08-2.8)2 
1 Anemia is defined according to the CDC criteria of 12 g/dL for non-smokers and 12.3 g/dL for smokers 
2 Breslow Day test for homogeneity of odds ratios is insignificant (p=0.833) 
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Assesment of clefting risk based on quartiles of hemoglobin also did not show 
any indication of an effect of maternal hemoglobin levels on the risk of having a child 
with a cleft. Table 3-6 shows the distribution of hemoglobin levels for cases and controls 
and Table 3-7 shows odds ratios associated with those levels ofhemoglobin both crude 
and adjusted. With all point estimates and confidence intervals centrally located around 
1, it is safe to conclude that there is no discemable risk increase for clefting with maternal 
hemoglobin. 
Table 3-6: Percentage of cases and controls by hemoglobin quartiles, stratified by 
active smoking status1 
Non-smokers Smokers 
Cases Controls Cases Controls 
Quartile 1 80 (25.16%) 105 (28.15%) 9 (16.98%) 6 (16.7%) 
Quartile 2 80 (25.16%) 89 (23.86%) 12 (22.6%) 7 (19.4%) 
Quartile 3 84 (26.42%) 101 (27.08%) 14 (26.4%) 9 (25.0%) 
Quartile 4 74 (23.27%) 78 (20.91%) 18 (33.96%) 14 (38.9%) 
I All chi squared p-values for Tables (2x4) are insignificant 
Table 3-7: Adjusted and unadjusted odds ratios and 95% confidence intervals for risk of 
cleft (all types combined) by level of hemoglobin 
All Controls Odds Ratios (95% Confidence Interval) 
Clefts 
N N Crude Adjusted 1 Adjusted2 
Quartile 1 89 111 .78 (.53-1.14) .808 (.53-1.24) .843 (.56-1.26) 
Quartile 2 92 96 0.99 (0.67-1.46) .988 (.64-1.52) .995 (.66-1.49) 
Quartile 3 98 110 0.88 (0.60-1.29) .938 (.62-1.43) .920 (.62-1.37) 
Quartile 4 92 92 1.0 (ref) 1.0 (ref) 1.0 (ref) 
I Controlling for active smoking only 
2 Adjusted for education, income, ethnicity, BMI, mother's age, vitamin supplementation, parity, alcohol consumption, 
child's gender and active smoking 
Log likelihood test statistics were used to compare logistic regression models both 
with and without smoking and hemoglobin interaction terms. These comparisons showed 
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little to no added benefit to having interaction terms in the model, another indication that 
hemoglobin and anemia have little if any bearing on clefting in this population (Appendix 
B). 
Discussion 
There is a considerable amount of literature on smoking and cleft birth defects, 
however a number of those studies have had methodological flaws, which makes 
interpretation difficult (4, 5). Some of the studies were looking for associations between 
smoking and clefts, with clefts being only a small subgroup of general birth defects- these 
studies did not distinguish between different types of birth defects, and diseases that may 
have no pathological similarities were lumped together (25, 26, 43, 44). Other studies 
were of a prospective nature and even with huge amounts of available births to consider, 
there were only small numbers of cleft cases available for analysis. Also, many studies 
rely on birth certificate or registry data to assess smoking status, which leaves smoking 
exposure uncertain, both as to relevance of exposure times and exposure amount ie. 
number of cigarettes smoked ( 4 ). Data from birth registries may also lack imperative 
information about possible confounding factors that need to be controlled for in statistical 
analyses. 
The design used in the Utah Child and Family Health Study follows closely the 
World Health Organization's recommendations for studies of clefts, which adds a 
measure of validity to the results that are presented herein (14, 59). First, the study is 
population-based with participation rates in the 70th percentile for cases and close to the , 
60m percentile for controls. Case status was confirmed using official Department of 
98 
Health records using standardized coding and detailed information was obtained to 
categorize cases as comprehensively as possible. All initial analysis was done with cleft 
groups separately so as to account for the cited differences in etiologies between different 
cleft subgroups. Only after finding consistent results for smoking across all groups were 
the cases combined to achieve higher statistical power. Detailed information was also 
obtained from participants regarding smoking behaviors during each trimester 
individually, including the number of cigarettes smoked. Information regarding a 
number of other factors pertinent for modeling purposes was also collected, including 
maternal education, income, race, alcohol consumption, vitamin supplementation, age 
and child's gender. The study also utilized materials like the birth calendar that may have 
helped the participants recall their diet and exposures more accurately. And although not 
used in this analysis, the study also has data from a food frequency questionnaire to help 
assess the participants' diets in future studies. Biological samples also contribute a 
tremendous amount of information about each participant for future analysis. The study 
also benefits from the availability of a large control group that, due to lifestyle habits, 
have lower exposure to cigarette and alcohol consumption than many other populations in 
the United States. Overall, this study is very comprehensive and since clinical trials to 
test the effects smoking and other exposures are undoubtedly out of the question due to 
ethical concerns, the Utah study has a lot to offer in terms of a comprehensive 
observational study. 
With that in mind, data from the Utah Study of Child and Family Health confirms 
an increased risk of smoking and oral clefts across all subgroups of clefts. The current 
data supports the fmdings of the most recent meta-analysis for smoking and cleft 
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research, which also indicates that smoking is related to cleft formation and may have a 
corresponding attributable risk of up to 30% (4). The public health implications seem 
obvious. Especially, since smoking is highly correlated with education, it seems that 
educating women, especially those of child bearing age, is a crucial step in reducing 
maternal smoking and the risk of clefting. Hopefully, being aware that smoking may 
increase the risk of having a child with an oral cleft may serve as an incentive for 
younger women not to smoke. Tills is even more crucial considering the trends found in 
this study, indicating that even though there is a pattern of smoking cessation over the 
course of pregnancy, the most significant reduction in percent of smokers who quite 
happens between the first and second trimesters, after the critical embryonic growth 
period for the cleft region. 
The addition of hemoglobin and anemia as co factors in the current analysis is a 
new component in the arena of smoking and cleft research. One early study on birth 
defects did report significant effects of anemia, smoking and the interaction between the 
two on birth weight, but no further analysis has looked specifically at that combination of 
risk factors for clefts (25, 26). While the current results do not show any significant signs 
of anemia contributing to cleft risk, there may be reason not to dismiss the hypothesis in 
its entirety. First, the hypothesis has a firm foundation on biological plausibility. The 
role of hypoxia has been confirmed in several animal studies and carboxyhemoglobin 
levels have a dose dependent effect on clefting ( 46). Other populations that exhibit 
higher rates and more extreme cases of anemia among women of childbearing age may 
be better suited to assess those risks (50, 60, 61). Smoking also confounds the levels of 
hemoglobin in the blood, and other more sensitive measures of red blood cell health may 
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be needed to determine a more complete picture of how the two are related and to tease 
out the effects of inflated levels ofhemoglobin in smokers (54). On that note, the 
smoking trends in this study show that the percent of women who were smoking at the 
time of the interviews was lower than the percent of women smoking before pregnancy 
and during the first trimester. The negative results of anemia in relation to clefting would 
be much more convincing if lab data was available for the participants at the time of 
pregnancy- not something that is practically possible even for future studies. Anemia 
itself is also a very complex physiological state, and a number of things contribute to the 
health and efficacy of the red blood cells besides iron, not a few of which are nutritional 
factors that are also suspected risk factors for clefts, like vitamin B6 and folate (62-68). 
Deficiencies in these and other nutritional biomarkers may be responsible for megoblastic 
anemia, and may decrease the oxygen distributing capacity of red blood cells without 
altering hemoglobin values (54). It could be argued that the biological mechanism by 
which folate, B 12 and B6 contribute to cleft risk is by means of compromised oxygen 
carrying capacity of red blood cells. Without a doubt there will be many more years of 
research in both smoking and nutritional factors associated with clefts and hopefully there 
will be more in-depth research looking at the two in conjunction with one another. 
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SUMMARY AND CONCLUSION 
Summary 
109 
Many factors, both genetic and environmental, are thought to be responsible for 
the formation of clefts in the lip or palate. The current database of literature is extensive, 
therefore the first objective of the research at hand was to review as thoroughly as 
possible the available information regarding cleft lip and palate birth defects (Chapter 2). 
Of particular interest were the many epidemiological studies on smoking and clefts, 
which is a main focus of this study, and a comprehensive review of those studies is 
presented in Table 2-2. Factors affecting nutritional anemias were also reviewed, as well 
as the relationship that anemia has with smoking status. An alternative mechanism by 
which smoking and anemia may contribute to cleft formation was set forth based on how 
the two conditions contribute to hypoxia, a known risk factor for clefts. Data from the 
population-based case control study of clefts in Utah, the Utah Child and Family Health 
Study, was analyzed to test for associations between maternal smoking, anemia and risk 
of cleft. The data suggests that smoking does indeed increase the risk of clefts across all 
subgroups, which coincides with the most current meta-analysis. In Utah where the 
prevalence of anemia is low, there was no indication of any association between anemia 
and clefting, and anemia did not have an effect on the risk estimates associated with 
smoking. 
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Conclusion 
The findings from the Utah Child and Family Health Study bring to light several 
important public health issues regarding the prevention of cleft lip and palate. The 
analysis presented herein confirms that maternal smoking is a risk factor for clefts. The 
data also indicates that smoking rates are highest among women who are less educated, 
which makes educating women, particularly oflow education and income status, a top 
priority for prevention programs. This is even more pertinent considering the startling 
data that shows that even when women stop smoking during pregnancy, many of them 
are not quitting early enough in the pregnancy to eliminate cigarette smoke as a risk 
factor for having a child with a cleft. Targeting young women and other women of child 
bearing age for prevention education will be an important step in stopping increasing 
numbers of women from taking up smoking. 
Due to the fact that smoking also significantly alters nutritional status, and that 
poor nutrition can likewise have detrimental effect on birth outcome, monitoring the two 
.· ; 
conditions together should continue to gain importance. More sensitive and specific 
measures of nutritional health can be used in future studies to gain a more complete and 
accurate picture of how red blood cell health and the development of hypoxia in fetal 
tissue may contribute cleft formation. 
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Utah State 
UNIVERSITY 
The Utah Child and Family Health Study 
Telephone Interview 
Questionnaire 
NIH Grant Number R01 HD39061 
Center for Epidemiologic Studies 
Department of Nutrition and Food Sciences 
Utah State University 
Logan, UT 84322-4450 
May 6, 2002 
/ 
INTRODUCTION TO THE INTERVIEW 
1. Hello, (MOTHER'S NAME), this is (INTERVIEWER'S NAME) from Utah State University. This is the time 
we arranged for me to call you to do the telephone interview for the Utah Child and Family Health 
. Study. 
2. Do you have the materials that we sent to you? Those include the 
Summary of the Utah Child and Family Health Study 
Pregnancy Calendar 
Diet Interview Card 
3. REVIEW OF SUMMARY OF THE STUDY 
YES NO 
YES NO 
YES NO 
We'll talk more about the Pregnancy Calendar and Diet Interview Card later. Let's talk about the 
Summary of the study now. Did you have a chance to read the Summary of the study? Before we 
begin, I need to review the study procedures with you. 
As you know, at this time, I'd like to interview you about your pregnancy history and your diet and 
health shortly before and during your pregnancy (with CHILD 'S NAME/that ended on DATE). After you 
complete the interview, we'll make arrangements to measure your height and weight and to obtain a 
small blood sample, equal to the amount in about one tablespoon, from your arm. We'll measure the 
levels of several vitamins and other nutrients and study the DNA in your blood sample. 
To make our genetic studies complete, we'd like to obtain samples of cells from inside your child's and 
his/her biological father ' s cheek to collect a small amount of genetic material or DNA The cheek cells 
will be collected by gently brushing the inside of the cheek with a soft brush. 
Your participation in this study will contribute to knowledge that may lead to the prevention of cleft lip, 
cleft palate and related birth defects and improve the health of children in the future. There is no 
immediate health benefit to you or your family; however, your family will receive $50 for full 
participation in the study to compensate you for your time and effort. "Full participation" means that 
you've completed the interview and we've collected a blood sample from you and we've obtained 
cheek cell samples from (CHILD'S NAME) and (his/her) biological father. You'll receive less than $50 
for less than full participation in the study. 
All research information will be treated in a confidential manner and you will not be personally 
identified in the reporting of results. Members of the research team will have access to study 
information only after they have signed an Agreement of Confidentiality. 
Your participation is entirely voluntary. If you refuse to participate there will be no penalty or loss of 
benefits to which you're otherwise entitled. You may stop your participation at any time. 
4. Do you have questions about any of the information in the Summary? (ANSWER ANY QUESTIONS) 
5. Do you agree to participate in this interview? / 
YES .... .............. .... ... .. .. ........ .. .......... I 
N0 ... .... .. .. ... .. ... .... ... .. .. , .... .. ............ . 2 
Signature of Interviewer--------------------
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6. Your responses in this interview will make a great contribution to our knowledge about the causes of 
cleft birth defects. Because of this, it's important that your answers be as accurate as possible. Let me 
explain a few things about the structure of the interview. 
• All of the questions have been carefully designed and, for research purposes, must be asked exactly as 
they're written. Some questions may not seem applicable based on answers you've given previously 
but just answer them as best you can. · 
• If you don't understand a question, make sure that you ask me for clarification. 
• If you're not sure about your answer, we'd like your best judgment. If you really can't remember 
something or you just don't know, it's OK to say, "I don't know." 
• We'll be talking mostly about your pregnancy (with CHTI...D'S NAME/that ended on DATE) and I'll make 
sure you know what time period we're referring to before I ask a question. 
• The interview should last about an hour. If you need to take a break before we're firushed, just tell me 
and we'll work it out. 
7. Do you have any other questions before we start? 
B. MOTHER'S DEMOGRAPHICS 
First J"d like to ask you a few questions about your background . 
81. In what state were you born? 
82. What is your birth date? 
83 . What is your maiden name? 
84a. At the time (CHILD'S NAME was born/ 
that your pregnancy ended), what was 
the total number of years you had lived 
in Utah? 
B4b. 
84c. 
BS . 
Are you now a permanent resident of 
Utah? 
How long have you lived in your 
current residence? 
What was your marital status when 
(CHILD 'S NAME was born/your 
pregnancy ended) 
Were you . 
UTAH .. . ........ I 
OTHER (SPECIFY) . . .... .. ..... 2 
SPECIFY STATE OR COUNTRY: 
I I I I 
MONTH LU DAY w YEAR I I I I I 
NUMBER OF YEARS ... 
YES .......... .. ..... .. .... .. .... .. ... . 
NO ................. .. 
LESS THAN 1 YEAR 
1-3 YEARS . 
4--6 YEARS ... .... . .. .. 
7-9 YEARS ... 
10 YEARS OR MORE 
Married . 
Living with someone as married 
Separated or divorced .. . 
Widow/widower _ ........................... .. 
Never married 
RF ........ . ... .. .. 
/ 
.... .. .. ! 
.... .... .. . 2 
..... 1 
... 2 
3 
. . .4 
. .. 5 
.. 1 
..... 2 
.. .................... 3 
4 
. . 5 
... .. ....... ..... . 7 
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B6. What racial or ethnic group do you 
consider yourself a part of? You may 
tell me more than one group . Would 
you consider yourself . 
(IF MOTHER REPORTS MORE TiiAN ONE 
RACIAL GROUP, CODE "OTHER" AND 
SPECIFY GROUPS , I.E. BLACK AND 
HISPANIC) 
IF NEEDED, SEE DEFINITIONS ON PAGE 6. 
B7. At the time that (CHILD'S NAME was 
born/ your pregnancy ended), how 
many years of school had you 
completed? 
B8. At the time that (CHILD'S NAME was 
born/ your pregnancy ended), what was 
your religious preference, if any? 
•NOTE: PROTEST ANT. INCLUDES 
METIIODIST, BAPTIST, EPISCOPALIAN, 
LUTHERAN, PRESBYrERIAN, AND 
CHURCH OF ENGLAND 
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American Indian or Alaska Native 
······· ······ ····· .. I 
TI@E _______________ [IJ 
Asian .... ............ ...... : ..... .. .... ... ......... .... ......... .............. 2 
COUNTRY __________ [I] 
Black or African American ............. ........ ........ ........... 3 
Native Hawaiian or Other Pacific Islander .. ........ ........ 4 
GROUP __________ [I] 
White ... .. ...... ... ... .................... ... ................. ................ 5 
Hispanic or Latino ........................ .......... ....... ....... ...... 6 
GROUP [I] 
Other ..... .............. ...... ......... .. ..... ........... ............ ......... 7 
SPECIFY----------[I] 
RF .......................................................... ...... .... ......... 97 
DK ............................................... .. ........................... 98 
NO FORMAL SCHOOLING .............................. .. ......... .. ......... 1 
J.{) YEARS .. ...... .... ........ ................................... .......... ... ........ .. 2 
7-8YEARS ................................ .............................................. 3 
9-1 I YEARS ......................................................... ... .. ....... .. ...... 4 
HIGH SCHOOL GRADUATE OR GED .. ...... .... ................. .. .... 5 
VOCATIONAL ED. AFfER H.S. DIPLOMA OR GED ........... 6 
SOME COLLEGE (INCLUDES AA DEGREE) ........................ 7 
COLLEGE GRADUATE (BS, BA) .................... ....................... 8 
GRADUATE DEGREE (MS, MA, PH.D, MD, JD, DVM) ....... 9 
RF .... .............................................................. ...... ... ... ............ 97 
DK ..................... ....... ....... ............. ... ...... ...... .. ...... ... ...... .. ....... 98 
CATIIOLIC .......... , ................................................................... l 
EASTERN ORTIIODOX (GREEK OR RUSSIAN) ....... .. ..... .... 2 
ISLAM ... .............. .. .......... ..... .... ... ..................... .. ..... ...... .. ... .. ... 3 
JEWISH ............... ........ .... ....... .. ........... .. ........... ... ... ..... ..... .. ..... 4 
LDS (MORMON) ............... ........... ............................ ............... 5 
PROTEST ANT* ............................................. .... ..... ...... ... ........ 6 
SEVENTII DAY ADVENTIST ............................................ .... 7 
OTHER (SPECIFY) .................... ... ........... ...... .. .... ......... ... ........ 8 
SPECIFY:--------- rn 
NO RELIGIOUS PREFERENCE ................... ............ .... ........ ... 9 
RF ...................... -:; ........................... ............................. ......... 97 
B9. Did XQ1! have a congenital anomaly or 
malformation at birth or a birth defect 
that was found at any time thereafter? 
This doesn't include minor conditions 
like birthmarks, skin tags, postnatal 
jaundice, etc. 
(SEE LIST BELOW FOR EXAMPLES OF 
SOME MINOR BIRTII DEFECTS) 
MINOR BIRTH DEFECTS -DO NOT LIST IN B9 
Umbilical hernia 
Cafe au lait spots 
Birthmark 
Port wine stain (Fiammus Nevus) 
Tongue tie 
Lop ear 
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YES (LIST BELOW) .......... .................... ... ...... .. ........ .... ......... 1 
N0 ....... ... .. ......... .... ..... ........ .... ............... ...... ................. ... ....... 2 
DK ...... ...... .......... ... .................................... . ... .. ..... .. ... ..... 8 
SPECIFY: I I 
----------~~~.~~~ 
----------~~~'·'~~~ ----------~~~'·'~~~ 
DEFINITIONS OF RACIAL AND ETHNIC CATEGORIES (Question B6) 
American or Alaska Native: A person having origins in any of the original peoples ofNorth, Central, or 
South America, and who maintains tribal affiliation or community attachment. 
Asian: A person having origins in any of the original peoples of the Far East, Southeast Asia, or the 
Indian subcontinent inclucling, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the 
Philippine Islands, Thailand, and Vietnam. (Note: Individuals from the Philippine Islands have been 
recorded as Pacific Islanders in previous data collection strategies). 
Black or African American: A person having origins in any of the black racial groups of Africa. Terms 
such as "Haitian" or "Negro" can be used in addition to "Black" or "African .Ainerican." 
Native Hawaiian or Other Pacific Islander: A person having origins in any of the original people of 
Hawaii, Guam, Samoa, or other Pacific Islands (including Australian Aborigine and New Zealand Maori) . 
White: A person having origins in any of the original peoples of Europe, the Middle East, or North 
Africa. 
Hispanic or Latino: A person of Cuban, Mexican, Puerto Rican, South or Central American, or other 
Spanish culture or origin, regardless of race. The term, "Spanish origin," can be used in addition to 
"Hispanic or Latino". 
/ 
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C. BIOLOGICAL FATHER'S DEMOGRAPHICS 
LIVE BIRTII!STIT...LBIRlli: Now I'd like to ask you a few questions about (CHILD's NAME/ the baby)'s 
biological father's background. 
:MJSCARRIAGE/ABORTION: Now I'd like to ask you a few questions about the biological father involved in 
your pregnancy that ended on (DATE). 
Cl. 
C2. 
In what state was (the /CHILD 'S NAME's) 
biological father born? 
What is his birth date? 
C3a. At the time that (CHILD'S NAME was 
born/ your pregnancy ended), what was 
the total number of years he had lived in 
Utah? 
C3b. Is he now a permanent resident of Utah? 
C3c. How long has he lived in his current 
residence? 
C4. What was the father's marital status 
when (CHILD'S NAME was born/ your 
pregnancy ended)? Was he .. . 
UTAH ... .. ....... ... .... ... ... .... ............ ... .. ... ..................... ..... .... ...... I 
OlliER (SPECIFY) ............ ....... ..... ... ........ .... .. .......... ....... .. .. .. 2 
RF ................................. .. ............. ................................. .. .... .... 7 
DK ............. .... .. ............ ... .... .... ... ......... ... .......... . , ................... .. 8 
SPECIFY STATE OR COUNTRY 
I I I I 
MONlli LU DAY w 'YEARI I I I I 
RF ................ ......... ........ .......... ......... .... .. ................... .... ...... .... 7 
DK ............... ....................... ....... ... .. ...... .. ................. ...... ......... 8 
NUMBEROFYEARS ............. ... ... ........... .... ............. ... W 
RF ............................................ ............................................ ... 7 
DK ...................................................... .......... : .. .. ............ ...... .. . 8 
YES .. .. .. ..... .. ... ....... ....... .... ....... .. .... .. .... .... ...... ......................... l 
N0 ............... .. ................. .. ......... ..... ..... ............. ......... ......... ... . 2 
RF ........................ ... ..... ...... ... .... ... .... .............. ... .. ... .... ...... ..... .. 7 
DK ........ ... ... ...... ... ..................................... .. ... .... ........ ........ .... . 8 
LESS TiiAN 1 YEAR ............................................................. I 
1-3 YEARS ... .. ........................ ................ .......... .......... .......... .. 2 
4-6 YEARS ....... .... .... ........ .. .. ... ... ........ .. .......... ........... ... .......... 3 
7-9 YEARS .... ... .. .. .... .......... .. .... .. .. .... ..... ............... ... .. .. ......... .. 4 
10 YEARS OR MORE .............................. .. ................... .. ....... 5 
RF .................................. ... ............. : .. ............. ..... ......... .. ......... 7 
DK .................. ....... ....... ............................................ .............. 8 
Married .................. ........................ ... ...................... ! 
Living with someone as married ..... .... ................... .. . 2 
Separated or divorced ............................ ....... .... ...... .. 3 
Widow/widower. .............. .... .... ..... ... ....... ................. 4 
Never married ... .......... ....... ....... .. .................. ....... .... 5 
RF .................................. ........ .... ........... ....................... ........... 7 
DK .............................................................. .. ......... .. ....... ..... ... 8 
CS. What racial group or racial groups does 
he consider himself a part of? You may 
tell me more than one group. 
C6. 
(IF FATHER REPORTS MORE THAN ONE 
RACIAL GROUP, I.E. BLACK AND 
HISPANIC, CODE "OTHERn AND SPECIFY 
GROUPS) 
IF NEEDED SEE DEFINITIONS ON PAGE 9. 
At the time that (CHILD'S NAME was 
born/ your pregnancy ended), how many 
years of school had the father 
completed? 
C7. At the time that (CHILD'S NAME was 
born/ your pregnancy ended) what was 
the father ' s religious preference, if any? 
*NOTE: PROTEST ANT INCLUDES 
METIIODIST, BAPTIST, EPISCOPALIAN, 
LliTHERAN, PRESBYTERIAN, AND 
CHURCH OF ENGLAND 
American Indian or Alaska Native ..... ...... .. .... .. .. 
TRIBE ________ []] 
Asian .... 
COUNTRY __________ []] 
120 
.. l 
. .... ... 2 
Black or African American .... .... ....................... ........ ... 3 
Native Hawaiian or Other Pacific Islander.. .. ...... .. ....... 4 
GROUP __________ []] 
White ...... .............................. .. .. ..... .. .. .. ...... .. ............ ... 5 
Hispanic or Latino ...................................... .... ... .......... 6 
GROUP []] 
Other.. .... ............... .......... .. .. .... ...... ........................... 7 
SPECIFY----------[]] 
RF .. .............. ..... ........ ........ .. ..... ...... ..... ....................... 97 
DK . ........................................ ... ..... ......... ... .... ........ .... 98 
NO FORMAL SCHOOLING .......... .. .. .. .................................. ! 
1-Q YEARS ....... ... .. ......... ...... ......... .. .... ........................ ..... ...... 2 
7-8 YEARS ... ............... ....... .. ..... .............. ..... ... ...... ... .. .... ........ 3 
9-11 YEARS ....... ... ..... .. ............................................ ....... ....... 4 
HIGH SCHOOL GRADUATE OR GED ...................... .... .... .. . S 
VOCATIONAL ED. AFTER RS. DIPLOMA OR GED .......... 6 
SOME COLLEGE (lNCLUDES AA DEGREE) ...................... 7 
COLLEGE GRADUATE (BS, BA) ............. .. ......................... 8 
GRADUATE DEGREE {MS, MA, PH.D, MD, JD, DVM) ...... 9 
RF .................................................... .. .... .......................... ..... 97 
DK ....... .... .......................... .... ....... ................. .. .......... .. ...... ... 98 
CATIIOLIC ... .. .... ... ....... ... .. .... ................. .. ... .. ... .. .. ................. l 
EASTERN ORTHODOX (GREEK OR RUSSIAN) ............... 2 
ISLAM ....... .................... ...... .... ............ ....... .. .... ...... ............... 3 
JEWISH ..................................... .. ..... ......... .. .. .. .. ..................... 4 
LDS (MORMON) .................................................................. 5 
PROTESTANT* ...... ..... ... .................................. ...... ...... .. ....... 6 
SEVENTH DAY ADVENTIST ........... .............. .. ........ .. .......... 7 
OTIIER (SPECIFY) ............ .. ............ ...... ....... ..... ..... .. ............ 8 
SPECIFY: _________ [][] 
NO RELIGIOUS PREFERENCE ................ .... ... ... .......... ...... . 9 
RF ..... .. ................ ~: .. ..... ........ .... .... ..... .... ................................ 97 
DK ... .... .. ... ................. .... ........... ......... ................ ........ ..... .. ..... 98 
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C8 . Did the father have a congenital anomaly YES (LIST BELOW) .... .. .... .. ....... .. ................ .. ..... ..... .. .. ....... I · 
or malformation at birth or a birth defect NO .. .. ....... .... ......•.. •••• ... .•. .. .. .... ... .. .. .. ...... ....... ....... .... .. ....... ... 2 
that was found at any time thereafter? DK ................ .. ..... ..... ....... ... ... .... .. ... .... ...... .. .. . ... ..... . .. .... 
This doesn' t include minor conditions 
like birthmarks, skin tags, postnatal 
jaundice, etc. 
(SEE LIST BELOW FOR EXAMPLES OF 
MINOR BIRTI:l DEFECTS) 
MINOR BIRTH DEFECTS -DO NOT LIST IN Cs 
Umbilical hernia 
Cafe au lait spots 
Birthmark 
Port wine stain (Flarnrnus Nevus) 
Tongue tie 
Lop ear 
SPECrFY: 
DEFINITIONS OF RACIAL AND ETHJI.'IC CATEGORIES (Question C5) 
I I I 1.1 I 
I I I 1.1 I 
I I I 1.1 I 
American or Alaska Native: A person having origins in any of the original peoples ofNorth, Central, 
or South America, and who maintains tribal affiliation or community attachment. 
Asian: A person having origins in any of the original peoples of the Far East, Southeast Asia, or the 
Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, 
the Philippine Islands, Thailand, and Vietnam. (Note: Individuals from the Philippine Islands have 
been recorded as Pacific Islanders in previous data collection strategies). 
· Black or African American: A person having origins in any of the black racial groups of Africa. 
Terms such as "Haitian" or "Negro" can be used in addition to "Black" or "African American." 
Native Hawaiian or Other Pacific ]slander: A person having origins in any of the original people of 
Hawaii, Guam, Samoa, or other Pacific Islands (including Australian Aborigine or New Zealand 
Maori). 
White: A person having origins in any of the original peoples of Europe, the Middle East, or North 
Africa. 
Hispanic or Latino: A person of Cuban, Mexican, Puerto Rican, South or Central American, or other 
Spanish culture or origin, regardless of race. The term, "Spanish origin," can be used in addition to 
"Hispanic or Latino". 
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ThiTERVffiWER~ORMATION 
DEFINITIONS OF PREGNANCY RESULTS 
STILLBIRTII: PREGNANCY LASTED MORE TIIAN 4 MONTIIS; INFANT DIED BEFORE 
BIRTII. 
MISCARRIAGE: PREGNANCY LASTED 4 MONTIIS OR LESS. 
ABORTIONrrERMINA TION: PREGNANCY ThiTENTIONALL Y TERMINATED. 
TUBAL/ECTOPIC: FERTILIZED EGG DEVELOPED OUTSIDE OF TIIE WOMB (IN STOMACH, 
OVARY, TUBES, ETC.). 
MOLAR PREGNANCY: RESULT OF AN ABNORMAL PREGNANCY WHEN TIIE FERTILIZED EGG 
DOESN'T DEVELOP AND TIIE PLACENTA OVERGROWS AND TinCKENS, 
SOMETIMES BECOJIAING A TIJMOR. 
D. PREGNANCY HISTORY 
The next questions are about your pregnancy history and fertility . 
Dl . How old were you when you had your 
AGE IN YEARS L1J first menstrual period? 
DK ... ... ........ ............ ....... 98 
D2. How many times have you been pregnant 
TOTAL NUMBER OF PAST PREGNANCIES L1J in the past, including all pregnancies that 
may have ended in a live birth, 
miscarriage, stillbirth, termination, 
abortion, or a tubal or molar pregnancy? 
If you ' re pregnant now, don't count that 
pregnancy in this number. 
D3. Which one was the pregnancy (with 
NUMBER OF INDEX PREGNANCY L1J CHILD 'S NAME/ that ended on DATE)? 
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12 
FIRST PREGNANCY: 
Now I'm going to ask you some questions about each of your pregnancies, starting with your first one. 
D4. How old were you when you became LLJ pregnant for the first time? AGE IN YEARS 
DS. What was the result of your first LIVE BIRTII.. ... ..... .. ............ ............ : .......... ...... ....... ..... .......... 1 
pregnancy? By tbis I mean was it a live STillBIRTII (GO TO 07) .... .... ... ....................... .. ............. .... 2 
birth, stillbirth or some other outcome? MISCARRIAGE (GO TO 07) .... .... .. ... ... ........... ...... ... .... .. .. ... .. 3 
ABORTION (GO TO 07) ....................................................... 4 
TIJBAUECTOPIC (GO TO 07) .............................................. 5 
MOLAR PREGNANCY (GO TO 07) ............ ......................... 6 
OTHER ........ .. .............. ... ............... .. ... .... ................... 7 
SPECIFY 
RF (GO TO CHECKPOINT#2, PG. 13) .................... .. .... ...... 97 
OK (GOTO CHECKPOINT#2, PG. 13) ............ .. ................. 98 
D6a. LIVE BIRTII: Was the pregnancy full-term Fullterm (ON TIME) ..... 1 
or did it end early or late? Early (PREMA TIJRE) ..... 2 
BYLU WEEKS (IF EARLY OR LATE, ASK AND RECORD Late (OVER-DUE) ......... 3 
NUMBER OF WEEKS) 
D6b. LIVE BIRTII: What date did your first 
MONTIILL] DAYLU YE~ I I I I pregnancy end? 
D6c. LIVE BIRTII: How many babies did you 
LU 
carry in your first pregnancy? TOTAL NUMBER OF BABIES 
D6d. LIVE BIRTH: What was the (first) baby's PRINT FULL NAME: 
name? 
D7. INDEX BABY? YES ... .. .... ...... .. .... .... .... ............... ... ....... .. ... ............. .... ... .. ....... 1 
(LIVE BIRTH GO TO 09) N0 ............................ .. .................. .......... ... .... ... ..... ................. 2 
D8a. STILL/MIS/AB/TIJB/MOL: How far along 
LU were you when the pregnancy ended? WEEKS 
PROBE TO GET BEST ESTIMATE OF# WEEKS 
(CONVERT MONTIIS TO WEEKS IF 
NECESSARY). 
D8b. STILIMIS/ AB/TIJB/MOL: Do you know how 
LU many babies you were carrying? TOTAL NUMBER OF BABIES 
D8c. STILL/MIS/ AB/TIJB/MOL: Were you told YES .................. :.:-....... ... ................ ........ .. .... .. .......... ................ 1 
anything about the baby you lost, such as NO (GO TO CHECKPOINT# I) .... .... .. ....... .. ... ........ .......... .. . 2 
its sex or if there were any apparent health 
problems? 
D9. What (is/was) (CHll.lJ'S NAME/ the baby)'s MALE ........... ............ ............. ... .. .. ... ................. .... ..... ....... .... .. ! 
sex? FEMALE ............................................ : .. ......... .. .. ... ................. 2 
DlO. Did this baby have a cleft lip or cleft 
palate? 
D 1 Oa. Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
D10b. Was the cleft on one side, both sides or 
in the middle of the lip? (IF ONE SIDE 
REPORTED, ASK WHETHER RIGHT OR 
LEFT.) 
D 1 Oc. Was there a cleft of the palate, that is the 
roof of the mouth? 
D I Od . Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
DIOe. Did the cleft involve the gums and teeth? 
D 11 . Did this baby have any other birth defects? 
UNKNOWN ................ .. .............. ...................................... ..... . 3 
YES .... .. .. ....................... .. ....... .. .......... . : ............................. ..... ! 
NO(GOTOD11) ................. .... .................. ..... ........................ 2 
DK (GO TO 011) .................................................................... 8 
YES ....................................... ... ...... .. ................... ... ........ .. ..... . ! 
NO(GOTOD!Oc) .................. ... .......... ............ ............ ........ ... 2 
DK(GOTOD10c) .................. ......... ...... ................................. 8 
RIGHT SIDE ONLY .... ...... ...... ...... .... .............. ... .. .. ..... .... ..... .. 1 
LEFT SIDE ONL ¥ ...... ...... ... .... .... ............. .. .. ........ .... .. ... ......... 2 
BOTif SIDES (Bll.ATERAL) .... .... ........ .. .. .. ....... .... : ............... 3 
MIDLINE ........................................ .. .. .......... ........ .. ......... ....... 4 
.DK ............................................................... ... ........ ... ........... .. 8 
YES ............ ....... ... ................................ ... .... .................... ..... .. ! 
NO (GO TO D10e) .............. .. ............................................ .. .... 2 
DK (GO TO D!Oe) : .......... : ............................ .. .. ....... .... .. ......... 8 
SOFT PALATE ONLY .................................... ...... .. ............... ! 
SOFT AND HARD PALATE .... ....... ........ ... .. ......... ... .. ......... .. . 2 
DK .. ... ............... .... .......... ................. .. ..... .. ... .. ... ...... ................ 8 
YES ...................................... ... ................... .... ....... ... ............. . l 
N0 ......................................................................... .. ......... ...... 2 
DK ... ........................ .. .......... .. .......... ...... ..... ........ .. ... .. .... .. ....... 8 
YES (LIST BELOW) ............ ....................... ... .. .......... .... ..... .... I 
N0 ..................................................................... ............ ... ...... 2 
DK ..... ............................................ ...... ............... ........ .. ... ....... 8 
SPECIFY: 
'---'-__.___.I.L--1 _.__......___. 
_____ .__.__...___.I.L--1 _.__......___. 
L.......l..--'----'1. L--1 --'---L--J 
#I INTERVIEWER SINGLE BAB"'': ONE PREGNANCY ONLY <GO TO D?-k PG. 16l ...... ... . 1 
CHECKPOINT· SfNGLE BABY: ADDITIONAL PREGNANCIES tGO TO 2ND PREGNANCY. PG . l~ L .. 1 
MULTIPLE BABIES IN THIS PREGNANCY <CONTINUE!. ..... ......... .... . ...... .... ·' 
Now I'd like to ask some questions about the second baby in this pregnancy. 
D12. 
Dl3. 
LIVE BIR1H: What was the second 
baby's name? 
INDEX BABY? 
(LIVE BIR1H GO TO Dl5) 
PRINT FULL NAME: 
/ 
YE$ ........................ .... .......................................... .. .... ........... 1 
N0 .............................. ............................ .......... ......... ....... ..... 2 
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Dl4. 
Dl5 . 
STILUMIS/ABmJB/MOL: Were you told 
anything about the baby you lost, such as 
its sex or if there were any apparent 
health problems? 
What (is/was) (CHILD'S NAMFJ the 
second baby)'s sex? 
Dl6. Did this baby have a cleft lip or cleft 
palate? 
D 16a. Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
DI6b. Was the cleft on one side, both sides or 
in the middle of the lip? (PROBE IF ONE 
SIDE REPORTED, ASK WHETHER RIGIIT 
OR LEFT.) 
Dl6c. Was there a cleft of the palate, that is the 
roof of the mouth? 
D 16d. Did it involve only the soft part at the 
rear ofthe palate or both the soft and 
hard parts of the palate? 
D 16e. Did the cleft involve the gums and teeth? 
Dl7. Did this baby have any other birth 
defects? 
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YES .... ....... ..... ...... .. ......... ....................................................... ! 
NO (GO TO CHECKPOINT# 2) ............................................ 2 
MALE ....... .......... .. ................................................................. I 
FEMALE ............................................................................... 2 
UNKNOWN .......................................... .. .. ................ .. ........... J 
YES ................. .. .... .... .. ... ....... ... .............. .... .... ..... ................... ! 
NO(GOTOD17) .. .. ................... .... ... ........ .. ............. ...... ...... ... 2 
DK (GO TO 017) .................................................................... 8 
YES .................... ............ .... , ............. .. ..... ...... ..... ................... . l 
NO(GOTOD16c) .................................................................. 2 
DK(GOTO DI6c) ............................. ... ...... .. ......... .. ........ .. ..... 8 
RIGHT SIDE ONLY ............ .... .................. .... .................... .. ... 1 
LEFT SIDEONLY ........ .......... ...... .. .............................. .. .... ... . 2 
BOTH SIDES (BILATERAL) ...... .... .. ... .... .... ........ .. .... .... ........ ) 
MIDL1NE ........................... .. ........... .. .......... ......................... .. . 4 
DK ........ ..... .............. .. ..................................... ... ..................... 8 
YES ................. ...... .. .. ..... ............................... ... ...................... ] 
NO(GOTOD16e) ..................................... ..... ........ ............. ... 2 
DK (GO TO Dl6e) ...... ............. ........ .......... ............... ........ ...... 8 
SOFT PALATE ONLY ........ .. .. .. ............................. : ............... ! 
SOFT AND HARD PALATE .................................... .... .......... 2 
DK ..................... ............... ..... ............ .. .... ..... .......... ...... ... .... ... 8 
YES ........... ... ........ ........ ............... .... ...... ..... .... .......... ... .. .... ..... l 
N0 .................. .......... ...... ......... ..... .. .. ............ ............ ... .... .. ... .. 2 
DK ................................................... .... ...... ..... ........... ...... ... ... . 8 
YES (LIST BELOW) ............................................................... I 
N0 ......................................................... ........ .... ... ....... ....... ... . 2 
DK ................. ................... .... ....... ..... ................ ...... ... ............. 8 
SPECIFY: I I 
---- L-l---l...---.J eL--L-.J....__j 
____ L-l___I__..JI.L-1 --L-.J....__j 
____ L-l---l...---.JI.L-1 --L-,..1..__,; 
#2 I~TERVIEWER 2 BABIES IN THIS PREGNANCY; 1 PREGNANCY ONLY (GO TO 074, PG. 26) ......... 1 
CHECKPOI:-IT: 2 BABIES IN THIS PREGNANCY; ADD'LPREGNANCIES (CONTINUE) .. .............. .. .. 2 
3+ BABIES IN THIS PREGNANCY (GO TO PREG. CONTINUATION FORM) .... ........ . 3 
SECOND PREGNANCY: 
Now I'd like to ask you a few questions about your second pregnancy. 
DI8. How old were you when you became LU pregnant for the second time? AGE IN YEARS 
DI9. What was the result of your second LIVE BIRTIL ........................... ........ ................ ...... ................ 1 
pregnancy? By this I mean was it a live STILLBIRTH (GO TO 021) ... .. .... ........ ..... ............................. 2 
birth, stillbirth or some other outcome? MISCARRIAGE (GO TO 021) ... ...... ...... ... ........... ..... .... ......... 3 
ABORTION (GO TO 021) ........................ .. ...... ..................... 4 
TUBAUECTOPIC (GO TO 021) ............... ... .... ........... .. .... ..... 5 
MOLAR PREG (GO TO 021) ........................ ... .. .................... 6 
OTHER (SPECIFY) .. .. ................... ..... ....... ..... .... ... ... .. .. 7 
SPECIFY 
RF (GO TO CHECKPOINT #4 PG. 16) ...................... .. ......... 97 
OK (GO TO CHECKPOINT #4 PG.16) ... ... ........................... 98 
D20a. LIVE BIRTH: Was the pregnancy full- On time (FULL TERM) ... ... 1 
BYLU term or did it end early or late? (IF Early (PREMATURE) ........ 1 WEEKS 
EARLY OR LATE, ASK AND RECORD Late (OVER-DUE) ... ........ 3 
NUMBER OF WEEKS) 
D20b. LIVE BIRTH: What date did your second 
MONTHL_j_J DAYL_j_J YE~ I I I I pregnancy end? 
D20c. LIVE BIRTH: How many babies did you 
TOTAL NUMBER OF BABIES LlJ carry in your second pregnancy? 
D20d. LIVE BIRTH: What was the (first) baby's PRINT FULL NAME: 
name? 
D21. INDEX BABY? YES .. ................. ....... .... .............. ..................... .. ............. .... .... l (LIVE BIRTH GO TO 023) N0 ...... .. ......... ................................ ..... ............. .. ... .. ......... .... .. . 2 
D22a. STILL/MIS/ ABITUB/MOL: How far along LU were you when the pregnancy ended? WEEKS 
PROBE TO GET BEST ESTIMATE OF# 
WEEKS (CONVERT MONTHS TO WEEKS 
IF NECESSARY). 
D22b. STIL/MIS/ ABITUB/MOL: Do you know LlJ how many babies you were carrying? TOTAL NUMBER OF BABIES 
D22c. STILL/MIS/ ABITUB/MOL: Were you told YES .................... .. .......................... ........................................ l 
anything about the baby you lost, such NO (GO TO ~CKPOINT # 3) ........................................... . 2 
as its sex or if there were any apparent 
health problems? 
D23 . What (is/was) (CHILD'S NAME/the MALE ......... .. .. ......................... .. ..................... ........ ...... .......... I 
baby)'s sex? FEMALE ..................... .... ..... .. .................................. ...... .. .. .... 2 
I 
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D24. Did this baby have a cleft lip or cleft 
palate? 
D24a. Please tell me the structures that were 
involved in the baby' s cleft. Did the 
baby have a cleft lip? 
D24b. Was the cleft on one side or both sides 
of the lip? (PROBE IF ONE SIDE 
REPORTED, ASK WHETHER RJGHT OR 
LEFT.) 
D24c. Was there a cleft of the palate, that is 
the roof of the mouth? 
D24d. Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
D24e. Did the cleft involve the gums and · 
teeth? 
D25 . Did this baby have any other birth 
defects? · 
YES ......... .... ....... ...... ............. ..... ........... ... .. .. ... ....... .. ... .... ..... .. ! 
NO (GO TO 025) ... ... ... ........... .... ... .. ... ............ .... .. ..... ............. 2 
DK (GO TO 025) .. .. ... ... .... ... ...... ......... ... ..... ..... ... ....... .... .. .... . 18 
YES ... ... .. ... ......... ........ ..... ................. .. .... ..... ... ........ ... ..... .. ...... ! 
NO (GO TO D24c) ..... ... .... .. .... .... ...... .... ....... ................ ...... ..... 2 
DK (GO TO D24c) ............ .... .... ..... .... .. ... .............. ... .. ... .. .. .... .. 8 
RJGHT SIDE ONL¥ ..... ..... .......... ...... .. ..... .................... .......... 1 
LEFT SIDE ONL ¥ ................... ........ ... ......... ...... .. ... .... ............ 2 
BOTII SIDES (BILATERAL) .. ......... ........ ...... ....... ..... ............ 3 
MIDLINE .. ...... .. .... ... ... ............... ... ..... ........ .. ... .... .... .. ... ....... ... 4 
DK .. ... ... ........ ...... .... .......... ........ .. ... .. ... ........... .... .... .. .... ........... 8 
YES ...... ...... .. ........ ........ ... ..... ...... ... .......... ..... .. .. ... ...... ... .. .... .... ! 
NO (GO TO D24e) .. .. .... ........ .. ..... .... ..... .......... ......... .. ....... ... ... 2 
DK (GO TO D24e) ..... .... ........... ... .. .. .. ..... ...... .... .......... ............ 8 
SOFT PALATE ONLY ..... .... ... ....... .... ...... .... ........... ........... 1 
SOFT AND HARD PALATE .... ....... .............. ...... .. ..... ..... ...... . 2 
DK ............................ ....... ... .... ... ..... ...... ........ .. ..... .......... .. .... ... 8 
YES ..... .. .. ....... ... .. .. : ......... ...... ... ... .... .......... ..... .. , ... .. ........ ........ ! 
N0 ........ ... .............. ..... .. ... ....... .... ........ .. ... ....... .......... ....... ..... .. 2 
DK .. .. ....... ..... ............ .. ..... .... .... ... ....... ............ ............. ..... .... ... 8 
YES (LIST BELOW) ........ ..... .... .... ..... ...................... ...... ........ 1 
N0 .... ... ........ ............... ....... .. ... .. .. ..... .. .... .. ... ... .. .. .......... ........... 2 
DK.... . ..... ........... .. ........... . ................. 8 
SPECIFY: 
'---'----'----''· '-----''---'---'1 
.__.__L.--JI. '--'---'---'1 
'---'----'----''· '---'----'--'\ 
#3 1:'\TERVIEWER SINGLE BABY: TWO PREGNANCIES ONI. Y !GO TO D74. PG. 261 . . ... ... ... .......... 1 
CHECKPOINT: SINGLE BABY·. ADDITIONAL PREGNANCIES 1GOTO :>RD PREGNANCY. PG. 1il . .. 2 
l'viUL TJPLE BABIES IN TI-llS PREGNANCY !CONTINUE!. ........ .. .. ...... ..... ........ :; 
Now I'd like to ask some questions about the second baby in this pregnancy. 
D26. 
D27. 
LIVE BIRTII: What was the second 
baby's name? 
INDEX BABY? 
(LIVE BIRTH GO TO D29) 
PRINT FULL NAME: 
YES ....... ........ ... .............. ........ : ...... ... ........ ....... .. ... .. ... ... .. ... .... l 
N0 ............... ....... .. ............... .. ... ... ...... ..... ... .. ........... : ... ... ....... . 2 
D28. 
D29. 
D30. 
D30a. 
D30b. 
D30c. 
D30d. 
D30e. 
D31. 
STILLIMIS/ABmJB/MOL: Were you told 
anything about the baby you lost, such 
as its sex or if there were any apparent 
health problems? 
What (is/was) (CHU,D'S NAME/ the 
second baby)'s sex? 
Did this baby have a cleft lip or cleft 
palate? 
Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
Was the cleft on one side or both sides 
of the lip? (PROBE IF ONE SIDE 
REPORTED, ASK WHETIIER RlGHT OR 
LEFT.) 
Was there a cleft of the palate, that is 
the roof of the mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and 
teeth? 
Did this baby have any other birth 
defects? 
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YES ................... .......... ............. .. ..... .................................. ..... 1 
NO (GO TO CHECKPOINT# 4) ........... .. ... .. .............. .. ...... ... ] 
MALE ......... .. ...................................... ..................... .............. I 
FEMALE ...................... .. ............ ...... .. .... ........... ... ................. 2 
UNKNOWN ........ ................ ...... .. ... ......................... ... ............ 3 
YES ........ .......... ....................... .. .... ......... ....... .. ................. ..... . 1 
NO (GO TO D31) ............................ ...... ...... .................. ......... . 1 
DK (GO TO 031) ........ ....... ..... .. ........ .. ........ ...... .................. .. .. 8 
YES ..... ...... ......................... .............. .................. ....... .... .. ....... 1 
NO (GO TO D30c) ...................................... .. .... ... .... ............... 1 
DK (GO TO D30c) ......... .... .. ... ... ........... .... .......... ..... ... ........ .... 8 
RlGHT SIDE ONLY ..... ... ....................... ........ ... .. .. .. ... ... ......... 1 
LEFT SIDE ONLY .... ........ .. ...... .......... ... ... .... ..... ..... ... .. ........... 1 
B01H SIDES (BILATERAL) ............. ...... ..... .... ........ ... .......... 3 
MIDLINE ............. : ...... ... .. ... .. ... ..... ... ... .... ....... .......... .. ............ 4 
DK ...... ....... ... ....................................... .............. ....... ..... .. .... ... 8 
YES ....... .. ...... .. .... ... ......... .... ... ...... .. ................ ..... ... .. ..... .. .. ..... I 
NO (GO TO D30e) .......................................... .. ............ .......... 1 
DK(GOTOD30e) ................................................ ... ... ........ .... 8 
SOFT PALATE ONL ¥ .... ... ...... ... ..... ... .. ..... ....... .. ....... ............ 1 
SOFT ANDHARDPALATE .............. ........................... .. ....... 2 
DK ............. ...... ............ ..... ... ... .. ...... .. .... ... ... .... ........ ................ 8 
YES ..................... ...... ........... ... ...... ............... ....... ..... .............. 1 
N0 .......... .. ......... .. ... ....... .................. ................. ... ............ .... ... 2 
DK ... .. .............................. ...... ... ...... ....... ..... .............. ..... ..... ... . 8 
YES (LIST BELOW) ........................... .................... .. ...... ... .... 1 
N0 ... ..... ......... .. .............. ... ....... ..... ... ...... .. ........ .... ......... .. ........ 2 
DK ........ .. .. ......................... .......... ...... ..... ..... .. ......... .. .... ... ....... 8 
SPECIFY: L---L---1--JI • ...___..____.~ 
1..-J..--L.--.JI • ....__....__,_--1! 
1..-J..--L.--.JI ~....__....__,_-'! 
#4 INTERVIEWER 2 BABIES IN TillS PREGNANCY; 2 PREGNANCIES ONLY (GO TO D74, PG. 26) .... 1 
CHECKPOINT: 2 BABIES IN TillS PREGNANCY; ADD'L PREGNANCIES (CONTINUE) .................. 2 
3+ BABIES IN TillS PREGNANCY (GO TO PREG. CONTINUATION FORM) ... ......... :; 
THIRD PREGNANCY: 
Now I'd like to ask you a few questions about your third pregnancy. , 
D32. How old were you when you became 
AGE IN YEARS LU pregnant for the third time? 
D33. What was the result of your third LIVE BI.RTii .... .... ........ ....... ........... ... .... .... ... .... ........ .. ........ ..... 1 
pregnancy? STJLLBIRTii (GO TO 035) ................................................... 2 
MISCARRIAGE (GO TO 035) ......................... ............ ...... . .. 3 
ABORTION (GO TO 035) ................... ....... .. ..... .. ............... .. . 4 
TUBAL/ECTOPIC (GO TO 035) ..... .... .. .. ......... .. .. .. ........ .. ...... 5 
MOLAR PREG (GO TO 035) ..... .... .. ........ ...... ....... .. ............ ... 6 
OTIIER (SPECIFY) ............ .. .......... .... .. .. . .. .. ................. 7 
SPECIFY 
RF (GO TO CHECKPOINT #6 PG. 19) ... .. ...... .... ...... .. .......... 97 
DK (GO TO CHECKPOINT #6 PG. 19) .... ...... .. ................... 98 
D34a. LIVE BIRTii: Was the pregnancy full-term On time (FULL TERM) .. 1 
or did it end early or late? (IF EARLY OR Early (PREMATURE) .... 2 
BYL_lj WEEKS LATE, ASK AND RECORD NUMBER OF Late (OVER-DUE) ........ 3 
WEEKS) 
D34b. What date did your third pregnancy end? 
MONTiil_lj DAYLlJ YEA.Rj I I I I 
D34c. LIVE BIRTii: How many babies did you 
TOTAL Nm1BER OF BABIEsLlJ carry in your third pregnancy? 
D34d. LIVE BIRTii: What was the (first) baby' s PRINT FUll NAME: 
name? 
D35. INDEX BABY? YES ............. ...... ......... .......... ...... .... ...... .... ..... ... ... ..... ... ........... l 
(LIVE BIRTii GO TO 037) N0 ......... ............... .. ..... ................ ...... .... ....... ............. ..... ...... .. 2 
D36a. STJLUMIS/ AB/TUB/MOL: How far along UJ were you when the pregnancy ended? WEEKS 
PROBE TO GET BEST ESTIMATE OF # 
WEEKS (CONVERT MONTiiS TO WEEKS IF 
NECESSARY). 
D36b. STJL/MIS/ AB/TUB/MOL: Do you know 
LlJ how many babies you were carrying? TOTAL NUMBER OF BABIES 
D36c. STJLUMIS/ AB/TUB/MOL: Were you told YES ..................... -' .. ... .... ... .... ........................ .................... .... ... 1 
anything about the baby you lost, such as NO(GOTO CHECKPOINT#5) .. .... .. ..... .. .... ........... .... .......... 2 
its sex or if there were any apparent 
health problems? 
' 
D37. 
D38 . 
D38a. 
D38b. 
D38c. 
D38d. 
D38e. 
D39. 
What (is/was) (CHILD'S NAME/ the 
baby)' s sex? 
Did this baby have a cleft lip or cleft 
palate? 
Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
Was the cleft on one side or both sides of 
the lip? (PROBE IF ONE SIDE REPORTED, 
ASK WHETHER RJG!:IT OR LEFT.) 
Was there a cleft of the palate, that is the 
roof of the mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
MALE ..... ............ ......... ..... ............... ... ...... ..... ....... .................. ! 
FEMALE .. ... ... ......... .... ........... ... .... ................................ ... .. .... 2 
UNKNOWN .. .... ..................... .. .... .. .... ... .... ............. .... .. ....... .... 3 
YES .. ..... ........ .. .......................... ...................... ..... .. ......... .. .. ... ! 
NO (GO TO 039) .......... .... .................................... .. .. .. .......... . 2 
DK (GO TO D39) .... .... .. .................... ........ ..... ......................... 8 
YES ........ ... ..... ..... ... ... ...... .. .. ... ............. .... ~ ...... ... ... .................. ! 
NO(GOTOD38c) ......... ........ .. .... ... .... .................................... 2 
DK(GOTOD38c .... ........ ............ ................. .... ...................... 8 
RJG!:IT SIDE ONLY .............................. .... ............................. 1 
LEFT SIDE ONLY. .. .. ............................ .. ......... .......... ... ......... 2 
BOTH SIDES (BILATERAL) ....... .. ........... .... ......................... 3 
MIDLINE ..... ........................................................... ....... ....... . 4 
DK ..................... ......... .......... ........................ .................. ........ 8 
YES ..... .......... ..... ..... .... ............ .. ...... ............ .. ... ...................... l 
NO (GO TO D38e) ............................. ..... ............... .......... ... .. .. 2 
DK (GO TO D38e) ... ........... .. ............ .. ... : ........... .... .. ............... 8 
SOFTPALATEONLY ............................. .... .............. .. ... ....... l 
SOFT AND HARD PALATE ........ ........ ...... .. .. .. .. .. .. .... ... ... ...... 2 
DK ................................. ............ ... ......... ..... ....... ... ...... ....... .. .. 8 
YES .. ... ..... ..................... ................ ..... .. ............. .. .... ........ .. ..... ! 
NO .. ... ....................... .. .. .. .. ........ ........................... 2 
DK ............. ... .. .... ... ................ .. ................ .. .. : ........... .. ............ . 8 
YES (LIST BELOW) ..... .. ..... ....................... ................ ........... 1 
N0 .......... .... ............ ............................... .. ............................. .. 2 
DK .. ................... ............. ... .... ..... ................. .. ......................... 8 
SPECIFY: 
.____.____.__! _,1. '----'----'---'! 
'----'--'-1--'1. '----'----'----'1 
_____ .__.___._I __.1 • .____.___.__.
1 
#5 INTERVIEWER SINGLE BABY: THREE PREGNANCIES ONLY (GQ TO 07-t PG. 261.. . ... ...... ... . . 
CHECKPOINT: SINGLE BABY: ADDITiONAL PREGNANCIES (GO TO -ITH PREGNANCY. PG. 201 ... 2 
!V1UL TIPLE BABIES IN THIS PREGNANCY (CONTINUE! .. ..... .. .... .. .. ........ .... , 
Now I'd like to ask some questions about the second baby in this pre~ancy. 
D40. 
D41 . 
LIVE BIRTH: What was the second 
baby's name? 
INDEX BABY? 
(LIVE BIRTH GO TO 043) 
PRJNT FULL NAME: 
YES .. .... ..... .. ......... .. .. .... .... .. ....... ... .... ... .. .. ................. .... .. .... ... l 
N0 ..... .. ........ ..... ....... .... ......... .. ............ .... .................. ............. 2 
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D42. 
D43. 
STILUMIS/ABrruB/MOL: Were you told 
anything about the baby you lost, such as 
its sex or ifthere were any apparent 
health problems? 
What (is/was) (CHILD'S NAME/ the 
second baby)'s sex? 
D44. Did this baby have a cleft lip or cleft 
palate? 
D44a. Please tell me the structures that were 
involved in the baby' s cleft. Did the 
baby have a cleft lip? 
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YES ..... ...... , ..... ......... ..... .... ... ....... .. ..... .. .. ... ........ .. ..... ........... ... ! 
NO (GO TO CHECKPOINT# 6) .. ....... ..... .... .. .. ............... : .... . 2 
MALE ..... ............... .... ........ ... .... .. .... ...... ... ... .. ... .... .. ..... .... ....... I 
FEMALE .. ........ ... .... ... ................. ... .............. ..... .. ...... ............ 2 
UNKNOWN ........................ ... ...... ........ .. .. .............. ............... . 3 
YES .. .. .. ..... .. . ....... ....... ... ...... .... ...... .......................... .. .. ... ....... . ! 
NO (GO TO D45) .... .. .. .......... ... .... .. .. ... ................. .. ..... ....... ..... 2 
DK (GO TO D45 .. .. .................... ........... .... ........ .. ......... ...... .. .. . 8 
YES .......... .. ... .. ... ..... ....... ............... ... ... .. ................... .. ... ........ . ! 
NO (GO TO D44c) ................................ ....... .. .. .... ............. ... ... 2 
DK (GO TO D44c) .... .. .. ... .. ................. ... ............ ....... .. ............ 8 
D44b. Was the cleft on one side or both sides of RIGHT SIDE ONLY ............... .. ......................................... ..... I 
D44c. 
D44d. 
D44e. 
D45. 
the lip? (PROBE IF ONE SIDE REPORTED, LEIT SIDE ONLY ..... ....... ... ........... ... .. ................ ... ....... ...... .. . 2 
ASK WHETHER RIGHT OR LEIT.) BOTif SIDES (BILATERAL) ......... ..... .. ...... .. ..... .. ... .. ............. 3 
Was there a cleft of the palate, that is the 
roofofthe mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
MIDLINE ... ................ .... .. ..... ..... ......... ............... ......... .... ....... 4 
DK ..... .. ......................... ...... ... ... .. ... ... ......... .... .................. .... .. . 8 
YES .... ...................... .................. ................ ..... .... .... ............... ! 
NO (GO TO D44e) .. .. ... .. .... ....... .. .... .... ... ....... .......... .. .. .. .......... 2 
DK(GO TO D44e) ...... .... .. .............. .. .......... .. ......... .................. 8 
SOITPALATEONLY .... .. ..... .... ........................ .. .. ................ l 
SOFf AND HARD PALATE ....... .. ...... .. .. .. .................. .. .. ... .. . 2 
DK .. ........ .. ... .... .............. ......... .. ..... .. ....... .......... ........ .... ... ....... 8 
YES ....... ... .. .. ....... ... .. ....... ...................... ....... ... ...... ..... .... ...... .. ! 
N0 ....... ......... ........ .. .. .. .. .. .. ..... .. ... ... ... .. ... ......... ................. .... ... 2 
DK ...... .. ....... .... ... .' .... .. .. ..... .. ..................... ..... .... ......... ............ . 8 
YES (LIST BELOW) .. .. ....... ..... ... ...... ..... .. ..... ... , ... ........ ..... ..... ! 
N0 .. ................................................................... .. ... ..... ... .. ... ... 2 
DK ... ... ... .................... .. ..... .. ....... : .. ......... ............ .. ..... ..... ... ..... . 8 
SPECIFY: I 
----- '----'--..L-..1 •'---'---'--....JI 
----------- ~~~~~-~~~ 
----------- ~~~~I.L-~~ 
116 INTERVIEWER 2 BABIES IN TifiS PREGNANCY; 3 PREGNANCIES ONLY (GO TO D74, PG. 26) ........ . 1 
CHECKPOINT: 2 BABIES IN TifiS PREGNANCY; ADD 'L PREGNANCIES (CONTINUE) .. .... .... ... .. .. ... ... 2 
3+ BABIES IN TifiS PREGNANCY (GO TO PREG. CONTINUATION FORM) .. .. .. ....... ... 3 
FOURTH PREGNANCY: 
Now I'd like to ask you a few questions about your fourth pregnancy. 
l 
D46. How old were you when you became UJ pregnant for the fourth time? AGE IN YEARS 
D47. What was the result of your fourth LIVE BIRTIL. .. ... ... ..... ... .......... .. ..... ...... ....... .... ... .. ... .. .... .... .. .. l 
pregnancy? STILLBIRTII (GO TO 049) ........ .... ..... ..... .. ..... .. ..... .. .. ... ... ..... 2 
l\11SCARRIAGE (GO TO D49) .. ......... ..... .... ........ .... .... ... ... ..... 3 
ABORTION (GO TO D49) ... .. ..... ........... ... .... ...... ......... .......... 4 
TUBAL!ECfOPIC (GO TO 049) ......... ..... .... ........ ... ............ ... 5 
MOLAR PREG (GO TO 049) .. ...... ....... ... ............ ..... ... , ... .... .. . 6 
OTIIER (SPECIFY) ...... ..... ... . .... . . .... ... ... .. ...... ... ... ......... 7 
SPECIFY 
RF (GO TO CHECKPOINT #8, PG. 22) ..... .. .. ...... .... ..... .... .. .. 97 
OK (GO TO CHECKPOINT #8, PG. 22) ......... ..... ......... ........ 98 
D48a. LIVE BIRTII: Was the pregnancy full-term On time (FULL TERM) .. 1 
or did it end early or late? (IF EARLY OR Early (PREMATURE) .... 2 
BY LU WEEKS LATE, ASK AND RECORD NUMBER OF Late (OVER-DUE) .... .... 3 
WEEKS) 
D48b. LIVE BIRTII: What date did your fourth 
MONTIILU OAYLLJ YEARj I I I I pregnancy end? 
D48c. LIVE BIRTII: How many babies did you 
TOTAL NUMBER OF BABIEsLU carry in your fourth pregnancy? 
D48d. LIVE BIRTH: What was the (first) baby's PRINT FULL NAME: 
name? 
D49. INDEX BABY? YES .. ...... .. ..... .......... ............................. ......... .................... .. ... l 
(LIVE BIRTH GO TO 051 ) N0 ... ... .. .... ....... ......... .... ...... .... ........ .... ... ... ... .. .. ... ... .. ...... .. ..... .. 2 
DSOa. STILL/MIS/ AB/TUB/MOL: How far along 
LU were you when the pregnancy ended? WEEKS 
PROBE TO GET BEST ESTIMATE OF # 
WEEKS (CONVERT MONTIIS TO WEEKS IF 
NECESSARY). 
DSOb. STIL/MIS/ AB/TUB/MOL: Do you know UJ how many babies you were carrying? TOTAL NUMBER OF BABIES 
D50c. STILL/MIS/ AB/TUB/MOL: Were you told YES ......... ................... ........ ...... ........ ........... ..... .. ..... .. .. .......... . l 
anything about the baby you lost, such as NO (GO TO CHECKPOINT# 7) ........ .. ...... .. ..... .... .. ............... 2 
its sex or ifthere were any apparent / 
health problems? 
DSI. What (is/was) (CHILD'S NAMFJ the MAL£ ........... ... ... .... ........ .. .. ............ ....................................... . 1 
baby)'s sex? FEMAL£ .. .. ........ ...... ..... ...... ........ .... .. ..... .... ... .. ....... ... ......... .. .. 2 
Tn.TT,-,.TA11n. T ., 
D52. Did this baby have a cleft lip or cleft 
palate? 
D52a. Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
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YES ....... ... ..... ................. ... ..... ......... .... ... .............................. .. l 
NO (GO TO 053) .......... .. .... .. .... .. .. .. .. ..... .' .... ............................ 2 
DK (GO TO 053) ........................................... .. ....................... 8 
YES ...... ................................................ ... ..................... .. ........ l 
NO (GO TO D52c) .......................... .......... .. .... ............. ........... 2 
DK (GO TO D52c) .................................................................. 8 
D52b. Was the cleft on one side or both sides of RIGHT SIDE ONLY ... ....... ... ............ ... .... .... ....... .... ........ ...... .. l 
D52c. 
D52d. 
D52e. 
D53. 
the lip? (PROBE IF ONE SIDE REPORTED, LEFT SIDE ONLY. ... ......... ........ ..... .. ...... ... ...... .. .. ........... .. ..... . 2 
ASK WHETIIER RIGHT OR LEFT.) BOTII SIDES (BILATERAL) .......... ........ ... .......... ..... ... ...... .... 3 
Was there a cleft of the palate, that is the 
roof of the mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
MIDLINE .. ............... ...................... ...... .... .. .......... ..... ... .......... 4 
DK ................................... ... ........... ....... ... ............. ...... ............ 8 
YES ......... ...... ..... ....................... .... ...... ............ .. .. ... .. .............. l 
NO (GO TO D52e) .... .. .. : .... ....... .... .. .. ............ .... .. .. ...... ............ 2 
DK (GO TO D52e) .... ... .......... .. ................ .. ...... .... ... .... ... .. ....... 8 
SOFT PALATE ONLY ................................................ ... .... .... ! 
SOFT AND HARD PALATE .......... .... .. .......... ........................ 2 
DK ....... .... ... .... ......... ............................................................... 8 
YES .. ..................................... .... ............ ....................... .......... l 
N0 ... ............. .. ............... ...................... .. .......... .. ......... ... .. ....... 2 
DK ..... .. .. ...... .. ...... ................. ... ............... .......... ..... ..... ..... ... .... S 
YES (LIST BELOW) ................................................ .. ............ 1 
N0 ............... ........ ... ............. ........ ... .............. ...................... .... 2 
DK .................. .. .... ................... ........ .............. .... .... .. ............... 8 
SPECIFY: 
'----'-----'---'1. '--'---'---'1 
L__.._L.._...JI.L.._...J'----'---'1 
.___.___.___.l.l--..l..___!---IJ 
#7 - INTERVIEWER SINGLE BABY: FOUR PREGNANCIES ONLY (GO TO DR PG. 2<>1. . .. ... .. .... ........ . .. . . 1 
CHECKPOINT: SINGLE BABY: /illDTTJONAL PREGNANCIES (GO TO 5TH PREGNANCY. PG. 131 ' 
• M~ 0 • •~ 0 ·~ 0 1\fULTIPLE BABIES fN THIS PREGNANCY(CONTINUE> .. ....... ........... .. ..................... , 
Now I'd like to ask some questions about the second baby in this pregnancy. 
D54. LIVE BIRTIIS ONLY: What was the 
second baby's name? 
PRINT FULL NAME: 
D55 . INDEXBABY? YES .... .. ............ -:: .............. .. ...... : ...... .... ... ........ .. .................. ... 1 
(LIVE BIRTII GO TO 057) N0 ........................................... .. ....................... .. ...... .. ........... 2 
D56. STILL!MlS/ABmJB/MOL: Were you told YES .... ........ ........................................ ... ............... .. ...... .. .... .. .. l 
anything about the baby you lost, such as NO (GO TO CHECKPOINT# 8) ............ .... ........................... 2 
its sex or if there were any apparent 
' n 
I 
D57. 
D58. 
D58a. 
D58b. 
D58c. 
D58d. 
D58e. 
D59. 
What (is/was) (CHILD'S NAME/the 
baby)' s sex? 
Did this baby have a cleft lip or cleft 
palate? 
Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
Was the cleft on one side or both sides of 
the lip? (PROBE IF ONE SIDE REPORTED, 
ASK WHETIIER RJGHT OR LEIT.) 
Was there a cleft of the palate, that is the 
roof of the mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? · 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
134 
MALE ....... .. ..... .. .. ...... .. .. ....... .. ... .... ........ .......... ... ....... ... .. ....... I 
FEMALE ....... ............... ......................................................... 2 
UNKNOWN ............... ........................................................... 3 
YES ................... ..... ... ..... ............................ .. .. .. ...................... l 
NO (GO TO D59) ....... .. ................................... ......... ............... 2 
DK (GO TO D59) ............ ............ ........ .... .... ............................ 8 
YES ............ ........ .................................................................... l 
NO (GO TO D58c) ........................ .. .............. ................... ....... 2 
DK (GO TO D58c) .................... ............................. ... .............. 8 
RJGHT SIDE ONLY ........ : .................................... .. ................ 1 
LEIT SIDE ONLY .................................................................. 2 
BOTH SIDES (BTI.,A TERAL) .. .. ... .......... ............... .. .............. 3 
MIDLINE .................. ...... .......... .. ......................... ................ .. 4 
DK .. ............ ... ..... .... ............ ......... .......... .... ............ .-.......... ...... 8 
YES ......... ................. ........... ...... ................... ....... ...... ..... .... .... ! 
NO (GO TO D58e) ............................................... .. ................. 2 
DK (GO TO D58e) .................................................................. 8 
SOITPALATEONLY ...... .... .... ...... ............. ............ .......... .... ! 
SOIT AND HARD PALATE ................................................. . 2 
DK ........ ....... .. .... .. .... ......... ......................... ............................. 8 
YES ................... .. . ............... .......... ................. ........... .... ...... ... l 
N0 ......... ... ........ .. ....... ......... ......... ..... ......... ........ ... ............ ...... 2 
DK .. ......... ........................................................................ ....... 8 
YES (LIST BELOW) .. .. .. .... .. .... ... .. .. .. ..... .. .. .. .. .. .. .. .... .. .. ...... .. l 
N0 ............................................................... ....... ................. ... 1 
DK ........ .. .. ........... ................ .... .. .. .............. ..................... ..... ... 8 
SPECIFY: 
.__I -'----'-_,1. '---'---'---lj 
.__I -'---'-_,I.L-..L--L.......J
1 
--------- - ~~ ~~~.~~~ 
#8 I~TERVIEWER 2 BABIES IN THIS PREGNANCY; 4 PREGNANCIES ONLY (GO TO D74, PG. 26) ......... l 
CHECKPOINT: 2 BABIES IN THIS PREGNANCY; ADD'L PREGNANCIES (CONTINUE) ....................... 2 
ADD'L BABIES IN TillS PREGNANCY (GO TO PREG. CONTINUATION FORMk ...... 3 
/ 
FIFTH PREGNANCY: 
Now I'd like to ask you a few questions about your fifth pregnancy. 
D60. How old were you when you became LLJ pregnant for the fifth time? AGErNYEARS 
D61. What was the result of your fifth LIVE Bffi.TII ... ........ .... .. ................ .................. .... .... ...... .. ..... .. 1 
pregnancy? STILLBffi.TII (GO TO 063) .......... ....... .. ..... ... ........ ... .... ......... 2 
MISCARRIAGE (GO TO 063) .. ... ..... .... ......... ..... .. .. ... ....... ... .. 3 
ABORTION (GO TO 063) .. .... : ... ........ .. .... ..... ... .... ........ .. .. .... . 4 
TUBAL/ECTOPIC (GO TO 063) .. ..... .................... .. ... .. ...... ... 5 
MOLAR PREG (GO TO 063) . .... ..... ......... .. ..... .............. ........ 6 
OTIIER (SPECIFY) ..... ... .................... ... ...... . .. ... , .......... 7 
SPECIFY 
RF (GO TO CHECKPOINT #10, PG. 25) ................ ..... ....... .. 97 
DK (GO TO CHECKPOINT #10, PG. 25) ............ .. ............... 98 
D62a. LfVE BIR.TII: Was pregnancy full-term or On time (FULL TERM) ... 1 
did it end early or late? (IF EARLY OR Early (PREMATIJRE) ... .. 2 w LATE, ASK AND RECORD NUMBER OF Late (OVER-DUE) ......... 3 BY WEEKS 
WEEKS) 
D62b. LIVE BIR.TII: What date did your fifth 
MONTIILlj DAYLlJ YEARj I I I I pregnancy end? 
D62c. LIVE BIR.TII: How many babies did you 
TOTAL NUMBER OF BABIES LlJ carry in your fifth pregnancy? 
D62d. LIVE Bffi.TII: What was the (first) baby's PRINT FULL NAME: 
name? 
D63 . INDEX BABY? YES ... .... .. .......... ... ... .. ................. : .............. ................ ............. l 
(LIVE Bffi.TII GO TO 065) N0 .............................. ... ..... .. .... .......... .... ......... ............... .. ...... 2 
D64a. STILL/MIS/ ABmJB/MOL: How far along 
were you when the pregnancy ended? LLJ WEEKS 
PROBE TO GET BEST ESTIMATE OF # 
WEEKS (CONVERT MONTHS TO WEEKS IF 
NECESSARY). 
D64b. STIL/MIS/ ABmJB/MOL: Do you know LLJ how many babies you were canying? TOTAL NUMBER OF BABIES 
D64c. STILL/MIS/ ABmJB/MOL: Were you told YES .... ........ ..... . -:: .... .. .................. ......... .... .... .. ... ... ..... .... .. ........ 1 
anything about the baby you lost, such as NO (GO TO CHECKPOINT# 9) .......................... .... ... ......... 2 
its sex or if there were any apparent 
health problems? 
D65 . 
D66. 
D66a. 
D66b. 
D66c. 
D66d. 
D66e. 
D67. 
What (is/was) (CHIT...D 'S NAME/ the 
baby)'s sex? 
Did this baby have a cleft lip or cleft 
palate? 
Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
Was the cleft on one side or both sides of 
the lip? (PROBE IF ONE SIDE REPORTED, 
ASK WHETHER RIGHr OR LEIT.) 
Was there a cleft of the palate, that is the 
roofofthe mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
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MALE ...... ............... .. ...... ..... .. ............. .. .. .... ..... .. ...... .. ............. I 
FEMALE .. ... ... ...................... ................. ... ...... ....... .... ..... .. .. ... . 2 
UNKNOWN .... .......... .. ......... ... .... .. ......... ......... ... ..... .. .......... ... J 
YES ... .. .... ............... .... ...... .. ....... ....... ...... .... ............ .... ... ...... ... ! 
NO (GO TO 067) ..... ... .. .. ........ .... .... .. ..... ........ .. .... .. , ............... 2 
OK (GO TO 067) ..... .............................. ............... .. .... ..... ...... 8 
YES ....... .... ...... .... .... .. .. ..... ... ............. .. ........ ..... ......... ............ .. I 
NO (GO TO 066c) ... .. .. .. ... .. .. .. .. .. .. .. .. ...... .. .. ............................ 2 
OK (GO TO 066c) .... ... ..... .... .... ... . : ............ ... .................. .. ...... 8 
RIGHr SIDE ONLY ...... .. .... .. ...... .. ................... .... ... .. ........... .. I 
LEIT SIDE ONLY .. ........................... ... .. ...... .. ..... .................. 2 
BOTII SIDES (Bll..ATERAL) .......... .. .... ... ........... .. ....... .... .... .. 3 
MIDLINE ................ ...... ... ........... .. .......... ....... .... ... ... ...... .. .. .. .. 4 
OK ................ ... ......... .. ... ... .. .......... ....... .... ......... ... .. ... .............. 8 
YES .............. ................... ........ ... ..... ... ... ........... ........... .... .. .... . ! 
NO (GO TO 066e) ........ ... ....... .. .. .. ............. .. .......... .... ..... .. ...... 2 
OK (GO TO 066e) .... .. ........................................... .. ... .. ... .... .. . 8 
SOIT PALATE ONLY .............................. .. ................... .. ... .. . 1 
SOIT ANDHARDPALATE .... .. .. ..... ... .... ................. .. ........... 2 
DK ....... .. ............ ....... ...... ..... .......... ... ...... .. ........ .... .... .............. 8 
YES ........... ............ .............. ... .... .. ... ........... .............. .. .... ....... . 1 
N0 .... ....... ................... ........... ....... ........ ........ ....... .......... ...... ... 2 
OK ........... .... .... ....... ... .... ... .. .... .... ... .. ... .. ..... .... .......... ..... ......... . 8 
YES (LIST BELOW) ...... .. ................... .. ................... ... ... .. ...... 1 
N0 ....................... ............. .. ............................... ...... .... .. .. ... .. .. 2 
OK ..................... .. .......... .......... .. .......... ..... .... ..... ............. ........ 8 
SPECIFY: CITJ .L-.L.-...1__,, 
L-...J'--l--',•'---'--''--'1 
'----''----''----''· '----''----''--'1 
Jf.9 ... .. . _INTER,V!EWER .. SINGLE BABY; FIVE PREGNANCIES ONLY (GO TO 074, PG. 26) ....... ..... .. ...... ......... 1 
CHECKPOINT: SINGLE BABY; ADDITIONAL PREGNANCIES (GO TO PREG HISTORY SUPPL.) ..... 2 
··-~ ..... - ·-- -.... - ~~· .... .. -- ··-· ... ,. 
MULTIPLE BABIES !N THIS PREGNANCY (CONTINUE) .................. .. ............ .. .. .. ..... 3 
Now I'd like to ask some questions about the second baby in this pregnancy. 
D68. 
D69. 
LIVE BIRTII: What was the second 
baby's name? 
INDEX BABY? 
(LIVE BIRTH GO TO 071) 
PRINT FULL NAME: 
YES ..... .... ........ .... .... ... ... ............... ......... .. ... ...... ...... .. .... ......... l 
N() ? 
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D70. STILL!MIS/ABmJB/MOL: Were you told YES .......... .... .. .... ...... .. .... .. ... ........ .......... ............. .. ...... ... ...... ... 1 
anything about the baby you lost, such as NO (GO TO CHECKPOINT# 10) .... .. .... ... .... .. .. .... ........ .... .. .. 1 
its sex or if there were any apparent 
health problems? 
D7l . What (is/was) (CHILD'S NAME/ the MALE ....... ........ ................................... .. ...................... .......... 1 
D72. 
D72a. 
D72b. 
D72c. 
D72d. 
D72e. 
D73 . 
baby)'s sex? FEMALE .. ...... ............... .. .. .. .................................................. 2 
Did this baby have a cleft lip or cleft 
palate? 
Please tell me the structures that were 
involved in the baby's cleft. Did the 
baby have a cleft lip? 
Was the cleft on one side or both sides of 
the lip? (PROBE IF ONE SIDE REPORTED, 
ASK WHETHER RIGIIT OR LEFT.) 
Was there a cleft of the palate, that is the 
roof of the mouth? 
Did it involve only the soft part at the 
rear of the palate or both the soft and 
hard parts of the palate? 
Did the cleft involve the gums and teeth? 
Did this baby have any other birth 
defects? 
UNKNOWN ..... ... .................... ....... ... ... ........... .... ......... ... ...... 3 
YES ..... .................... .... ............... .. .. .. ... .......... ....... .... ...... ........ ! 
NO (GO TO D73) ...................................... ............................. 1 
DK (GO TO D73) ....................... ... ........ .... ................. ........ .... 8 
YES ....... .. ......... ............ .. ... ............. .... ......... .... ....................... 1 
NO (GO TO D72c) .... ....... .. ..... .... ... .. ........... .... ....... ............. .... 1 
DK (GO TO D72c) .......................... .. .... ....... ... ..... .. .... .. .. ......... 8 
RIGHT SIDE ONLY ............. .... ....... .... ................................... 1 
LEFT SIDE ONLY ........................................ .. .. .... ....... ......... 1 
BOTH SIDES (ElLA TERAL) ............. .... ...... ... ... .. .................. 3 
MIDLINE ................ .. ...... ... .. ............. ... ... .......... .... ................. 4 
DK ....................... ....... .. ... ............ .. ............. ... ........................ . 8 
YES ....... ................................................. ......... ......... .............. ! 
NO (GO TO D72e) .................................................................. 1 
DK (GO TO D72e) .......... .. ................... ..... .... ... ...... ....... .. ........ 8 
SOFT PALATE ONLY ..................... ... .................. ....... .......... ! 
SOFT AND HARD PALATE ....... .............. ............................. 2 
DK ............................................................. .......... .... .... .. ...... ... 8 
YES ... ....... ......... .. ..... : ................ .. .. ...... ......... ................. .. ....... 1 
N0 ........... ... ......... ..... .............. ......... ... .. ... ....... ... ...... .... .. .. ....... 1 
DK ........................................... ..... ................................... ....... 8 
YES (LIST BELOW) .... ... .. ... .. .... .......... .. .. ........... ................... 1 
N0 ... ........... .. ... .. ................................................. ... .... ..... .... .... 2 
DK ..... ..... .... .. ........................... ...................... ......................... 8 
SPECIFY: 
'---'--' ~'·'---'----'--.lJ 
'---'-- ~'·'---'---'----'1 
'---'--' ~' · '---'---'---'1 
#10 INTERVIEWER 2 BABIES IN THIS PREGNACY; 5 PREGNANCIES ONLY (CONTINUE) ......... ............... 1 
CHECKPOINT: 2 BABIES IN THIS PREGNANCY; ADD'L PREGNANCIES (GO TO PREG. HISTORY 
SUPPLEJ\.1ENT) ......... ......... ..................... .......... ........................................ ...................... 2 
3+ BABIES IN THIS PREGNANCY (GO TO PREG. CONTINUATION FORM) .... .... .... ..... 3 
D74 . Are you currently pregnant? 
D74a. What is your due date? 
D74b. What was the date of the first day ofyour 
last menstrual period before you became 
pregnant? 
YES ......................... ... .... ..... ....... .... .................. ...... ...... .. .. .. .. . ! 
NO (GO TO CHECKPOINT #11) .......... ..... ...... .. .... ....... ........ 2 
RF (GO TO CHECKPOINT#!!) ..... .. .. .... .... ....... ..... ....... .. .. ... 7 
DK (GO TO CHECKPOINT #11) ........ .............. .... ... .......... ... 8 
MONTHLU DAYLU YEAR I I I I 
MONTH LU DAy LU YEAI{ I I I I 
THE NUMBER OF PREGNANCIES REPORTED IN D2 <PAGE lO) SHOULD EQUAL 
THE NUMBER OF PREGNANCIES COVERED IN THE PREGNANCY IDSTORY. 
STARTING WITH D~. 
D75. 
D76. 
YES .. 
NO. 
Have any of your biological relatives, 
not including your children, had a cleft 
lip or palate? This would include your 
parents, sisters or brothers. 
Have any of (INDEX CHILD)' s biological 
father' s relatives had a cleft lip or 
palate? This would include his parents, 
sisters or brothers. 
···· ·· ........... I 
. ..... ... ..... 1 
YES (SPECIFY BELOW) ...... .... ... .... ........ ....... .. ... .. ..... .... .. .. .. I 
N0 ............ ..... .. ........... ........ ................ ......... .......................... 2 
RF ........... ... ... .... .. .. ........................ .............. ..... ... .................. ? 
DK .............. ........... ............ ....... ......... ............. ..... ... ... ... ..... ... 8 
------------~OJ 
OJ 
YES (SPECIFY BELOW) ...... ... .... .. ....... ... ........... ..... ....... ...... I 
N0 ........... .......... ..................................... ... .... .... ..... ............. .. 2 
RF ................ ....... ..................... ....... ........ ... .... ... ... .... ............. ? 
DK ..... ............ .. .......... .................... ....... ... .. ... ........ ........ ........ 8 
----~--------·OJ 
OJ 
/ 
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INTRODUCTION TO INDEX PREGNANCY AND PREGNANCY CALENDAR 
For the rest of the interview, I'll be asking you about things you did during the period shortly before 
and during your pregnancy (with CHILD'S NAME/ that ended on DATE). 
Please take out the Pregnancy Calendar that we sent you and let's review it together. 
(INTERVIEWER SHOULD HAVE A COPY OF MOTHER'S PREGNANCY CALENDAR FOR REFERENCE) 
The calendar is based on (CHILD'S NAME's birth date/ the date your pregnancy ended) and the length of 
your pregnancy. The important dates and time periods I'll be asking about are: 
• the three months before you became pregnant, from (DATE) to (DATE), which are shown in 
green on the calendar; 
• the estimated date you became pregnant, (DATE), shown in a red box; 
• the first trimester of your pregnancy, from (DATE) to (DATE), shown in yellow; 
• the second trimester of your pregnancy, from (DATE) to (DATE), shown in pink; 
• the third trimester of your pregnancy, from (DATE) to (DATE), shown in blue; and 
• (CHILD'S NAME's date ofbirth (DATE)/ the date your pregnancy ended) is shown in a red .box. 
Sometimes it ' s helpful to recall other things that happened during a time period to help give a clearer 
picture when you ' re answering questions. Try to write down a few things about each time period now, 
for instance: 
• Did you take any trips or vacations just before or while you were pregnant? 
• Were there any big family events like weddings, deaths, other births? 
• What was your employment situation at the time - (WHERE APPLICABLE) both yours and your 
spouse's? 
• Were there any serious illnesses or health problems among family members? 
• Did you buy a new house, move or otherwise change your living situation? 
• Anything else that will help you recall that time period? 
(ALLOW TIME FOR MOTHER TO RECALL AND MAKE NOTES ON HER CALENDAR. THERE IS NO NEED FOR 
HER TO RESPOND TO THE QUESTIONS VERBALLY) 
If you ' re ready to continue, we' ll start with some questions about your weight and height and then go 
on to questions about your diet before and during your pregnancy (with CHILD'S NAME). 
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E. WEIGHT AND HEIGHT IDSTORY 
El. About how much did you weigh at the POUNDS I I I time you became pregnant (with CHILD'S 
NAME)? 
Tlus would be about LLJ of LLJ 
Month Year 
E2. How much weight did you gain or lose 
POUNDJ I I I from the beginning to the end of your 
pregnancy (with CHILD'S NAME)? GAINED ... .. ... .. 1 
LOST .. ... ....... ... 2 
E3 . What is your current height without 
shoes? FEETlLJ INCI-IELlJ u 
E4. What is your current weight? POUND~ I I I 
E5 . LIVE BIRTH ONLY: 
What was (CHILD'S NAME) 's weight at POUNDt_lj OUNCEW 
birth? 
E6. LIVE BIRTH ONLY: 
What was (CHILD 'S NAME)' s length at INCHES LU u 
birth? 
F. DIET INTERVIEW 
Now I'd like to ask you about your typical diet during the period three months before you became pregnant 
(with CHD...D 'S NAME) and the first three months of your pregnancy. This would be from (DATE) to (DATE) 
which is shown in the green and yellow sections of your pregnancy calendar. 
I'll read through a list of foods one at a time. After I read each food, please tell me how often, on average, 
you had the food during that period. This should include your total intake from meals and snacks. 
We want to know your average intake over the whole six month time period, including the months before you 
became pregnant. So if there were foods you ate only before or only after you became pregnant, we'll need to 
figure out your average. I'll help you do that. Here is an example: 
• If you ate fish four times a month before you became pregnant but never ate it in the first three months 
after you became pregnant, then your average over the six months would be two times per month. 
If you didn ' t change your frequency of eating a food during the six month time period we're interested in, 
then just report your average frequency. For example: 
• If you ate .!lgg§ once a week both before and after you were pregnant, then your average frequency 
would be once a week for the whole six months. 
The response choices are listed on the back of the card we sent you marked "Diet Interview Card." Let's 
review them. They are: 
• Never or less than 1 time per month 
• 1-3 times per month 
• I time per week 
• 2-4 times per week 
• 5-6 times per week 
• 1 time per day 
• 2-3 times per day 
• 4-5 times per day 
• 6 or more times per day 
Let's begin with ... 
Fl. Skim or fat free milk (8 oz. 
glass) . 
Never or < 1 per month .... .. .. . ···: 1 
1-3 per month ... .. .. ..... ............... 2 
1 per week ........ .. ..... .......... .. ..... 3 
2-4 per week ........ ..... ..... ........ ... 4 
5-6 per week ..... ........ ............... .. 5 
1 per day ... .. .................... ... .... .. 6 
2-3 per day .... ........ ........ ........... . 7 
4-5 per day ... .... .... .. ...... ............. 8 
6 +per day .............................. .. . 9 
DAIRY FOODS 
F2. 1% or 2% milk (8 oz. glass) 
Never or < 1 per month .............. I 
1-3 per month ...... , .................. .. 2 
1 per week .. .............................. 3 
2-4 per week .. ........................... 4 
5-6 per week ............................ .. 5 
1 per day ...................... ............. 6 / 
2-3 per day ................ .... ........... 7 
4-5 per day .......................... ..... 8 
6 +per day ............ .. .. ................ 9 
FJ. Whole milk (8 oz. glass) 
Never or < I per month .............. 1 
l-3 per month. ............................ 2 
1 per week .............. ........ ........... 3 
2-4 per week ............................. .4 
5-6 per week ....... ........ ...... .......... 5 
l per day .... .................... ... ......... 6 
2-3 perday ....... .. ............... .. .. ..... 7 
4-5 per day ...... .. ...... .. .... .. .. .. ....... 8 
6 +per day .......................... .. ...... 9 
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F4. Cream, e.g., coffee, whipped or 
sour cream (1Ths) 
Never or < 1 per month .............. 1 
1-3 per month .. ... .... ...... .... ... .... .. 2 
1 per week .. ....... .... ....... .. ........... 3 
2-4 per week ... ....... .. .... .. ........... 4 
5-6 per week ... ... ......... .. ............. 5 
1 per day ...... .. .... ............... ........ 6 
2-3 per day .............. .. .... ............ 7 
4-5 per day .. ............. .... .... ........ . 8 
6 + perday .... .. .......... .. ... .. .......... 9 
F7. Ice cream (1/2 cup) 
Never or < 1 per month .... ... .. .... 1 
1-3 per month .. ........ ........... ...... 2 
1 per week .......... ...... .. ... ... .. ..... . 3 
2-4 per week ... .. .. ..... .... .. .... ....... 4 
5-6 per week ....... .... ........... ....... 5 
1 per day .. .... ............. ..... ....... .... 6 
2-3 per day ..... ........... ... ... ...... ... 7 
4-5 per day .... .. ........ .......... ... ... .. 8 
6+perday .......... ......... ........ ..... 9 
FlO. Did you usually eat · 
unsweetened or plain yogurt, yogurt 
sweetened with fruit or sugar, or 
artificially sweetened yogurt? 
Unsweetened (plain) ......... ........ . 1 
Sweetened with fruit or sugar .... 2 
Artificially sweetened ............ .... 3 
F5. Non-dairy coffee whitener ( 1 
tsp) 
Never or < 1 per month ............. 1 
1-3 per month ...... .... .................. 2 
1 per week ........... ..... ................. 3 
2-4 per week .... ......................... 4 
5-6 per week ...... ...... .... .. .... .. ... .. . 5 
1perday .... ........ .. ................... .. 6 
2-3 per day ...... .. ............ .. ..... ... .. 7 
4-5 per day ... .. .. ... ......... ... .. .... .... 8 
6 + perday ........ ..... .......... .......... 9 
F8. Yogurt (1 cup) 
Never ;< 1 per month (TO F11 ). 1 
1-3 per month .... ....... .... . .. ......... 2 
1 per week .. .. .. ....... .. ...... .... ....... 3 
2-4 per week .. .......... ........ ......... . 4 
5-6 per week ......... .................... 5 
1 per day ... ...... ........ .................. 6 
2-3 per day ........... ............... ... .. 7 
4-5 per day .... ... ......... ..... ... .. .... . 8 
6+perday ........ ....... .... .... ..... .... 9 
Fll. Cottage or ricotta cheese (112 
cup) 
Never or < 1 per month .............. 1 
1-3 per month ...... ........... ...... .... 2 
1 per week .... .. .... ...... ...... .......... 3 
2-4 per week .. .... ...... ........ ..... .... 4 
5-6 per week ... ..... ........ .. ..... ... ... 5 
1 per day ........ ..... .. ... ........ ... .... .. 6 
2-3 per day ..... .... ...... ... ........... .. 7 
4-5 per day ............................ ... 8 
6 + per day ...... ...... ..... ........ ....... 9 
F6. Frozen yogurt, sherbet or non-
fat ice cream (112 cup) 
Never or < 1 per month ...... ........ 1 
1-3 per month ................... ....... . 2 
1 per week ........... ... .. .. .. ... ... ..... .. 3 
2-4 perweek .. .... ... .......... ... ... ... ..4 
5-6 per week ... ...... .... ... .. .. .......... . 5 
1 per day .... ..... ... .. ... .. ... ... ..... ... .. . 6 
2-3 perday ... ..... .... .. ...... ..... .. .. .. .. 7 
4-5 per day ....... .... .... ........ .... .... .. 8 
6 + perday .. .. .... ........ .... ... .... .. ..... 9 
F9. Did you usually eat regular, 
low fat or non-fat yogurt? 
Regular ... ....... .... ...... .. ......... .. .... 1 
Low fat. ................... ... .. ... ... .... .. 2 
Nonfat ........ .. ........................... . 3 
Fll. Cream cheese (1 oz.) 
Never or < 1 per month ... ... .... .. ... 1 
1-3 per month ........ ... ... ... .... ....... 2 
1 perweek ........... ........ .............. 3 
2-4 per week ... .................. .. ...... .4 
5-6 per week .. .... .. .................... .. 5 
1 per day ......... ....... .............. .. ... 6 
2-3 per day ...................... .. ...... :.7 
4-5 per day ... .. ..... .... ... .. . ... .... ..... 8 
6 +per day .... .. ... ... .... .... ......... : ... 9 
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FlJ. Other cheese, e.g., American, 
Swiss, cheddar, etc. by itself or as 
part of a sandwich or dish (a slice or 
I oz. serving) 
Never ;< 1 per month (TO F15) . 1 
1-3 per month .. ... .......... .... .... ... . 2 
1 per week ...... .......... .... ......... . .. 3 
2-4 per week .. ...... ...... .... .... ...... . 4 
5-6 per week ................ ....... .. .. .. 5 
1 per day ............ ......... ..... ......... 6 
2-3 per day ............................... 7 
4-5 per day .. .... .......................... 8 
6 +per day ................................ 9 
F16. Margarine (small pat or tsp.), 
added to food or bread; exclude use 
in cooking or use of spray 
margarine 
Never;< I per month (TO F18) .. 1 
1-3 per month ........................... 2 
I per week ....... .. ....................... 3 
2-4 per week .. ..... ...................... 4 
5-6 per week ............................. 5 
1 per day .................... ...... ......... 6 
2-3 per day ................... ............ 7 
4-5 per day ......... .............. ......... 8 
6 +per day ................................ 9 
Next I'll ask you about 
F14. Did you usually eat regular, 
low fat or nonfat cheese? 
Regular .............. .... ...... .... ... .... .. 1 
Low fat or lite ............ ............... 2 
Nonfat .... .............. .. ..... ........ ..... 3 
F17a. What form of margarine did 
you usually use? 
Stick ...... ....... ........ ......... ... ..... ... . 1 
Tub ........ .. .................................. 2 
Squeeze (liquid) ........................ . 3 
FRIDTS 
F18. Raisins (1 oz. or small pack) or F19. Prunes (1/2 cup or 7 prunes) 
grapes 
Never or < 1 per month .. .. ......... 1 Never or < 1 per month .............. I 
1-3 per month ................. .... ... ... 2 1-3 per month ......................... .. 2 
1 per week ................................ 3 I per week ........................... .... . 3 
2-4 per week ............................. 4 2-4 per week ............ .............. ... 4 
5-6 per week .......... .......... ......... 5 5-6 per week ... ... ........ ............... 5 
1 per day ..... ... ........................... 6 I per day ......... .. ........................ 6 / 
2-3 per day .. .... ......................... 7 2-3 per day ... ...... .... .......... ........ 7 
4-5 per day .......................... .. .... 8 4-5 per day ..... .. ... .. ............... .. .. 8 
6+perday ................................ 9 6+perday ................. ........ .. .. ... 9 
F15. Butter (small pat or tsp.), 
added to food or bread; exclude use 
in cooking 
Never or < I per inonth .. ... ......... 1 
1-3 per month ................... .. .... ... 2 
1 per week ............................ .. ... 3 
2-4 per week .......... ... ................. 4 
5-6 per week.. ..... ... ................... .5 
1 per day .......... .. ....................... 6 
2-3 per day ........... ......... ..... .. ..... 7 
4-5 per day .......... .. ...... .. ............ 8 
6 +per day .......................... ....... 9 
F17b. What type of margarine did 
you usually use? 
Regular ... ....... ........................... 1 
Light spread ................. .... ... .... ... 2 
Extra light spread ...... ..... .. ......... .3 
Nonfat ...................................... .4 
F17c. What specific brand and type 
was it (e.g., Land O'Lakes Country 
Morning Blend Light)? 
F20. Bananas (I) 
Never or < I per month ............... 1 
1-3 permonth ........... .............. ... 2 
I perweek .. .. .. .......... ....... ....... : .. 3 
2-4 per week. ................. ...... ...... 4 
5-6 per week ...... .. ...... .......... .. .... 5 
1 per day .......... .. ....................... 6 
2-3 perday ................................ 7 
4-5 per day ......................... .. ..... 8 
6 + perday .. ... .. ...... .............. .... .. 9 
143 
F21. Cantaloupe (1/4 melon) 
Never or < I per month ..... ... ..... 1 
1-3 per month ... ........... ............. 2 
1 per week .... ............. ..... .... ... .. . 3 
2-4 per week .......... ................... 4 
5-6 per week ............................. 5 
1 per day .................... ....... .. ...... 6 
2-3 per day ............................... 7 
4-5 per day ............ .. .................. 8 
6+perday ........ .. ........... ...... ..... 9 
F24. Fresh apples or pears (1) 
Never or< 1 per month .......... ... I 
1-3 per month ........................... 2 
1 per week ........ ....................... . 3 
2-4 per week ............................. 4 
5-6 per week ............................. 5 
I per day .. .. .... ...... .. ........ .. ......... 6 
2-3 per day .. ................... .......... 7 
4-5 per day ........... .. ............. ...... 8 
6 +per day ........ .................... .. .. 9 
F27. Orange juice (small glass) 
Never or< I per month ...... .... ... 1 
1-3 per month .... .... ........ ........ ... 2 
1 per week .... ............................ 3 
2-4 per week ........... ....... ........... 4 
5-6 per week ............................. 5 
1 per day ............... .. .................. 6 
2-3 per day .. ............................. 7 
4-5 per day ...... .. ...... ..... .. ...... ..... 8 
6 +per day .. .............................. 9 
F22. Avocado('!. fruit or'/, cup) 
Never or< 1 per month .......... ... 1 
1-3 per month .............. .. .. ......... 2 
1 per week .... .. ........................ .. 3 
2-4 per week ............................. 4 
5-6 per week .................... ......... 5 
1 per day .................... .. .. .. ......... 6 
2-3 per day ............................... 7 
4-5 per day ............................... 8 
6 +per day ................................ 9 
F25. Apple juice or cider (small 
glass) 
Never or < 1 per month ............. 1 
1-3 per month ........................... 2 
1 per week ................................ 3 
2-4 per week .................... .. ....... 4 
5-6 per week ............................. 5 
1 per day ............. .. ........ .... .. ...... 6 
2-3 per day .... .. ........ ............ ..... 7 
4-5 per day .... .. ................... ...... 8 
6 +per day ............................ .. .. 9 
F28. Grapefruit ( 112) 
Never or< 1 per month .... .... .... . 
1-3 per month .... .... .... .... ........... 2 
1 per week ................................ 3 
2-4 per week .. .............. .. .. ......... 4 
5-6 per week .......... .. ...... ...... ..... 5 
I per day ........................ .... ....... 6 
2-3 per day ............................... 7 
4-5 per day ................ .......... ..... 8 
6 +per day ................................ 9 
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F23. Applesauce (1/2 cup) 
Never or< 1 per month ............ .. 1 
l-3 per month ............................ 2 
1 perweek ................................. 3 
2-4 per week .............................. 4 
5-6 per week .... .. .......... .......... .... 5 
1 per day .... ...... .......... .. ............. 6 
2-3 per day ................................ 7 
4-5 per day ...... .......................... 8 
6 + perday ................ .. ........ ...... . 9 
F26. Oranges (1) 
Never or< 1 per month .. ............ ! 
1-3 per month ............................ 2 
1 perweek ................................. 3 
2-4 per -week .............................. 4 
5-6 per week .... ...... .............. ...... 5 
1 per day ................................... 6 
2-3 per day ................................ 7 
4-5 per day ................................ 8 
6 + perday ............ .. .... .. .... ......... 9 
F29. Grapefruit juice (small glass) 
Never or < I per month .............. 1 
1-3 per month ............................ 2 
I perweek .................... .. .. ......... 3 
2-4 per week .............................. 4 
5-6 per week ...... .......... .............. 5 
1 per day .......... .......... ............... 6 
2-3 per day ........ .. ................ .... .. 7 
4-5 per day ................................ 8 
6+perday ................................. 9 
/ 
FJO. Other fruit juices (small glass) 
Never or < I per month ........... .. I 
1-3 per month ........ .... .. .. ........... 2 
I per week .... .. .... .... .. .. .............. 3 
2-4 per week ............... .. .. .......... 4 
5-6 per week .......... .. ...... .. ...... .. . 5 
1 per day ................ .... .............. . 6 
2-3 per day ... .... ... ... .. .. ..... .. .. ..... 7 
4-5 per day .. .. .................. .......... 8 
6 +per day .. .... ......... .... ........... .. 9 
FJJ. Peaches, apricots or plums (1 
fresh, or Yz cup canoed) 
Never or < 1 per month ... 
1-3 per month.. ............. . ... 2 
1 per week ...... ..... ... ................. . 3 
2-4 per week .......... .. .. .. ..... .. ..... 4 
5-6 per week ... .. .... .. ..... .. ........... 5 
1 per day ... .. .. ... .. .. ........... ...... .. .. 6 
2-3 per day .. .... ..... ..... .. .......... .. . 7 
4-5 per day .. .............. .. .............. 8 
6 +per day ................. .. ............. 9 
Next I'll ask you about 
F34. Fresh tomatoes (1) 
Never or < 1 per month ............. I 
1-3 per month .................... .. .... . 2 
1 per week ......... .......... .. .... .. ... .. 3 
2-4 per week ...... .. .. ........... .. .... .. 4 
5-6 per week .. .. .... ...... ........ .... .. . 5 
1 per day ......... ... .. .... ................ . 6 
2-3 per day ...... .. ........ ... ......... ... 7 
4-5 per day .. ... .. ... .. .. ............... .. . 8 
6 +per day .. .............................. 9 
FJl. Strawberries, fresh, frozen or 
canoed ( 1/2 cup) 
Never or < I per month .. ......... .. I 
1-3 per month .. ..... .. .................. 2 
I per week ............................ .. .. 3 
2-4 per week .. .. ................. .. ... ... 4 
5-6 per week ......... ... .. ... ............ 5 
I per day .... .. ......... .. .. .... ........ .. .. 6 
2-3 per day .. .. .. ...... .......... .... .. ... 7 
4-5 per day .......... .. .. .. ........ .. ..... 8 
6 +per day ................ ...... .......... 9 
VEGETABLES 
FJS. Tomato or V8 juice (small 
glass) 
Never or < 1 per month .. .. .......... 1 
1-3 per month .... ..... ..... .. ........... 2 
I per week ........ ...... .. .. .. ........ .... 3 
2-4 per week .... .. .. .. .. .. ........ .. ..... 4 
5-6 per week ........ .. ...... .. ...... ..... 5 
1 per day .. .. ................ .. .. .. ........ . 6 
2-3 per day .... .............. .. ...... .. .. . 7 
4-5 per day .... .. .......... ............... 8 
6 +per day .... .. ........ .. .......... .. .... 9 
/ 
F32. Blueberries, fresb, frozen or 
canned (1/2 cup) 
Never or< I per month ..... .. .. .. .. .! 
1-3 per month ............................ 2 
I per week ............... ...... : ........... 3 
2-4 per week. ........ .... .. .. .. .... .... .. .4 
5-6 per week .............. .. .... .... ...... 5 
I per day ....................... .. .. .. ...... 6 
2-3 per day .. ...... ... ....... .. ........ .. .. ? 
4-5 per day .... ... .. ... .. .... .. ....... .... . 8 
6 +per day .. ................ .. .. .. .. .. ... .. 9 
F36. Canned tomatoes or tomato 
sauce (1/2 cup) e.g., spaghetti sauce 
Never or < I per month .. ............ ! 
1-3 permonth .. .. .. ................... .. . 2 
1 per week .. ... ............. ........ ...... . 3 
2-4 per week ..... .... ..... ............ .... 4 
5-6 per week ............. .. ........ ... .. .. 5 
1 per day ............ .... .. .. ... .... .. ...... 6 
2-3 per day ....... ..... ........ .. .... .. ... . 7 
4-5 per day .. ........ .. ............ ........ 8 
6 +per day ....... .. ........ .. ............ .. 9 
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F37. Salsa, picantc or taco sauce 
(1/4 cup) 
Never or < I per month .......... ... 1 
1-3 per month ... ... .. ....... ........ ... 2 
I per week ............. .... ........ .... ... 3 
2-4 per week ... .... ..... ................. 4 
5-6 per week ........... ........ ..... .... . 5 
I per day ................................ .. . 6 
2-3 per day ..... .. ... ................ ... .. 7 
4-5 per day ............... .. ............ ... 8 
6 +per day ....... ......... ...... .......... 9 
F40. Broccoli ( 1/2 cup) 
Never or < 1 per month .. .. ....... .. 1 
1-3 per month ....... .. .... ... ........... 2 
I per week .......... .. .. .. ............. ... 3 
2-4 per week ........... ........ ..... ..... 4 
5-6 per week .... ......................... 5 
1 per day .. ............. ...... .. ............ 6 
2-3 per day ............ ......... ...... .... 7 
4-5 per day .......... .. .. .. ..... ........... 8 
6 +per day ... ...... .... ................... 9 
F43. Brussels sprouts (1/2 cup) 
Never or < 1 per month ............. I 
1-3 per month ... .. .......... .......... .. 2 
1 per week ........................ ........ 3 
2-4 per week ........ .. .... ... .. ..... .... . 4 
5-6 per week .... .. ... ......... .... ....... 5 
I per day .............. .. ...... ............. 6 
2-3 per day .. ....... ... ..... .... .... ...... 7 
4-5 per day ................................ 8 
6 +per day ............................. ... 9 
F38. Tofu or soybeans (3-4 oz.) 
Never or< I per month ............. I 
1-3 per month ....................... .. .. 2 
I per week .................. .... .... ...... 3 
2-4 per week .. .... ....................... 4 
5-6 per week ....... ..................... . 5 
1 per day ....... ................... .. ....... 6 
2-3 per day ..... .......... ...... .. ........ 7 
4-5 per day .... .. ..... .. ............. ... .. 8 
6 +per day .................. .. .... ...... .. 9 
F41. Cabbage or cole slaw (1/2 cup) 
Never or< 1 per month .. ..... ...... 1 
1-3 per month ...... ... ..... ............. 2 
1 per week ................................ 3 
2-4 per week ............................ . 4 
5-6 per week ...... ..... .. ................ 5 
1 per day .......................... .. ....... 6 
2-3 per day ........... .. .. .......... ...... 7 
4-5 per day .. .......... ...... ......... .... 8 
6 +per day ............ .................... 9 
F44. Carrots, raw (112 carrot or 2-4 
sticks) 
Never or< 1 per month ....... .... .. I 
I-3 per month ...... .. ... .. .... .... ...... 2 
I per week .................... .... ...... .. 3 
2-4 per week ................. ............ 4 
5-6 per week ........ .......... ........... 5 
I per day ....... .... .............. .......... 6 
2-3 per day .......... ....... ........ ...... 7 
4-5 per day ..................... .. .... .... 8 
6+perday .. .. ... ..................... ... . 9 
/ 
F39. String beans (112 cup) 
Never or< 1 per month ..... .... ..... I 
1-3 per month ....................... ..... 2 
I perweek .. ................ .......... ..... 3 
2-4 per week .......................... .. .. 4 
5-6 per week .. ..... ............ .. .. ..... .. 5 
1 per day ...................... .... ......... 6 
2-3 per day ....... ................... ...... 7 
4-5 per day ................... .. .. ....... .. 8 
6 + perday .... ............. .. .... .......... 9 
F42. Cauliflower (l/2 cup) 
Never or < 1 per month ...... ..... ... 1 
1-3 per month ....... .......... .. .. .... ... 2 
1 perweek .................... .... .... ..... 3 
2-4 per week .. ..... ..................... .. 4 
5-6 per week. .. .. .. ....... .. ........... ... 5 
I per day ........ ....... .. ............ .. .. .. 6 
2-3perday ... ... ........ ............... .. . 7 
4-5 per day .... ........ .. ............ .. .. .. 8 
6+perday ................................. 9 
F45. Carrots cooked (l/2 cup) 
Never or < I per month .......... .... ! 
1-3 permonth .. ..... .. ...... ........ .. ... 2 
I perweek .... ........ ....... .............. 3 
2-4 perweek .. ....... .. ... .......... ...... 4 
5-6 per week .... ....... .... ....... .... .. .. 5 
I per day .. .. .... ... .. ...... .. ..... ... ...... 6 
2-3 per day ... ; ... .. .. .. ......... .. ........ 7 
4-5 per day .... .. ..... .... ................. 8 
6+perday ........... .... .................. 9 
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F46. Corn (I ear or Y, cup frozen or 
canned) 
Never or< 1 per month .... ......... 1 
1-3 per month ... ... ............. ...... .. 2 
1 per week ... ... .. .... ... ........ .... .... . 3 
2-4 per week .............. ... ......... ... 4 
5-Q per week .. .. ....... ...... ....... ..... 5 
1 per day .............. ... : ...... ......... .. 6 
2-3 per day ... .... ....... .. ............ ... 7 
4-5 per day ........................ ........ 8 
6 +per day .................. .. .......... .. 9 
F49. Beans or lentils, baked or 
dried ( l/2 cup) 
Never or < 1 per month ... .. .. ...... 1 
1-3 per month ...... .... ..... .... .... .... 2 
I per week .. ............ ... ............... 3 
2-4 per week ................ .... ... ... ... 4 
5-Q per week .......... .. ... ... .. ...... ... 5 
I per day .. ..... ............. ............... 6 
2-3 per day .. ........ .... .. ... .... ........ 7 
4-5 per day ......... ......... ........ ...... 8 
6 +per day ...................... .... .. .... 9 
F52. Yams or sweet potatoes (In 
cup) 
Never or < I per month ........... .. I 
J-3 per month .. .. .. .... ................. 2 
1 per week ................................ 3 
2-4 per week ........................... .. 4 
5-Q per week ........ .. ........... ... ..... 5 
I per day ............ .. .... .. .......... ..... 6 
2-3 per day .............. ..... .... ........ 7 
4-5 per day .................... .. .. .... .. :. 8 
6 +per day .... .. ......... ...... ... ........ 9 
F47. Peas, or lima beans (tn cup 
fresh, frozen, canned) 
Never or< I per month ...... .... .. . 1 
1-3 per month .. ........ ......... ........ 2 
I per week ...... ... .. .... .. ............... 3 
2-4 per week.. ..... .... .......... .. ...... 4 
5-Q per week .. ... ...... .................. 5 
I per day ......... .... .................... .. 6 
2-3 per day ... ................... ......... 7 
4-5 per day ... .... .. ....... ......... .. .... 8 
6 +per day ..... ........................... 9 
FSO. Dark orange (winter) squash 
(ln cup) 
Never or< 1 per month ............. I 
1-3 per month .... .................... ... 2 
I per week ........................ .... .. .. 3 
2-4 per week ...... .... ....... .... .... .... 4 
5-Q per week ............................. 5 
I per day ...................... ....... ...... 6 
2-3 per day ............................ ... 7 
4-5 per day ...................... .... .. ... 8 
6+perday .. .. .... .......... .............. 9 
F53. Spinach, cooked (V, cup) 
Never or < I per month ..... ......... 1 
1-3 per month .. ... ........ .... .......... 2 
I per week ... ..... .. ............ .......... 3 
2-4 per week.. ......... ... .... ..... ...... 4 
5-Q per week ......... ... ........ ......... 5 
I per day .................. ..... ... .... ..... 6 
2-3 per day ..... ....... ... .. ... .... ....... 7 
4-5 per day ...... ... ....... ... .. ......... . 8 
6 +per day ........... ............... ... ... 9 
/ 
F48. Mixed vegetables (112 cup); 
any type of mixture 
Never or< 1 per month .... ... .... .. .I 
1-3 permonth .... .......... .............. 2 
1 perweek .... ....... .... ....... .. ........ J 
2-4 per week .. .. .. .. ......... ............ .4 
5-Q per week .............. .. .............. 5 
1 per day ......................... .... .. .... 6 
2-3 perday .... ..................... .... ... 7 
4-5 per day .. .... ........ ....... ........ ... 8 
6+perday ................ ... ... .. ... ... ... 9 
FSl. Eggplant, zucchini, or other 
summer squash on cup) 
Never or < I per month .............. I 
1-3 permonth ...................... ..... . 2 
I per week .............................. ... 3 
2-4 per week. ............ ...... ........... 4 
5-Q per week ... ..... .... ..... ...... ... .. .. 5 
I per day ........ .. .. ... .. .... ....... ..... .. 6 
2-3 per day ....... ....... ..... ... .......... ? 
4-5 per day .......................... .. .... 8 
6+ perday ...... .. ...................... .. . 9 
F54. Spinach, raw as in salad (1 
cup) 
Never or < I per month ........ .... ... 1 
I-3 per month .. .. ...... .......... ........ 2 
I perweek .............. ... ...... ....... ... 3 
2-4 per week .. ................ ............ 4 
5-Q per week ............ .... .............. 5 
I per day ... .. ......... ... ..... .. ........... 6 
2-3 per day .... .. .... ............. .. ....... ? 
4-5 per day ..................... .... ....... 8 
6+perday ...... ... ..... ........ ........... 9 
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FSS. Kale, mustard, collard or 
chard greens (In cup) 
Never or < 1 per month .. .. ....... .. 1 
l-3 per month ....... ... ......... .. ..... . 2 
1 per week .................... ............ 3 
2-4 per week ........... ...... ........ .. .. 4 
5-6 per week .. .... ...... .... ......... .... 5 
1 per day ....... ... ........ .... ...... .... ... 6 
2-3 per day ... .... ............. ..... ...... 7 
4-5 per day ............ ...... ..... ...... ... 8 
6 +per day ................. .. ......... .... 9 
F58. Celery (4" stick) 
Never or < 1 per month ............. 1 
1-3 per month ........................... 2 
1 per week ............... ... ..... .. ....... 3 
2-4 per week.. .......... .... .... ...... ... 4 
5-6 per week ............ ..... ........... 5 
1 per day .. ....... .. .... .... ............... 6 
2-3 per day .. ............................. 7 
4-5 per day ... ... .. ... ............. ........ 8 
6 + per day ... ..................... ... ..... 9 
F61. Onions as a vegetable, rings or 
soup (1 onion) 
Never or < 1 per month ............. 1 
1-3 per month ........ ...... ..... ... .. ... 2 
1 per week ..... ... ...... ............ .... .. 3 
2-4 per week .. .. .... .... .. .. .... ......... 4 
5-6 per week .. ... .. ............ ........ .. 5 
1 per day ...................... .... ......... 6 
2-3 per day ........ .... .......... ... ...... 7 
4-5 per day .......... .... ..... .. .......... 8 
6+perday .......... .... .......... ....... 9 
F56. Iceberg or bead lettuce (I cup) 
Never or< 1 per month ..... ........ 1 
l-3 per month .... .. ........ .. .. .. .... ... 2 
1 per week .... .. .... ...... .. ...... ..... ... 3 
2-4 per week .. .... .......... ..... ...... .. 4 
5-6 per week .. ........................... 5 
1 per day .. ...... .. ..................... .. .. 6 
2-3 per day ........................... .. .. 7 
4-5 per day ............................... 8 . 
6 +per day .. .... ........... ...... .... ..... 9 
F59. Green, red or yellow sweet 
peppers (3 slices or y, pepper) 
Never or < 1 per month ......... .... 1 
1-3 per month .......... ............ ..... 2 
I per week .... .... .... .......... .. ........ 3 
2-4 per week .... ........ .............. ... 4 
5-6 per week .............. .. .... ......... 5 
I per day .. .. ....... ........ ....... .. ...... . 6 
2-3 per day ................... .. ....... .. . 7 
4-5 per day ... .... ................ ..... ... 8 
6 +per day ................... ... ....... .. . 9 
/ 
F57. Romaine or leaf lettuce (1 cup) 
Never or < 1 per month ............. . 1 
l-3 per month ...... ............... .. ..... 2 
1 perweek ............. .. .... ... ....... .. .. 3 
2-4 per week ............ .... ............. .4 
5-6 per week.. ..... ....... ................ 5 
1 per day ... .. .............................. 6 
2-3 per day ........ ............ ............ 7 
4-5 per day .... ...... ...................... 8 
6 +per day .......... .... .. .... ......... .... 9 
F60. Onions as a garnish or in a 
salad (1 slice) 
Never or < 1 per month ......... : .... I 
1-3 per month ....... ...... ........ ....... 2 
1 perweek ......... ............... .. .. ..... 3 
2-4 per week .... ............ ... ...... ..... 4 
5-6 per week ... .... ..... .. .. .. .... ...... .. 5 
1 per day ... ........ .... .. ....... ........ ... 6 
2-3 per day ................................ 7 
4-5 per day ............................ .... 8 
6 + perday ...... .......... ... .............. 9 
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Next I'll ask you about 
F62. Egg beaters or egg whites 
only ( 1/2 cup or l egg white) 
Never or< l per month ... .. ... ..... 1 
1-3 per month ......... ... ... ............ 2 
l per week ... .. ........ ........ ....... .... 3 
2-4 per week .. .... ... ... ..... ... . ....... . 4 
5-6 per week ........... .. .... ..... ....... 5 
I per day ........ ..... .... ....... .. ... .. ... . 6 
2-3 per day .. ... .......... .. ..... ........ . 7 
4-5 per day ......... .... ........... .. ... .. . 8 
6 +per day .. .... ...... ...... .............. 9 
F65. Chicken or turkey sandwich 
Never or < l per month .. .. ...... .. . l 
1-3 per month .... .. .......... ..... ... ... 2 
I per week ..... ... ................. ... .... 3 
2-4 per week ..... ... ... . ... ..... ........ . 4 
5-6 per week ......... .. ... .. ....... .... .. 5 
I per day ... .. ... .. ....... ... ........ ....... 6 
2-3 per day .... ....... .. .................. 7 
4-5 per day ......... ......... ...... ...... .. 8 
6 +per day ...................... .......... 9 
F68. Beef or pork bot dogs ( 1) 
Never or< I per month ............. I 
1-3 per month ............... ........... 2 
I per week ............. ... . .. .. ......... . 3 
2-4 per week .......... .... ............... 4 
5-6 per week ........... ......... .... .... . 5 
I per day .. ... .. ....... .... ..... ............ 6 
2-3 per day .. ....... ..... ........ ..... .... 7 
4-5 per day ..... ...... ........ ... ... ..... .. 8 
6 +per day .......... . ... ..... ..... ...... .. 9 
EGGS, MEAT, ETC. 
F63. Eggs whole, with yolk (1) 
Never or< 1 per month. .... ..... ..... 1 
1-3 permonth .... .............. ..... ..... 2 
1 (lCr week ................... .............. 3 
2-4 per week ........................... ..4 
5-6 per week .. ......... .. ... ... ... ....... 5 
1 per day .............. .... ....... .... ...... 6 
2-3 per day ...... .. .... ...... .............. 7 
4-5 per day ................... .. .. ...... .. . 8 
6 +per day .. .... ........................... 9 
F66. Other chicken or turkey, 
with skin ( 4-6 oz.) 
Never or < l per month. .. ........... l 
1-3 per month .. ........... ... .. .... .... .. 2 
1 perweek ......... .. ...... .. ....... ....... 3 
2-4 per week ........... ........... ...... .4 
5-6 per week ............. .... .. ... ....... 5 
I per day .... .................... .......... . 6 
2-3 per day ................................ 7 
4-5 per day ..... .. ............... ..... ..... 8 
6 + perday ...................... .. ........ . 9 
F69. Chicken or turkey bot dogs 
(1) 
Never or < 1 per month. ........... .. I 
1-3 per month ................... ........ . 2 
1 per week ...... .... ...... .. ... ............ 3 
2-4 per week ..................... ....... .4 
5-6 per week ............... ............ .. 5 
1 per day ............... ................ .. .. 6 
2-3 per day ......... . .... ............ .... .. 7 
4-5 per day ..... ... .......... ............ .. 8 
6 + perday .... ...... ........ .. ....... ...... 9 
F64. Bacon (2 slices) 
Never or < 1 per month .......... .. . 1 
1-3 per month. ............ .. .. ........... 2 
1 per week ................................ 3 
2~ perweek .... .............. .. ......... 4 
5-6 per week .. ... .... ...... ... .. .. .. ..... 5 
1 perday .. ........ ....... ... .. ............ . 6 
2-3perday .......... ............. .... ..... 7 
4-5perday .. .. .. ... .............. .. ....... 8 
6 +per day ...... .. ..... ........ . .......... 9 
F67. Other chicken or turkey, 
without skin ( 4-6 oz.) 
Never or < 1 per month ............. 1 
1-3 per month .... ... .................... 2 
1 per week .. .... .. . ........... ............ 3 
2-4 per week .. ........................... 4 
5-6 per week ... ........... ... .. .......... 5 
I perday .............. ... ...... .. .......... 6 
2-3perday ........................... ..... 7 
4-5 per day ...... ... ... ......... .. ......... 8 
6 +per day ............ .. .... ... .. .. ....... 9 
F70. Salami, bologna or other 
processed meat sandwiches ( 1 
piece or slice) 
Never or < 1 per month ............. 1 
1-3 permonth ..... .. .. .. .. ......... ..... 2 
1 per week .. ... ....... .... .. .. .... .... .. .. 3 
2-4 per week ......... .. ....... .. ... ...... 4 
5-6 per week ............................. 5 
1 perday ... ..... ...... ....... ........ ...... 6 
2-3 per day .... ....... ...... .. ... ........ .. 7 
4-5 per day .................... ............ 8 
6+perday ............. .. ................. 9 
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F71. Processed meats, e.g., 
sausage, kielbasa, etc. (2 oz. or 2 
small links) 
Never or< I per month .............. I 
1-3 per month ............ .. ............. 2 
I per week ..................... ......... .. 3 
2-4 per week ...... .............. ......... 4 
5-6 per week ........... ... ........... .... 5 
I per day .. .. . : ...... ....... ................ 6 
2-3 per day ... .. ..... ............ .... ..... 7 
4-5 per day .... ... .... ... ..... ........... .. 8 
6+perday .............. ................. . 9 
F74. Beef, pork, or lamb as a 
sandwich or mil:ed dish, e.g., stew, 
casserole, lasagna, etc. 
Never or< I per month ..... ...... .. I 
1-3 per month ............ .. ............. 2 
I per week ................................ 3 
2-4 per week ............................. 4 
5-6 per week.. ........ .. .... .. ........... 5 
I per day ........................ .......... . 6 
2-3 per day ............................... 7 
4-5 per day .......... .... .................. 8 
6+perday .................. .... .......... 9 
F77. Liver: beef, calf or pork ( 4 
oz.) 
Never or< I per month ............. 1 
1-3 per month ........................... 2 
I per week .............. : .. .... .. ...... .. . 3 
2-4 per week ........... ............ ...... 4 
5-6 per week ..................... .. ...... 5 
I per day ............. .. ....... .. .... ....... 6 
2-3 per day .... .... ......... .............. 7 
4-5 per day .. .. ....... .. ................... 8 
6+perday ............ ... .. ............... 9 
F72. Hamburger, lean or extra 
lean (I patty) 
Never or < I per month. ............ . I 
1-3 per month .... ........................ 2 
1 perweek ............ .. ................... 3 
2-4 per week .... ........................ .4 
5-6 per week ............................. 5 
1 per day ...... ....... .. ..... .............. . 6 
2-3 per day .... ..................... ....... 7 
4-5 per day ................................ 8 
6+perday ........................ ......... 9 
F75. Pork as a main dish, e.g., 
bam or chops (4-6 oz.) 
Never or< I per month. .... .......... 1 
1-3 per month ......... .. .. ..... .......... 2 
1 perweek .... ............................. 3 
2-4 per week .. ...... .... .... ........ .... .4 
5-6 per week .................. ........... 5 
I perday ................................... 6 
2;3 per day ........ .. .................. .. .. 7 
4-5 per day ................................ 8 
6 +per day ....... .. .... ...... .............. 9 
F78. Liver: chicken or turkey (I 
oz.) 
Never or < I per month. .............. 1 
1-3 per month ........ ............ .... .... 2 
I perweek ........................ .... ..... 3 
2-4 per week ..... .... .......... ......... .4 
5-6 per week .......... ........ ........... 5 
I per day ................................... 6 
2-3 per day .... .. .......................... 7 
4-5 per day ........ ... ..................... 8 
6 + perday ....... .. ........................ 9 
F73. Hamburger, regular (I patty) 
Never or < 1 per month ...... ..... .. 1 
1-3 per month. ....... .... .. ...... .. : ... .. 2 
I per week .... .... ................ .. ...... 3 
2-4 per week ............................. 4 
5-6 per week .......... ................... 5 
1 per day ... .. .. .... .... .... ................ 6 
2-3 per day ..................... .. ........ . 7 
4-5 per day ................................ 8 
6+perday ................................ 9 
F76. Beef or lamb as a main dish, 
e.g., steak, roast (4-6 oz.) 
Never or < I per month ............. 1 
1-3 per month. .... ................. .... .. 2 
1 per week ................................ 3 
2-4 perweek ............................. 4 
5-6 per week ............................. 5 
1 perday ................................... 6 
2-3 per day .. ...... .......... ....... .. .. .. . 7 
4-5 per day ................................ 8 
6+perday ................................ 9 
F79. Canned tuna fish (3-4 oz.) 
Never or < I per month ............. I 
1-3 per month. .................... .... .. . 2 
1 per week. .... .. .... .. .... .......... ...... 3 
2-4 perweek ................... .. . , .. .. .. 4 
5-6 per week ...... ........ .... ........... 5 
1 per day ................................... 6 
2-3 per day ........... .. .... .. .. ........... 7 
4-5 per day ........ ................. ....... 8 
6 +per day ...... ...... .. .... .............. 9 
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F80. Breaded fish cakes, pieces, or 
fish sticks (I serving, store bought) 
Never or < I per month .. .... .. ..... 1 
I-3 per month ... ............... ... ...... 2 
I per week .... ..... .. ................ .. ... 3 
2-4 per week. ...... .......... ............ 4 
5-6 per week ..... ...... ....... .... .. .... . 5 
1 per day .... .. .. ..... ... .......... ...... .. . 6 
2-3 per day ..... .. ...... ........... ....... 7 
4-5 per day ........ .. ..... ......... ........ 8 
6 +per day ................. ... ...... ... ... 9 
F83. Other fish (3-5 oz.) 
Never or < 1 per month ............ 1 
1-3 per month .......... .. ... .......... . 2 
I per week .. ........... .... ...... ......... 3 
2-4 per week ............... ..... .... ... .. 4 
5-6 per week .... .. ..... ....... .. ........ . 5 
1 per day .... ...... ... ............ .......... 6 
2-3 per day .. ....... .. ... ... ...... ... ..... 7 
4-5 per day ...... .... .... .... ........... .. 8 
6+perday .... ...... ... ......... .......... 9 
Next I'll ask you about 
F81. Shrimp, lobster, scallops, or 
clams as a maio dish (1 serving) 
Never or < 1 per month .............. I 
1-3 per month ........... ....... .......... 2 
1 per week ............... ........... ....... 3 
2-4 per week .... ........ ........ ........ .4 
5-6 per week ..... ... .. .. ... ...... ...... .. 5 
I per day .. .. ... ...... .... ........ .. ........ 6 
2-3 per day ........ ..... ... ............... . 7 
4-5 per day .... ........... ...... ...... ..... 8 
6+perday ............ ... ..... ............. 9 
F82. Dark meat fish, e.g., 
mackerel, salmon, trout, sardines, 
bluefish, swordfish (3-5 oz.) 
Never or < 1 per month ..... .. ...... 1 
I-3 per month .............. ... ....... ... 2 
1 per week ............. .............. .... . 3 
2-4 per week ......... .... .. .... .. ........ 4 
5-6 per week ......... ... ... ......... ..... 5 
1 perday ........... ... .. ... ....... .. .... .. . 6 
2-3 per day .. ................. ... ... ....... 7 
4-5 per day .... .. .. .. .... ........ .... .. .... 8 
6+perday .......... ......... .. ........ ... 9 
BREADS, CEREALS, STARCHES 
F84. Cold breakfast cereal (1 cup) 
Never;< 1 per month (TO F85) .. I 
1-3 per month .......... .... ........ .. ... 2 
1 per week .... ....................... ..... 3 
2-4 per week .... ... .. .. ....... .... ....... 4 
5-6 per week ............................. 5 
1 per day ............ , ............ .... ...... 6 
2-3 per day .... .. ...... .. ................. 7 
4-5 per day ........... .. ........... .. ...... 8 
6+perday ................... .. ........... 9 
F84a.. What brand and type of cold 
breakfast cereal did you usually eat 
(e.g., Ralston Rice Chex}? 
F85. Cooked oatmeaVeooked oat 
bran (1 cup) 
Never or < 1 per month .... ..... .... 1 
1-3 per month ... ..... .. ............ .. ... 2 
I perweek ......... ..... ................... 3 
2-4 per week ........... . ........ ........ . 4 
5-6 per week ............................. 5 
1 per day ........... .. ......... ....... ...... 6 
2-3 per day ....... .. .... .. ...... .... ...... 7 
4-5 per day ... ..... . ..... ........... ....... 8 
.__-"-__.__..__-.Jr 6 + per day ..... ................ .. ......... 9 
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F86. Other cooked breakfast cereal 
(I cup) 
Never or < I per month ............. I 
1-3 per month ..... ..... ... .............. 2 
1 per week ............. .... ... ............ 3 
2-4 per week .... ....... ... ... ........... . 4 
5-6 per week ............................. 5 
1 per day ..................... .... ..... ..... 6 
2-3 per day ....... ...................... .. 7 
4-5 per day ................................ 8 
6 +per day ..................... ........... 9 
F89. Bagels, English muffms or 
rolls ( 1 whole) 
Never or < 1 per month ............. l 
1-3 per month ... .. ...................... 2 
I per week ................................ 3 
2-4 per week .......... .. ............ .. ... 4 
5-6 per week ............................. 5 
I per day ................................... 6 
2-3 per day ... ................. .. ......... 7 
4-5 per day .... .... ......... ............... 8 
6 +per day ...... ................ ....... ... 9 
F92. White rice (1 cup) 
Never or < 1 per month .............. 1 
1-3 per month .... ............. .......... 2 
I per week ....................... ..... .. .. 3 
2-4 per week ............................. 4 
5-6 per week ...... ................ ... .... 5 
1 per day ..... .... .......................... 6 
2-3 per day .. ....... ...................... 7 
4-5 per day ........ .. .. ... ................. 8 
6+perday .. .. ............................ 9 
F87. White bread (slice), including 
pita bread 
Never or < 1 per month .............. 1 
1-3 per month. ................ .. ......... 2 
1 perweek ................................. 3 
2-4 per week ................. ........... .4 
5-6 per week ... .. ............ .... ........ 5 
I per day ................................... 6 
2-3 per day .... ............. , .............. 7 
4-5 per day ................................ 8 
6+perday ................................. 9 
F90. Muffins (regular) or biscuits 
(1) . 
Never or < I per mont11 ...... ....... I 
1-3 per month. ....................... ~ ... 2 
I perweek ................................. 3 
2-4 per week .. .............. ............ .4 
5-6 per week ............................. 5 
1 perday ........ .. ......................... 6 
2-3 per day ................. ... .. ... ....... 7 
4-5 per day ....... ....... .................. 8 
6+perday ................................. 9 
F93. Pasta, e.g., spaghetti, noodles, 
ete- (l cup) 
Never or < 1 per month .. ............ 1 
1-3 permonth .. .. .. ...................... 2 
I perweek ................................. 3 
2-4 per week ............................ .4 
5-6 per week .................... ... ...... 5 
I perday ........ .. ........................ . 6 
2-3perday ......... ....................... 7 
4-5 per day .. ...................... ........ 8 
6+perday .......... ......... .............. 9 
/ 
F88. Dark bread (slice), including 
wheat pita bread 
Never or< I per month .. ......... .. 1 
1-3 per month ........................... 2 
I per week ........................ ........ 3 
2-4 per week ............................. 4 
5-6 per week ............................. 5 
1 per day ................................... 6 
2-3 per day .. ...... ..................... .. 7 
4-5 per day ... ............. ..... .. ..... .... 8 
6 +per day ................................ 9 
F91. Brown rice (I cup) 
Never or< I per month ............. 1 
1-3 per month ........................... 2 
1 per week ... ...... ....................... 3 
2-4 per week ...... .. .............. .. ... .. 4 
5-6 per week .... ... .......... .. ...... .... 5 
1 per day .. .......................... ....... 6 
2-3 per day .... ..... ..... .............. ... 7 
4-5 per day ....................... .. ... .. .. 8 
6 +per day ................. .. .... ......... 9 
F94. Tortillas (1) or foods with 
tortillas like burritos, fajitas or 
sandwich wraps 
Never or < 1 per month ............. 1 
1-3 per month .............. ..... ...... .. 2 
I per week .......... ................. .. ... 3 
2-4 per week.. .............. .. .......... . 4 
5-6 per week.. .. ....... ............ .. .... 5 
1 per day .. ........................... .... .. 6 
2-3 per day ............. ............ .... .. 7 
4-5 per day ......... .... .................. . 8 
6+perday ................ ..... ..... ..... . 9 
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F95. Other grains, e.g., bulgur, 
kasha, couscous, etc. (I cup) 
Never or< I per month .... .. .. .... . I 
1-3 per month .. .. ..... ........... .. ..... 2 
I per week ........................... .... . 3 
2-4 per week.. ................. ...... .... 4 
5-6 per week ... ... ............. .. ........ 5 
I per day ......... ... .. ..................... 6 
2-3 per day ............................... 7 
4-5 per day ........ ... ..................... 8 
6 +per day .......... .. .. ........ ...... .. .. 9 
F98. Potatoes, baked, boiled (I) or 
mashed (I cup) 
Never or < I per month .. ....... .... l 
1-3 per month ..... ............... ...... . 2 
I per week ................................ 3 
2-4 per week ............ ..... ...... ...... 4 
5-6 per week ........ .. .............. .. .. . 5 
I per day ... .... .... .. .. .... ....... ......... 6 
2-3 per day ................. .. ......... ... 7 
4-5 per day .......................... .. .. .. 8 
6 +per day .................. ...... .. .. .... 9 
FlO!. Pizza (2 slices) 
Never or < 1 per month .... .. ... .. .. 1 
1-3 per month ........................... 2 
I per week .. ... .... ................. ... ... 3 
2-4 per week ........ ...... .. .. ........... 4 
5-6 per week ........... .. ........ .. .... .. 5 
1 per day ............................. ... ... 6 
2-3 per day ............ ........ .. ........ . 7 
4-5 per day ... .... .. ... .... ................ 8 
6 +per day ...... .. ..................... ... 9 
F96. Pancakes or waftles (3 pieces) 
Never or< I per month ............. 1 
1-3 per month ............... ........ ... .. 2 
I perweek ................... ...... ........ 3 
2-4 per week ..................... ........ 4 
5-6 per week ..... ..... ........ ........... 5 
I per day ............... .............. ...... 6 
2-3perday ................................ 7 
4-5 per day .... ..................... ...... . 8 
6+perday ........ ......................... 9 
F99. Potato chips or corn chips 
(small bag or I oz.) 
Never or < 1 per month ............. 1 
1-3 per month. ...... .. .............. ..... 2 
I perweek ............. .. .................. 3 
2-4 per week .......... ... ............... .4 
5-6 per week ............................. 5 
I per day ...... : ............. ........ ....... 6 
2-3 per day ................................ 7 
4-5 per day .............. .......... ........ 8 
6 +per day ...................... .. ......... 9 
/ 
F97. French fried potatoes (small 
order or Y, cup) 
Never or< 1 per month .. .... .... .... 1 
1-3 per month ........ ... ................ 2 
1 per week ..... ..... ...... ........ .. .... .. 3 
2-4 per week ......... ... ............... .. 4 
5-6 per week .................... ... ...... 5 
1 per day ................................... 6 
2-3 per day .... ........................... 7 
4-5 per day .......... ...................... 8 
6+perday ........ .... .. .. .............. .. 9 
FlOO. Crackers, Triscuits, Wheat 
Thins (5) 
Never or< 1 per month .. .. .... ...... I 
1-3 per month ......... .. .... .... .. .... .. 2 
1 per week ................ ................ 3 
2-4 per week ......... ....... .. .... .... ... 4 
5-6 per week ... ........ ....... ...... ..... 5 
1 per day .. .... .... .. ...... .. ...... ....... .. 6 
2-3 per·day ......................... .. .... 7 
4-5 per day .. .................... .. ...... .. 8 
6 +per day .............. ... .. .. .. .. .. ..... 9 
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Next I'll ask you about 
F102. Low-ulorie cola, e.g., Diet 
coke with caffeine (I glass, bottle, 
can) 
Never or< I per month ............. I 
1-3 per month ........ .. ................. 2 
I per week ................................ 3 
2-4 per week.. ........... .. .............. 4 
5-6 per week .. .. .... .............. .. ..... 5 
I per day ................................... 6 
2-3 per day .......................... .... . 7 
4-5 per day .... .. .............. .. .......... 8 
6 +per day .. ........ , .. ....... .. .......... 9 
FlOS. Coke, Pepsi, or other cola 
with sugar (1 glass, bottle, can) 
Never or < I per month .......... . .. 1 
1-3 per month .................... ....... 2 
I per week .. .................. ..... ... .. .. 3 
2-4 per week .......... ................... 4 
5-6 per week ............................. 5 · 
I per day ....................... ............ 6 
2-3 per day ............ .. ... .............. 7 
4-5 per day .. .................... .. ........ 8 
6+ perday ................... .. ........... 9 
F108. Hawaiian Punch, lemonade, 
Kool Aid or other non-carbonated 
drinks (I glass, bottle, can) 
Never or < I per month .............. I 
1-3 per month .... .. ..................... 2 
I per week ................................ 3 
2-4 per week ...... .. .. .. .. ... ............ 4 
5-6 per week ........ ...... ............... 5 
I per day .. .... .... .. ......... .. ............ 6 
2-3 per day ................. .... .. ........ 7 
4-5 per day .......................... .... .. 8 
6 +per day .. .. ............................ 9 
BEVERAGES 
Fl OJ. Low-<alorie caffeine-( ree cola 
(I glass, bottle, can) 
Never or< I per month ....... ....... I 
1-3 permonth ............ ............ .... 2 
I perweek ....................... .... ...... 3 
2-4 per week. ...................... ...... .4 
5-6 per week .......... .... ................ 5 
1 per day ................................... 6 
2-3 perday ............................... . 7 
4-5 per day ........ ... ..... ...... .......... 8 
6 +perday ................................. 9 
F106. Caffeine Free Coke, Pepsi, or 
other colas with sugar (1 glass, bottle, 
can) 
Never or < I per month .............. 1 
l-3 per month ..... ...... ... .. .... ........ 2 
1 perweek ................................ .3 
2-4 per week ....... _ ............... .. ..... .4 
5-6 per week .................. .. .......... 5 
I per day ... ............................. ... 6 
2-3 per day .................. .... .......... 7 
4-5 per day ............. ............ ....... 8 
6 +per day ........ .. ................. ...... 9 
F109. Regular beer (1 glass, bottle, 
can) 
Never or < I per month ............... 1 
1-3 per month ................. .. ...... ... 2 
I perweek ............. .................... 3 
2-4 per week. ........... .. ... ............ .4 
5-6 per week ...... .. .... .................. 5 
1 per day ............ .... .... .. ............. 6 
2-3 perday .......... ................. ..... 7 
4-5 per day ....... ......................... 8 / 
6+perday ................................. 9 
F104. Other low-<alorie carbonated 
beverage, e.g., Diet 7-Up, Fresca, 
diet ginger ale (I glass, bottle, can) 
Never or < 1 per month. ....... .... .. 1 
1-3 per month ............................ 2 
1 perweek .... .. ............ .... ........... 3 
2-4 per week ............................ .4 
5-6 per week ............................. 5 
I per day ... ............... ... ... ........... 6 
2-3 per day ...... .... .. ....... ......... .... 7 
4-5 per day .............. .. .. . .......... .. . 8 
6 +per day ................................. 9 
F107. Other carbonated beverage 
with sugar, e.g., 7-Up (I glass, bottle, 
can) 
Never or < I per month .... ........ .. 1 
1-3 per month ......... .... .......... .. ... 2 
1 perweek ..... .. .................. .. . ..... 3 
2-4 per week .... .. .............. ....... . .4 
5-6 per week .......... .. .. .. ............. 5 
lperday ................................... 6 
2-3 per day ............................... 7 
4-5perday ......... .............. ........ . 8 
6 + perday ........... .... ......... ...... ... 9 
FllO. Light beer e.g., Bud Light (I 
glass, bottle, can) 
Never or < 1 per month ............. I 
1-3 permonth .... .. .......... ....... .. ... 2 
1 perweek ......................... .. ...... 3 
2-4 per week ......... ...... ............. .4 
5-6 per week ............................. 5 
1 perday ......... .......................... 6 
2-3 per day ................................ 7 
4-5 per day .. ....... ...... ........ .. ... .. .. 8 
6+perday ................... .. ............ 9 
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Flll. Red wine (4 oz. glass) 
Never or < I per month .. .... .. ..... 1 
1-3 per month ...... .. .... .. ......... .... 2 
1 per week .... .... .. .... ..... ............. 3 
2-4 per week ...... ..... .... .............. 4 
5-6 per week ..... .......... ... ... . ... .... 5 
1 per day .............. ..... ... ............. 6 
2-3 per day ..... .. .... ... ..... .. ... ....... 7 
4-5 per day .... ... .................. .. .... . 8 
6 +per day .. ... ... ... .......... .. .. .. ... .. 9 
Fll4. Plain water, bottled or tap 
including mineral water and soda 
water (1 cup or glass) 
Never or < I per month ....... .. .... 1 
1-3 per month ....... .. .. ........... .. ... 2 
1 per week ...................... ...... ... . 3 
2-4 per week .............. .... .. .... ... .. 4 
5-6 per week ... ........ ................ .. 5 
1 per day ...... ........... .......... .. ...... 6 
2-3 per day ... ...... ................ .... .. 7 
4-5 per day ....... ......... ....... ...... ... 8 
6+perday .. .......... ........... .. ... .... 9 
F117. Decaffeinated coffee (1 cup) 
Never or < 1 per month .... ......... 1 
1-3 per month .... ....... ...... .... ...... 2 
1 per week ......... .. ... ............... ... 3 
2-4 per week ................. ....... .... . 4 
5-6 per week ........... ... ............. .. 5 
1 per day .......... ........ ... .............. 6 
2-3 per day ....... ........ .. ..... ......... 7 
4-5 per day ....... ... .... ...... ............ 8 
6 + per day ............... .............. ... 9 
F112. White wine (4 oz. glass) 
Never or < 1 per month .......... .. .. 1 
1-3 per month ........ ... ... ....... ....... 2 
1 perweek .............. .... .............. .3 
2-4 per week ......... .................... . 4 
5-6 per week ..... ...... ..... .. ........ . .... 5 
I per day .... ..... .. ... ... ..... ..... ... ..... 6 
2-3 per day .... ...................... .. .... 7 
4-5 per day .... ...... ........ ... ... ........ 8 
6 + perday ... ............ .... ... ........... 9 
FllS. Herbal tea, brewed; cold or 
hot (I cup) 
Never or < 1 per month ...... ........ 1 
1-3 per month ..... ... ...... ..... ......... 2 
I perweek .......... .. ... .... .............. 3 
2-4 per week. ...... .. ..... ..... ........... 4 
5-6 per week .................. ........... .5 
1 per day ..... .......... .. ..... ... .. ....... . 6 
2-3 per day .. .. ............................ 7 
4-5 per day ................................ 8 
6 +per day .... ...... ............ ... ..... ... 9 
Fl18. Coffee with caffeine (I cup) 
Never or < 1 per month .. ....... ..... I 
1-3 per month .... ...... .... .... .......... 2 
1 perweek ........... .... ...... .. ..... .. ... 3 
2-4 per week. .... ... .... .................. 4 
5-6 per week ...... ........ .. .. .. ...... .... 5 
1 per day .. .. .. .... ... .... .. ........... ... .. 6 
2-3 perday ... .. ... ....... ..... .... .. .. ... . 7 
4-5 per day ............................... . 8 
6 +perday .. ... ... .. .. .... ... ..... ..... .. .. 9 
FllJ. Liquor, e.g., whiskey, gin, etc. 
( 1 drink or 1 oz. shot) 
Never or < 1 per month. ....... ..... . 1 
1-3 per month ... .... ..... ...... ... ....... 2 
1 perweek ... ..... ............. ... .... ..... 3 
2-4 per week ...................... ...... .4 
5-6 per week ........ .......... .. ... ... .. . 5 
I per day .. ..... ..... ...... .... ...... ....... 6 
2-3 per day ········· ···· ···· ·· ········ ···· · 7 
4-5 per day .. .... ....... ....... .. ........ .. 8 
6 +per day .. .... .............. ... .. ... ..... 9 
Fll6. Regular Tea; brewed, cold or 
hot (1 cup) 
Never or < I per month .............. I 
1-3 per month ........... ...... ........... 2 
I perweek ...................... ...... ... .. 3 
2-4 per week .. .. ........ .. ... .. ..... ... . .4 
5-6 per week .. ..... .. .............. ...... 5 
1 per day .......................... ......... 6 
2-3 per day .... .. ... .. ........ ........ ..... 7 
4-5 per day .................. ............ .. 8 
6 +per day ........ ..... ... .. ... ............ 9 
Next I'll ask you about 
SWEETS, BAKED GOODS, MISCELLANEOUS 
Fl19. Pure chocolate candy bar or 
packet (e.g., Hershey's, M&M's) 
Never or< 1 per month ..... .. .. ... . 1 
1-3 per month ........ ..... ..... ...... ... 2 
1 per week ... ...... .. ........... .......... 3 
2-4 per week .......... .............. ... .. 4 
5-6 per week ..... ... .............. .. ..... 5 
I per day ......... .. ................... ..... 6 
2-3 per day ............... ... ............. 7 
4-5 per day .. ................. .. ... ..... ... 8 
6+perday ...... .. ..... ...... .. ........... 9 
Fl22. Jams, jemes, preserves, syrup, 
or honey (I Ths.) 
Never or< 1 per month .... .. ... .... I 
1-3 per month .. .. ... ............ ........ 2 
I perweek .................. .... ...... ... . 3 
2-4 per week .. .... .. .......... .... ....... 4 
5-6 per week ....... ................ ...... 5 
I per day ................... ....... ......... 6 
2-3 per day ..... .. .. .. ......... ..... ... ... 7 
4-5 per day .. .............. .......... .... .. 8 
6 +per day .... ...... ... .. .... ............. 9 
Fl25. Pretzels (I oz., or small bag) 
Never or< I per month .............. I 
1-3 per month .. ....... .................. 2 
1 per week·· ··· ····· ·· · ·· ···:············· 3 
2-4 per week ..... ........... .... ... .. ... . 4 
5-6 per week ...... ........... .. ...... .... 5 
I perday ... .. .. .. ............ .......... .. .. 6 
2-3 per day .. .... ..... ... .. ............... 7 
4-5 per day .. ..... .. ...... ... ......... ... .. 8 
6 +per day ....... .... .. ......... ... ...... . 9 
Fl20. Other mixed candy bars, (e.g., 
Snickers, Milky Way, Reescs) 
Never or < I per month .............. I 
1-3 per month ...... ..................... . 2 
I perweek ..... .. ............ ..... ... ... ... 3 
2-4 per week. ........ ... ... .... .. ........ . 4 
5-6 per week ... ........ ........... .. ...... 5 
I per day ................... .......... ...... 6 
2-3 per day ............ ......... .... ....... 7 
4-5 per day ....................... ... ...... 8 
6+perday ... ........ ... .. ......... .. ...... 9 
Fl23. Peanut butter (1 1bs.) 
Never or < I per month ... ........... 1 
.1-3 per month ............. .. ...... ... .... 2 
I perweek ......... .. .. ... ...... ... ....... .3 
2-4 per week ...... ...... .. ....... ... ..... .4 
5-6 per week ................... .. ..... ... .5 
I per day ...... ........................ ..... 6 
2-3 per day ... ......... ............ ..... .. . 7 
4-5 per day ............. .............. ..... 8 
6 +perday .... .. ........... ................ 9 
Fl26. Cookies, borne baked (I) 
Never or < I per month .............. I 
1-3 per month ........ .. .................. 2 
1 perweek ................................. 3 
2-4 per week. .......... ............ ....... 4 
5-6 per week.. ............................ 5 
1 per day ....... ..... ........ ...... ......... 6 
2-3perday ............ .......... .......... 7 
4-5 per day ................................ 8 
6+perday ................................. 9 / 
F121. Candy without chocolate (e.g., 
I pack mints, Lifesavers) 
Never or < 1 per month. .. ... ........ 1 
1-3 per month ......... .. .. .......... ..... 2 
I per week .. ............... ................ 3 
2-4 per week ........................... .4 
5-6 per week .......... ......... ......... 5 
I per day .. ... ........ ........... ..... ..... . 6 
2-3 per day ......... .. .. .. ............... .. 7 
4-5 per day ................................ 8 
6+perday .. ...... . , ........ ............... 9 
Fl24. Popcorn (I cup) 
Never or < I per month. ...... ....... I 
1-3 per month ............................ 2 
1 perweek.. ............................... 3 
2-4 per week ............................ .4 
5-6 per week ... .. ................ .... .... 5 
I perday ................................... 6 
2-3 per day .. .. .. .. .. ...... .. ... .. .. .. ..... 7 
4-5perday ............ .... .. .... ......... . 8 
6+perday ................... .... ........ .. 9 
Fl27. Cookies, ready made (1) 
Never or < 1 per month ............. 1 
1-3 per month ............................ 2 
1 perweek .. .. ............ .......... .... ... 3 
2-4 per week ...... .. .. ........ ..... .. .. . .4 
5-6 per week ............................. 5 
1 per day ...... ................... .. ........ 6 
2-3 per day ............... ... .... .. .... .. .. 7 
4-5 per day ... .. ... ...... .... ....... .. .... . 8 
6+perday .. ... .... .. .... .... .... .. .... .... 9 
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F128. Brownies (I) 
Never or < I per month ... ...... .... 1 
l-3 per month ..... ........ .. ........ .... 2 
I per week ... ......... .. ....... .... .... ... 3 
2-4 per week .... .... ........ .. .. .. ....... 4 
5..{5 per week.. ................. .. . .. ... .. 5 
l per day ........ .. .... : ............ .. ...... 6 
2-3 per day ...... .................. .. ..... 7 
4-5 per day .. .. ..... ....................... 8 
6 +per day .... .. .. .... ................ .. .. 9 
Fl31. Cake, ready made (slice) 
Never or < I per month .. .. .. ....... I 
1-3 per month ...... .. ................... 2 
I per week .. ......................... ..... 3 
2-4 per week .... .. .. .. ...... .... .. .. ..... 4 
5..{5 per week ..... ... .. ................... 5 
I per day ...................... .... ..... .. .. 6 
2-3 per day ...... ..... .................... 7 
4-5 per day ... .. ........................... 8 
6 +per day .. ..................... ..... .. .. 9 
F134. Sweet roll, coffee cake or 
other pastry, homemade (seiVing) 
Never or< I per month ............. I 
1-3 per month ........................... 2 
I per week .. .............. .... ............ 3 
2-4 per week ............................. 4 
5..{5 per week ........................... .. 5 
l per day .................. . ........... .. ... 6 
2-3 per day ... ... ............. ... .. ...... 7 
4-5 per day .............................. . 8 
6 + per day .. .. ................ .. .......... 9 
F129. Doughnuts (I) 
Never or < l per month .............. I 
1-3 per month ............. ........ ...... 2 
I perweek ..... .. ... ............. .. ...... .. 3 
2-4 per week ..... ......... .. .. ........ .... 4 
5..{5 per week ............ .. ........ . _ ....... 5 
I per day ........... ... .... ................. 6 
2-3 per day ................................ 7 
4-5 per day .. .... ........ .. ................ 8 
6 +perday ... .. .. .. ........ .. ...... .. .. .. .. 9 
F132. Pie, homemade (slice) 
Never or< l per month .............. l 
1-3 per month .... .. ............ .. ........ 2 
1 perweek .. .. ............... .. ... .. ....... J 
2-4 per week. ... .................. .. ...... 4 
5..{5 per week ....... ....... .. ............. .5 
I per day ................ ........... ........ 6 
2-3 per day .. .... .... ... ........ ........... 7 
4-5 per day .. .. ................ ............ 8 
6 + perday .................. ....... ... .... . 9 
Fl35. Sweet roll, coffee cake or 
other pastry, ready made (serving) 
Never or < I per month ... ....... .. .. ! 
1-3 permonth ....................... .. ... 2 
1 perweek ................................. J 
2-4 per week ............ .. ... ............. 4 
5..{5 perweek ............... ............... 5 
I per day .... .. ..... .......... .. ............ 6 
2-3 per day ................................ 7 
4-5 per day .... ............................ 8 
6+perday .......... ....................... 9 
/ 
F130. Cake, homemade (slice) 
Never or < I per month. ... ...... .... 1 
1-3 per month ........ ....... ........ .. ... 2 
I perweek.. .. ...... ... .. .... .. ........ .... 3 
2-4 per week ......... .. ................. .4 
5..{5 per week .................... ......... 5 
I per day .......... ......... .. ............ .. 6 
2-3 per day ........ .. ........ .............. 7 
4-5 per day .... .. ..... ..... .... .. ... .. ... .. 8 
6 +per day .. .. ....... .. ................ .. .. 9 
Fl33. Pie, ready made (slice) 
Never or < I per month. ............. I 
I-3 per month .......................... .. 2 
1 perweek .............. .. .... ..... ..... .. . 3 
2-4 per week .. .... , .. ...... ... .. .. .... ... 4 
5..{5 per week ......... .................... 5 
I perday ...... ....... .. ..... .. .... .... ... .. 6 
2-3 per day ...... .. ................. ....... 7 
4-5 per day ................ .. .............. 8 
6 + perday ..... .. ............ .. ...... ...... 9 
Fl36. Peanuts (small packet or 1 oz.) 
Never or < I per month. ............ . I 
l -3 per month ............................ 2 
l perweek ................ ... .. ....... ... .. 3 
2-4 per week .............. ...... .. ...... .4 
5..{5 per week ........................ .. ... 5 
I per day ........ . ...... .. .. .. .............. 6 
2-3 per day .................. ....... .... ... 7 
4-5 per day ........ , ... ..... ............... 8 
6 +per day .. ... ............ .... .... ...... .. 9 
r==============T==============~============~58 
F137. Other nuts (small packet or I 
oz.) 
Never or< I per month .... ......... . 1 
1-3 per month .... .. .. ........ ..... .. .... 2 
1 per week ..... ........ .... ..... ....... .. . 3 
2-4 per week .... .... .. .. ...... ... ........ 4 
5-{) per week ..... .. ... ........ ..... ... ... 5 
1 per day ... ...... .... .......... ......... ... 6 
2-3 per day ......... ...... ................ 7 
4-5 per day .............................. .. 8 
6+perday .......... .. ...... .............. 9 
F140. Wheat germ (I Ths.) 
Never or < 1 per month ...... ....... 1 
1-3 per month .............. .. .......... . 2 
1 per week .................... .. .... ...... 3 
2-4 per week ...... .. ...... ......... .... .. 4 
5-{) per week ............................. 5 
I per day .. .. ...... ... .... ............ c ..... 6 
2-3 per day .................. .... ...... .. . 7 
4-5 per day .. ................ .............. 8 
6 +per day .... .......... .. .... .... ........ 9 
Fl43. Salt added at table (1 shake) 
Never or < I per month ............. 1 
1-3 per month ........................... 2 
1 per week .. .... .... ... .... .... ........... 3 
2-4 per week .. .. ................. .. ...... 4 
5-{) per week.. .... .................... ... 5 
1 per day ...................... .. ..... : ..... 6 
2-3 per day .. ............................. 7 
4-5 per day .......... ............ .......... 8 
6 +per day .................. ........ .... .. 9 
F138. Oat bran, added to food (l 
Ths.) 
Never or < 1 per month .............. 1 
1-3 per month ...... .... .... .... .......... 2 
1 per week ............... ........ .. ........ 3 
2-4 per week ...................... .... .... 4 
5-{) per week ......... .. ................... 5 
I per day ........ .. .. .......... ........ ..... 6. 
2-3 per day .......... ...................... 7 
4-5 per day .. ........ .. .............. .. . : .. 8 
6+perday ................ ................. 9 
Fl41. Chowder or cream soup (1 
cup) 
Never or < 1 per month .. ............. 1 
1-3 per month .. ........ ...... ........ .... 2 
I per week .... .... .. ...................... . 3 
2-4 per week. .......... ............ ...... . 4 
5-{) per week .... .... ...... .... ............ 5 
I per day ................................... 6 
2-3 per day ...... .. .... .. .............. .... 7 
4-5 per day .......... ...... .... ............ 8 
6 +per day ................................. 9 
Fl44. H you added sugar to your 
beverages or food, bow many 
teaspoons of sugar did you add each 
day? 
Teaspoons I I I I 
IF NONE, CODE 000 
F139. Other bran, added to food (I 
Ths.) 
Never or < I per month ........... .. . 1 
1-3 permonth ............................ 2 
I perweek ....... .. ........................ 3 
2-4 per week ...................... ...... .4 
5-{) per week .... .. .. .. ................... 5 
1 per day ... _ .......... .. .... ................ 6 
2-3 per day ... .. .. .... .. .. .. ............. .. 7 
4-5 per day ................... .. ........... 8 
6+perday ................................. 9 
F142. Ketchup or red chili sauce (l 
Ths.) 
Never or < 1 per month .............. 1 
1-3 permonth ............... ............ . 2 
1 perweek .. .... .... .. .. ..... .. ...... ...... J 
2-4 per week ............................ .4 
5-{) per week .... ....... .... .............. 5 
1 per day .. - .................... .. ......... 6 
2-3 per day ............ .... .. .............. 7 
4-5 per day .. .. .... ........ .. .............. 8 
6 +per day ................................ . 9 
F145. NutraSweet or Equal (1 
packet) NOT Sweet 'N Low 
Never or < 1 per month .............. 1 
1-3 per month .... .. .................. . _ ... 2 
I per week ............ .... .. .. ............. 3 
2-4 per week ............ .... ............ .4 
5-{) per week ............................. 5 
1 per day ................................... 6 
2-3 per day ................................ 7 
4-5 per day .... .............. .. ........ ... . 8 
6+perday .... .... ........ ................. 9 
r==============r==============T=============~59 
FI46. G a rlic (1 clove or 4 shakes) 
Never or < 1 per month .. .. ..... .... I 
J-3 per month ........ .. .... ..... ........ 2 
1 per week ... .. .. .. ... ...... ... ...... ..... 3 
2-4 per week ....... .... .. ................ 4 
5-6 per week ............... ... ...... ..... 5 
1 per day ...... ........... ....... ... .. .. .. .. 6 
2-3 per day ..... ... ........... ... ... ...... 7 
4-5 per day .. .. .......... ...... .. .......... 8 
6 +per day .......... .............. ..... ... 9 
F149. Sa lad dressing (2 Tbs.) 
Never;< 1 per month (TO F150) 1 
1-3 per month ..... ....... ............... 2 
I per week .. ....................... ...... . 3 
2-4 per week ....... : ....... ........... ... 4 
5-6 per week ..... ... ........ .. ........... 5 
1 per day ... ...... . ... .... .. .... ...... ...... 6 
2-3 per day ....... ....... ............ .. ... 7 
4-5 per day ... ........ ..................... 8 
6 + per day .............................. .. 9 
FlSl. Bow much of the visible fat 
on your beef, pork or lamb did you 
remove before eating? 
Don' t eat meat.. ...................... .. .. 1 
Remove all visible fat.. .. .. ........... 2 
Remove most .... ... ...................... 3 
Remove small part of fat... .......... 4 
Remove none .................... .. ....... 5 
F147. Low fat mayonnaise! fat free 
mayonnaise (2 1bs.) 
Never or < I per month .... ..... .... .I 
1-3 per month .... ......... ............... 2 
I perweek .... ..... ... ...... ....... ...... .. 3 
2-4 per wcek. ...... ..... .... ..... .... ..... 4 
5-6 per week .... .. .. ..... .. ......... ...... 5 
1 per day ........ ... ....... .... , ............ 6 
2-3 per day ..... ... .... .... ................ ? 
4-5 per day .... .. .. ... .... ..... .... .... ... . 8 
6 + per day ...... ...... ...... .. ······:··· ···9 
Fl49a. Did you urually use nonfat, 
low fat or regular salad dressing? 
Nonfat. ............. ... ........... ................ I 
Low fat ............... .. .......................... 2 
Regular ........ .............................. .. .. . 3 
149b. Wbat brand and type of salad 
dressing did you usually use (e.g. Kraft 
Thousand Island)? 
FI52. Bow often did you eat food 
fried, stir-fried in oil, or sauteed at 
borne? 
NeVer (GO TO FI54) .... ..... .. ....... 1 
Less than once a week .. ...... ........ 2 
. Onoc: per week ........................... . 3 
2-4 times per week.. ...... ......... .' .... 4 
5-6 times per week .................. .... 5 
Daily ...................... .................... 6 
/ 
I 
Fl48. Regular mayonnaise (2 Tbs.) 
Never or< 1 per month. ..... ..... ... 1 
1-3 per month .... ...... ............. ... .. 2 
1 per week ....... ........ c •••• •••• • •••••••• 3 
2-4 per week .. .. .. .............. ...... .. .4 
5-6 Iier week .... .... ........ .. ........... 5 
1 per day .... ..... ....... ................ ... 6 
2-3 Per day .... ........ .. ...... ..... .... ... 7 
4-5 per day .. ......... ............. ..... .. . 8 
6 + perday .......... ...... ... ......... ..... 9 
FlSO. Olive oil added to food or 
bread (l Tbs. ); exclude use in 
cooking 
·Never or< 1 per month. ............. I 
1-3 per month ...... .. ....... .. ...... .. ... 2 
1 perweek. ................................ 3 
2-4 per week ... ................... .. .... .4 
5-6 per week ............ .. ............... 5 
1perday ......... .......................... 6 
2-3 per day .. .. .... ........................ 7 
4-5 per day .......... .. .............. .. .. .. 8 
6+perday ................................. 9 
Fl53. What kind of fat or oil did 
you usually use for frying, stir-frying 
or sauteing at borne? 
Real butter .. ................... ....... ... .. I 
Margarine (GO TO 153a) ... ........ 2 
Olive: oil ... ............. ... .................. 3 
Vegetable oil (GO TO 153a) ....... 4 
Vegetable shortening .......... .. .... .. 5 
Lard/bacon fat.. ......... .. ............... 6 
Pam type spray ......... .. ................ 7 
153a. What brand and type of 
(margarine/vegetable oil) did you 
use for frying, stir-frying or sauteing 
(e.g. Wesson Canula Oil)? 
F154. What kind of fat or oil was 
usually used for baking at home? 
Don't bake .. ........ ........... .... .... .. . I 
Real butter. .. ............... ............... 2 
Margarine (GO TO 154a) ........... 3 
Olive oil ....... ........... .. ... ... .......... 4 
Vegetable oil (GO TO 154a) ··:· ·· 5 
Vegetable shortening ...... .... ... .... 6 
Lard/bacon fat. ........... .. .......... .. . 7 
Pam type spray ....... .. ........ .. ..... .. 8 
154a. What brand and type of 
(margarine/vegetable oil) did you 
use for baking? 
---------- . ~' ~~~ 
F155. How often did you eat deep 
fried food away from home or as 
take out (e.g., french fries, fried 
chicken, fish, clams, shrimp, etc.)? 
Never ....... .. ........ .......... ... ... ..... ... ! 
Less than once a week .... .. .......... 2 
Once perweek ................... : ... .. .. . 3 
2-4 times per week ..... ......... .. ... ... 4 
5-6 times per week ... ... .. ..... ......... 5 
Daily .. .. .......... ...... ....... .. .. .. ... ...... 6 
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F156. Arc there any other foods not mentioned up to now that you usually ate at least once per week? 
Include for example: Pate, cream sauce, custard, radishes, fava beans, coconut, mango, horseradish, parsnips, rhubarb, 
papaya, dried apricots, dates, figs . (Do not include dry spices and do not list something that has been listed in the previous 
sections.) 
YES .......... .. ................... ..... .. .... . I 
NO (GO TO Fl57) ..... .. ....... ...... . 2 
What were the other foods that you usually ate at What was your usual serving size for (name How many times per 
least once per week? of food)? week did you eat it? 
a . I I I I w I I I I w 
b. I I I I w I I I I w 
c. I I I I w I I I I w 
Fl57. Did you follow a special diet! F157a. Was the diet F157b. For bow 
YES .. .. ......... ................ .. .. ............ ...... ........... .. ..................... l prescribed by a nurse, many years bad you physician or dietician or was it been following this 
NO (GO TO SECTION G) ...... .... . ... ............... ....... .... .......... . 2 chosen by yoo? diet? 
PHYSICIAN ... ... ... : ...... .. .... ! Number of years 
NURSE ......... ................... .. 2 w DIETICIAN ........ .. ............. 3 
SELF-PRESCRIBED ......... 4 
F157c. What kind of diet did you follow? Yes No 
Weight reduction (low calorie) 1 2 
Low cholesterol I 2 
Low sodium 1 2 
Diabetic 1 2 
Low fat I 2 
Low triglyceride 1 2 
Ulcer 1 / 2 
High Potassium I 2 
Other Specify I I I I 1 2 
G. NUTRITIONAL SUPPLEMENTS 
I'd like to ask you about your use of nutritional and dietary supplements including vitamins and 
minerals. I'd like to know about any supplements you took during the period three months 
before you became pregnant (with CHILD'S NAME) and during your entire pregnancy. This 
would be the period from (DA1E) to (DA1E) or the entire time period shown on your pregnancy 
calendar. 
If you have any vitamins, minerals or other supplements you took during that time period 
available in the house now, please refer to the information on their bottles for these questions. 
During this period did you take ... 
Gl. . . . multivitamins? 
G2. . . . any other combination of vitamins 
and minerals in the same tablet? 
G3 . The rest would be vitamins and 
minerals taken alone and not part of a 
multivitamin or other combination you already 
told me about. During this period did you take 
any Vitamin A or retinol? 
G4. . .. Beta-carotene? 
GS. . .. Vitamin C? 
G6. . .. Vitamin E? 
G7. . .. Calcium? 
G8. ... VitaminD? 
YES (GO TO SUPPLEMENT FORM) ............... .... ... ! 
N.0 .................................... .. .................... .................. 2 
RF .......................... .. ...... ..... ... .......... .. ... ... ..... ... ......... 7 
DK ................................. ........ .......... .......... ............ ... 8 
YES (GO TO SUPPLEMENT FORM) ........... ........... 1 
N.0 .......................... .. ..... ... ................... .... .... .. ..... ... ... 2 
RF ...... .......... ................................................ .. ........... 7 
DK ................................. ..................................... ...... 8 
YES (GO TO SUPPLEMENT FORM) .......... .... ........ 1 
N0 ........................................................ ........... ........ . 2 
RF ........... ............. ............. .. ...................................... 7 
DK .............. : .............................................. ............... 8 
YES (GO TO SUPPLEMENT FORM) .. ....... ............. 1 
N0 ................ .......... .. ............ ......... ........................... 2 
RF .......................... .. ........... .. .... ... .... ... .................... .. 7 
DK ............................................................................ 8 
YES (GO TO SUPPLEMENT FORM) ...................... 1 
N0 ......................... .... .................... ........................... 2 
RF ............................ .... .. ....... ... ...................... .. ......... 7 
DK ...................... ............... ............. ................ .. ...... .. 8 
YES (GO TO SUPPLEMENT FORM) ...................... ! 
N0 ............................................................. ............... 2 
RF ... ................ .................................. ..................... ... 7 
DK ............................................................... .... ......... 8 
YES (GO TO SUPPLEMENT FORM) ................. .. . .. 1 
N0 .. ........................................................... ............... 2 
RF ........... .. ......................................... .................. ..... 7 
DK ........................ :~~ ................................................. 8 
YES (GO TO SUPPLEMENT FORM) .. ......... .. ......... 1 
N0 .............................................................. .............. 2 
RF .. ... .... .......... ... .. ..... .. ..... ... ............... ....................... 7 
DK .................................................. ....... .. ................. 8 
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G9. . .. Thiamine or Vitamin B I? YES (GO TO SUPPLE!\1ENT FORM) ...... ....... ......... I 
N0 ............................ ............... ...................... ........... 2 
RF ......................................................... .................... 7 
DK ............................... ........................................ ..... 8 
G l 0. . . . Riboflavin or Vitamin B2? YES (GO TO SUPPLEMENT FORM) .............. .. ...... l 
N0 .................................... ~ ............ ....................... ... 2 
RF .................................................. : .......................... 7 
DK ............................................. .......... : .................... 8 
G II . . . . Vitamin B6? YES (GO TO SUPPLEMENT FORM) .... .................. l 
N0 ...................................... ...................... ...... ....... .. . 2 
(VITAMIN B6 IS ALSO KNOWN AS PYRIDOXINE) RF ............................................. .. .... ........... ......... ...... 7 
DK ........................................ .............................. ...... 8 
Gl 2. . .. Vitamin Bl 2? YES (GOTO SUPPLEMENT FORM) ...................... I 
N0 ....... : ........... : ........................................................ 2 
(VITAMIN Bl2 IS ALSO KNOWN AS RF .. .. ............ ............... ~ ........ ................................... . 7 
CYANOCOBALAMIN) DK ............................................................................ 8 
Gl3. .. . Folic Acid? 
GI4. .. .Niacin? 
G 15. .. . Selenium? 
Gl 6. . .. Iron? 
G17. . .. Zinc? 
G 18. . .. any other nutritional supplement or 
herbal preparation? 
YES (GO TO SUPPLEMENT FORM) ...................... 1 
N0 .................................................................... .. .. .. .. 2 
RF ................... ........................................................ .. 7 
DK ...................................................... ... ................... 8 
YES (GO TO SUPPLEMENT FORM) .... ... ..... .. .... .. .. 1 
N0 .............................. .. ............ ..... ....... .. ...... .... ........ 2 
RF .. ............. .............. .... .. .. ............. .......... ....... ... ....... 7 
DK .............................................................. ............. . 8 
YES (GO TO SUPPLEMENT FORM) .......... ............ 1 
N0 ............................................... ................. ............ 2 
RF ........................................................................... .. 7 
DK .. .. ... ..................................................................... 8 
YES (GO TO SUPPLEMENT FORM) ...................... 1 
N0 ............. .. .......... ............................ ....................... 2 
RF ........ ...... ............ .. ... ................ .......... .. .... ...... ........ 7 
DK ............................ ........................................... ..... 8 
YES (GO TO SUPPLE!\1ENT FORM) .. .... .. .. ..... ....... 1 
N0 ............................................................................ 2 
RF ................................ .............................. .. ... .... ...... 7 
DK .. .................................. ................... .... .. .... .. . : ... .. .. 8 
YES (GO TO SUPPLEMENT FORM) .. ............ .... .... I 
N0 ....................... / · ................................... ....... ........ 2 
RF ........ ............................... .. ......... .. .... ....... .............. 7 
DK .......................................... ............................. ..... 8 
163 
H. MEDICATIONS 
I'd like to ask you about some health cOnditions and your use of medications- including ones that 
were prescribed for you, ones you bought at the store without a prescription or ones given to you 
by some one else. I'd like to know about anything you took during the period three months before 
you became pregnant (with CHilD'S NAME) and during your entire pregnancy. This would be the 
period from (DATE) to (DATE) or the entire time period shown on your pregnancy calendar. 
If you have any prescription or non-prescription medications you took during that time period 
available in the house now, please refer to the information on their bottles for these questions. 
Hl. During the pregnancy, did you have 
morning sickness, nausea, or 
vomiting? 
Hla. During which months ofyour 
pregnancy did you have nausea or 
vomiting? 
Hlb. Did you take any medication for 
nausea or vomiting? · 
H2. Did you take medicine for sugar 
diabetes? 
H2a. Did you develop diabetes during your 
pregnancy? 
YES .......... , ............. , ......... ............. ........ ................... I 
NO (GO TO H2) .. ..................... ............. .......... ......... 2 
RF (GO TO H2) ........................................................ 7 
DK (GO TO H2) ...... ........................... ........... .. ..... .... 8 
PREG. 
MONTH YES NO ENDED DK 
1 -.. 1 ... 2 ... 3 ... 8 
2 -: . 1 .. . 2 ... 3 ... 8 
3 ... 1 ... 2 ... 3 ... 8 
4 . . -1 ... 2 ... 3 ... 8 
5 ... 1 ... 2 ... 3 ... 8 
6 ... 1 ... 2 ... 3 ... 8 
7 . .. 1 ... 2 ... 3 ... 8 
8 . -- I ... 2 ... 3 ... 8 
t---- ----- ----
.9 .. . 1 ... 2 ... 3 ... 8 
YES (GO TO SUPPLEMENT FORM) ...................... } 
N0 ............................................................................ 2 
RF ........ .................. .. ................... .. .................... ....... 7 
DK ... ........... ........................... ....... ..... .... ..... ...... ...... . 8 
YES (GO TO SUPPLEMENT FORM) .................. .... 1 
N0 ...................................................................... ...... 2 
RF .... .... : .... ...... ... ... ........ ........ ......... ........... ... .... ....... . 7 
DK ......................... _-;--· ··········-·-----· -·-·--·······-----·-········8 
YES .............................. .. ........... ... .... ............ .... ........ l 
NO (GO TO H3) ·· ·······--------·----·-··'--·--·-····· ················2 
RF (GO TO H3) .......... ..... ... ..... ...... .......... ................. 7 
DK (GO TO H3) ................ ....................................... 8 
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H2b. During which month of your 
pregnancy were you diagnosed with 
diabetes? 
H3. Did you take medication for high 
blood pressure or hypertension? 
H4. Did you take medication to help you 
lose weight? 
H5 . . .. to help you sleep? 
H6. . .. to help you stay awake? 
H7. . .. for anxiety, depression or your 
mood? 
H8 . . .. for epilepsy, convulsions, or 
seizures? 
H9. . .. for allergies, asthma, or hay fever? 
H 1 0. . . . for acne or other skin problems? 
Hll . . .. for headache, joint pain, arthritis or 
other pain? This includes aspirin, 
Tyleno~ Advil, ibuprofen, etc. 
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MONTIIW 
YES (GO TO SUPPLEMENT FORM) ..... , ............. ... ! 
N0 ............................................................................ 2 
RF .. ...... .... .................................. .. ... ..... ... ................. ? 
DK ................. .................................. ... ........ ............. 8 
YES (GO TO SUPPLEMENT FORM) ....... .......... ..... ! 
N0 .......................................................................... .. 2 
RF ....... ......... .......................... ............... ... ....... ... ...... ? 
DK ................................................. .-......................... 8 
YES (GO TO SUPPLEMENT FORM) ... ........ ...... ..... ! 
N0 ........................................... ................................. 2 
RF .............. _. ............................................... .............. ? 
DK ...... ................... ............................................ ...... 8 
YES (GO TO SUPPLEMENT FORM) ..... .... ..... ... .. ... 1 
N0 ................. ............................... ............................ 2 
RF ............... .............................................. ... ... ......... ? 
DK .............................................................. ............. 8 
YES (GO TO SUPPLEMENT FORM) ........ .............. 1 
N0 ............... ............ ... .................... .......... ................ 2 
RF ....... ... ........... ................. .. .... ..... .. .... ....... ............. . ? 
DK ..... .................. ... .-............ : ..................... ... ........... 8 
YES (GO TO SUPPLEMENT FORM) .. .. .................. 1 
N0 ..................................................................... ....... 2 
RF ................ .. ........................................ ... .. ... .... .. ... . ? 
DK ....................................................... .. .. .......... .... .. 8 
YES (GO TO SUPPLEMENT FORM) ..... .... .. .......... . 1 
N0 ......................................... .. .... ........................... .. 2 
RF ........... .............. .. ................. ............ ... ...... ...... ..... ? 
DK ................................................................ ... ....... . 8 
YES (GO TO SUPPLEMENT FORM) ..... ...... ........... 1 
N0 ............................. .............................. ................. 2 
RF ....... ................ ................................. .. ................ .. ? 
DK ...... ................... ............•..................................... 8 
YES (GO TO SUPPLEMENT FORM) ...................... 1 
N0 .................... , ..... ./.~ ............................................... 2 
RF , ............ ........... .. .................................. ......... ...... . 7 
DK ......... ............... ~ ............................ ................... .. 8 
Hl2. ...for urinary tract infection or any 
other infection, inflammation, fever? 
This includes antibiotics, aspirin, 
Tylenol, Advil, ibuprofen, etc. 
Hl3. ... for a thyroid condition? 
HI4. . .. forupset stomach, gas or an ulcer? 
(NOT INCLUDING WHAT TilEY TOOK 
FOR MORNING SICKNESS Hlb) 
HIS. .. . for constipation? 
Hl6. ... for hormonal or metabolic 
problems or anything you saw an 
endocrinologist for? (OTHER THAN 
DIABETES) 
Hl7. . .. to help yo1..1 conceive a child, such 
as Clomid or other fertility drugs? 
Hl8. Did you take any other medications, 
including herbal preparations, during 
the 3 months before you became 
pregnant and during your pregnancy 
that you have not already told me 
about? 
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YES (GO TO SUPPLEMENT FORM) .... .. ............. ... 1 
N0 .................................. ............................ : ...... ....... 2 
RF ............................................................................. ? 
DK ....................................... .................................... & 
YES (GO TO SUPPLEMENT FORM) .... .................. I 
N0 .................................... : ............ , .......................... 2 
RF ............................ c .................... .... ....................... 7 
DK .......................................................... .. ... ....... : .... 8 
YES (GO TO SUPPLEMENf FORM) ................ ...... I 
N0 ........................................... ............. .................... 2 
RF ............................................... ...... .................... ... ? 
DK ............................ : ............................ ........ .......... & 
YES (GO TO SUPPLEMENf FORM) ....... ..... .... ...... I 
N0 ........................................................ ................ .... 2 
RF ............... .' ..... ................... ........... ......................... ? 
DK .................................... ... .. .......... .... ................ .. .. & 
YES (GO TO SUPPLEMENf FORM) ...................... I 
N0 .................................. :: ........................................ 2 
RF ...................................... .. ......... .................. ......... ? 
DK ..................... : ..................................................... 8 
YES (GO TO SUPPLEMENf FORM) .. .. ....... .. ......... ! 
N0 ..... ....................................................................... 2 
RF ....... .' ................................................... .... ............. ? 
DK .................... ......... .' ............................................. 8 
YES (GOTO SUPPLEMENT FORM) .. .................... I 
N0 ............................................ ............ ................. ... 2 
RF ....................... .................................................. ... ? 
DK ............................................... ............................ 8 
J. CIGARETTE SMOKING 
Now I'd like to ask you some questions about some personal habits including cigarette smoking and 
drinking alcohol. 
Jl. YES ................................................ .. .. ................... ................ 1 
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Have you ever smoked cigarettes 
regularly? By this I mean smoking more 
than 100 cigarettes at any time in your 
life. 
NO (GOTO 110) .. ...... ............ .... ....... ............ ................... ...... 2 
12. 
13. 
J3a. 
J4. 
J4a. 
How old w ere you when you first started 
smoking cigarettes regularly? 
Did you smoke any cigarettes during the 
three-month period before you became 
pregnant (with CHll..D 'S NAME)? 
During the three months before your 
pregnancy, about how many cigarettes 
did you smoke a day? 
Did you smoke any cigarettes during the 
first three months of your pregnancy 
(with CHIT.D'S NAME)? 
During your first three months of your 
pregnancy, about how many cigarettes 
did you smoke a day? 
YEARSOFAGW 
YES .. ....... ............................ : ...... ..................... ..... .............. ... 1 
NO (GO TO 14) ...................... ........... .. .... .... .... ..... .......... ........ 2 
RF (GO TO 14) ......... ...... ................ .... ... .... .... ......... ................ 7 
DK (GO TO 14) .. ......................................... .... .................. ..... 8 
< I PERDAY .... .. ................... ..... ..... .... .. .. .. ....... ...... ........... .. .. 1 
l PERDAY ......................... .. ... ......... ..... .. .... .......... .. .. .. .... ..... . 2 
2-4 PER DAY ................. .............. ....... ... ... ................... ....... .. 3 
y, PACK (5-14) ..... ... ..... .... ... .... ............ ..... ... ... .. .... ....... .. .. ..... 4 
I PACK (I5-24) ....................... ..... .... ................. .. .. .. ............. 5 
I Y, PACK (25-34) ................... .. .... ....... .... .. ........... ..... .. ....... .. 6 
2 PACKS (35-44) .......................................... .. ............... ... ..... 7 
> 2 PACKS ............................................................ ....... .. ... .... 8 
RF ....... ....... ........ ........... ......... ..... ..... .................................... 97 
DK ................. .............. .......... ... .. ..... .............. .-.. .. .. ... ... ......... 98 
YES .. .............. ................... ............. ...... ... ...... ........................ 1 
NO (GO TO 15) ................. .. .... ... ... ............. .............. .. .... .. ..... . 2 
RF (GO TO 15) .......................... ........ .. ..... .............................. 7 
DK (GO TO 15) .................. ...... ................................. ........... .. 8 
< I PER DAY ......................... ......... ....... ............. ...... .... ..... .... 1 
I PER DAY ....... ......... ............... ... .... .. ...... ..... ........ .... .... .. ....... 2 
2-4 PER DAY ......... ......... ... ....... ........ ............... ..... ... ..... .. .. .... 3 
\I, PACK(5-I4) ... ......................... ............................ .......... .. . 4 
I PACK (15-24) ............ ................ .................... ..... ............... 5 
I Y, PACK (25-34) .... .... ................ .. ......... .. ... .... .. ... .. ........... .. . 6 
2 PACKS (35-44) ............................... ............ ..... .... .. ...... ....... 7 
>2PACKS ............. ...................... ...... .. ... .. ............... .... ......... 8 
RF ......... .......... : .. ... .. ................. ... .. ....... .. .... .... .... ...... . :: ........ . 97 
DK ...... .... ...... ...... ................. .......... ..... ... .......... ....... ........... .. 98 
15. 
J5a. 
16. 
16a. 
17. 
18 . 
19. 
Did you smoke any cigarettes during the 
fourth, fifth and sixth months of your 
pregnancy (with CHll..D'S NAME)? This is 
the second trimester. 
During your fourth, fifth, and sixth · 
month of pregnancy about how many 
cigarettes did you smoke a day? 
Did you smoke any cigarettes during the 
seventh, eighth, and ninth months of 
your pregnancy (with CHILD' S NAME)? 
This is the third trimester. 
During your seventh, eighth, and ninth 
month of pregnancy about how many 
cigarettes did you smoke a day? 
Do you smoke cigarettes now? 
On the average, how many cigarettes do 
you now smoke per day? 
How long ago did you stop smoking? 
11 0. During the three months before or 
during your entire pregnancy did anyone 
(besides you) regularly smoke cigarettes 
in your home, workplace or any other 
. place near you? · 
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YES ... .. ..... ........ ........ ....... ................ ... .. ........ ............ .. ..... : .... . 1 
NO (GO TO 16) ............ ..... ........ ............................ ............. .... 2 
RF (GO TO 16) ...... .... ... .. ..... ... .............. ............ .... .. ................ 7 
DK (GO TO 16) ...................................... .. .............. ........... ..... 8 
<I PER DAY ..... : .... .............. .. .. ........ ............. .. ....... .. ... .. ........ 1 
I PER DAY. ... ......... ............... ...... ....... ... ............ .......... ... ..... .. 2 
2-4 PER DAY ...... .......... .... .................. .. .... .............. .. ........ .... 3 
Y:zPACK(5-I4) ..... .................................. ....... ............. .......... 4 
I PACK (IS-24) .. ............ ......... ...... ..................... ....... .. ......... 5 
l Y:z PACK (25-34) .. ... ............. .... ............ ..... ........... ......... ...... 6 
2 PACKS (35-44) .... ... .................... ...... .......... ......... ... .. .......... 7 
>2PACKS ....... ................. ............................................. ....... 8 
RF .............. .... .... ................. ... ........... ....... ......... ........ ...... ..... 97 
DK ............... ... .. .. ... ........... .................... .. ...... .. ... .................. 98 
YES ......... ... .. ............................. .... ....... ............ .. ...... .. ........ ... 1 
NO (GO TO 17) .... .. ................ ...... ..................................... .... 2 
RF (GO TO 17) .. ................................................ .. ... ............. ... 7 
DK (GO TO 17) ..................................................... .... .. ........... 8 
<I -PER DAY ....................................... ............................... ... 1 
1 PER DAY ....... ...................... .............. .. ..................... ......... . 2 
2-4 PER DAY ................. .. ............... ............. .... ..... ... .. ........... 3 
Y:zPACK(5-I4) .... ............ .... .......... .... .... ........ .. ......... ............ 4 
l PACK(IS-24) ....................... ..................... .. ............ .......... 5 
1 Y:z PACK (25-34) ... ..................... ... ..... .. .. .. ....... ......... ........... 6 
2 PACKS (35-44) .............. ......... ....... : ..................... ..... .. ........ 7 
> 2 PACKS .............................. ...... ....... ........... ......... ... ... ... •. .. 8 
RF ........................................................................................ 97 
DK ........ .... ... ... .. ......... ........ ... ........................................ .... .. . 98 
YES .......... .. .... . .. .............. ... . ...... .. .............. ........... .. 1 
NO (GO TO 19) .. ...... ... .. ....... .... . . .... : ........ . : ... ................. 2 
PERDAY w GOTOJlO 
YES ..................... ........... ................ ...... .. ...... ..... .. .................. 1 
NO (GO TO SECTION K) ... ................................. ...... ......... .. . 2 
DK (GO TO SECTION K) .... ..... ........ ..... ..... ........ .. .. .............. . 8 
/ 
Jlla. 
Jllb. 
Jllc. 
Jlld. 
During the three months before you 
became pregnant did someone smoke in 
your home, workplace or any other place 
near you? · 
During the first three months of your 
pregnancy did someone smok~ in your -~ 
home, workplace or any other place near 
you? 
During the fourth, fifth, and sixth month 
of your pregnancy did someone smoke 
in your home, workplace or any other 
place near you? 
During the seventh, eighth, and ninth 
month of your pregnancy did someone 
smoke in yolir home, workplace or any 
other place near you? 
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YES ............... .... ............. . ..... .. .......... .. ... .. ... ........... . I 
N0 ....................... .............................. ... .. ................... 2 
RF ............... ......... ........ ... ...... .... ... ............. ... .......... 7 
DK ... ......... ...... ............................................. . .... .. .... 8 
YES ... ... ... ... ........ . ................................ . ................. .l 
N0 ...... ... ............... ..... ........... . .............. .............. .. .... .2 
RF ..... .... .... .. .. . .... .. ...... ............... .. ................. .. ..... ... 7 
DK ...... ......... ....... ... ......... . : . ............... ...................... 8 
YES .......... .. ... .... ... .... . ............. ................. .. ...... .... .... l 
N0 .......... ..... .......... . ....... ........................................... 2 
RF ......... ... ................. . .. .... .... ..... .................. .. .... ..... 7 
DK .................................. ..... .... . ... ... : .... .. .................. 8 
YES ... ... .... ............ ." ....... ... .. . ...... ... .. . .... ....... . ............ l 
N0 ........ . ..... ... ...................................... .. ....... .. .......... 2 
RF ......... ........................ .............. ............. .... .. ........ 7 
DK ......................... ....... .. .... .. ..... .. .. ...... ... ...... .......... 8 
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K. ALCOHOL CONSUMPTION 
Now I'm going to ask you some questions about drinking alcoholic beverages which include liquor, beer, 
or wine. 
Kl. Have you ever drank alcohol regularly, this includes 
beer, wine, wine coolers, mixed drinks, cocktails, or 
shots ofhard liquor, at any time in your life? 
K2. When you drank a! coho~ what type(s) of alcohol did 
you usually drink? · 
Did you drink .. . . 
K2a. Beer .. . .. .. .... ." . .. . ... . . ..... . ... ........ .. . . 
K2b. White wine .. . ... . . . . .. ... . .... . .. . . ... ... .. . 
.K2c. Red wine . . . . .. . .... .. . .. ...... .. .. .... ... .. . 
K2d. Mixed drink . ... ... . .... . . . .. . . .. . ....... .. . 
K2e. Shot liquor ........................ .. ....... . 
K2f Other liquor .. ... .. .. .... ...... . . ... . ..... . . . 
SPECIFY: rn 
K3 . During the three-month period before you became 
pregnant (with CHD..D·s NAME), did you drink any 
alcohol? This includes the same types of alcohol that 
I mentioned before. 
K3a. During this three-month period before you became 
pregnant, how often did you usually drink alcohol? 
Was it. .. 
YES ......... ... ... ......... ........ ... .. .. ... ........ ..... . I 
NO (GO TO SECTION L) .. .... ... .. ....... .. .. ... .. ...... 2 
RF (GO TO SECTION L) ... .... ..... ...... ..... .... ........ 7 
DK (GO TO SECTION L) ............................. ..... 8 
YES NO DK 
2 8 
1 2 8 
1 2 8 
2 8 
I 2 8 
2 8 
YES ......... .. ...... .... ..... ........ ... ........................... .. l 
NO(GOTOK4) .... ... .... .. .................. .... .. .... .. ... 2 
RF (GOTOK4) .. ....... ........... ....... ............... .. .... 7 
DK (GOTOK4) .... ... .......... .. ........... .. .... .. ........ 8 
Every day or most days .. .. , ..... .. .. .......... . 1 
3-4 times per week .......... : ... ............... .. 2 
1-2 times per week ............... .... ...... .... .. . 3 
1-3 times per month ...... ... ... .................. 4 
Less than once per month ... .. ..... ..... .... .. . 5 
RF ... ... ...... .. .... .... .... .-......... .. .. .. .. .... ........ ..... ... ..... 7 
DK .. .... ....... ......... .... ..... .... ... ... .. .. .... .... ...... .. ... ... . 8 
/ 
K3b. On the days you drank alcohol during the three-
month period before you became pregnant, how 
many drinks did you usually have? Was it.. . 
K3c. During the three-month period before you became 
pregnant, what was the greatest number of drinks that 
you had in one 24-hour period? Was it . .. 
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8 or more per day. ... ... ............. ... .... ...... . 1 
5-7 per day .. ... .......... .. .... ..... ... ....... ........ 2 
3-4 per day ... ........ ........ ..... ....... .... ......... 3 
1-2 per day .... ... ........ ... .............. ..... ... .. .. 4 
Less than 1 per day ... ... .... ........ ... ........ .. 5 
RF ..................... : .............. .............. ................... 7 
DK ................. .. .............. ................................... 8 
More than 24 ........ ......... ....... .......... ...... 1 
12-23 ······· ········ ········· ······ ·········· ·· ··· ······· 2 
6-11 .. ... ........ ... ................. ....... ... .. ......... 3 
3-5 .............. .. ..................... .............................. 4 
1-2 .................................... ........ .. ........... ......... 5 
RF ..... ... .. .. ................. ..... ....... ..... . : ..................... 7 
DK ...... ... ............... .. ... ...... .. ... ... .. ...... ...... ... ....... . 8 
Now, I'd like to ask you about the time during your pregnancy. This includes any time between the 
estimated date you became pregnant (with CHILD'S NAME), shown in a red box on your pregnancy 
calendar, and the end of your pregnancy. 
K4. 
K5. 
K5a. 
During your entire pregnancy did you drink any 
alcohol? 
During the first three months of your pregnancy, did 
you drink any alcohol? 
During the first three months of your pregnancy, how 
often did you usually drink alcohol? Was it.. . 
K5b. On the days you drank alcohol during the first three 
months of your pregnancy, how many drinks did you 
usually have? Was it.. . 
YES .............................. ............ ........... ............. ! 
NO (GO TO SECTION L) ..... ..... .... .. ................ 2 
RF (GO TO SECTION L) .. ... ................. .. ......... 7 
DK (GO TO SECTION L) ................................ 8 
YES ........... .. ........... ... ................ ............ ........... ! 
NO (GOTO K6) ..... .... .......... ...... .. .... .. ... ... .. .. ... 2 
RF (GO TO K6) ............. ............................... .... 7 
· DK(GOTOK6) ............................ .. ........ ...... .. 8 
Every day or most days ..... ...... .. ... ......... 1 
3-4 times per week ....................... ... ..... 2 
1-2 times per week .. ...... : ............. ...... .... 3 
1-3 times per month ....... ... ........... .. ....... 4 
Less than once per month ............ ... .... .. . 5 
RF ................. .. ........................... ........ ..... .......... 7 
DK ........................ ..... .. .... ......... .. .. .... .. .. ........ .... 8 
8 or more per day .... .... .. ..... ...... ....... .... .. 1 
5-7 per day .. .. .... ... .. .. ....... ... ...... ....... ... ... 2 
3-4 per day ... .. ...... ... .. ... .. ...... ................. 3 
1-2 per day ... .......... .. .. .. .... .. ........ ....... .... 4 
Less than 1 per day .......... ....... .............. 5 
RF .. ..... ....... ... ........... .. ...... ... ...... .... ............ ........ 7 
DK ....... .. ................ ... .. .. .... ..... .. ........... .. ......... ... 8 
K5c. During the first three months of your pregnancy, 
what was the greatest number of drinks that you bad 
in one 24-hour period? Was it ... 
K6. During the fourth. fifth, and sixth months of your 
pregnancy, did you drink any alcohol? This is the 
second trimester. 
K6a. During the fourth. fifth, and sixth months of your 
pregnancy, how often did you usually drink alcohol? 
Was it. .. 
K6b. On the days you drank alcohol during the fourth. 
fifth and sixth months of your pregnancy, how many 
drinks did you usually have? Was it... 
K6c. During the fourth. fifth. and sixth months of your 
pregnancy, what was the greatest number of drinks 
that you had in one 24-hour period? Was it.. . 
K7. During the. seventh. eighth. and ninth months of your 
pregnancy, did you drink any alcohol? This is the 
third trimester. 
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More than 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
12-23 ..... .... ............. ..... ............... ... .... ... 2 
6-11 ...................................... ................ 3 
3-5 ... ............. .................... ....................... ........ 4 
1-2 .................. ...... .. .............................. .......... 5 
RF ................................................ .... ........ .. ... .... 7 
DK .................. ...... ......... ... ............. ..... .. ... ......... 8 
YES .................... .... ... ............. ......... ........ ....... .. l 
NO (GOTOK7) ... ........ ... .... ............. .... .. .......... 2 
RF(GOTOK7) ..... .. ................ .... .................. .. 7 
DK(GOTOK7) ........................ .. ........... .. ..... .. 8 
Every day or most days ..... ....... .... ........ . I 
3-4 times per week ..... ......... .. ............... 2 
1-2 times per week ..... ... ....................... . 3 
1-3 times per month ........... ... ..... .... .... ... 4 
Less than once per month ......... .... ... ...... 5 
RF ...... ........................ .. ......................... .. ......... . 7 
DK .................... : .............. .................. .. .... ......... 8 
8 or more per day......... .... .. ...... .. ... ... ..... I 
5-7 per day ........ ........... ........ ... ....... ..... .. 2 
3-4 per day ... ........ ........ .... ............ ...... ... 3 
1-2 per day ... ... ...... ...... .. ..... ...... .... ......... 4 
Less than 1 per day ... .... ......... .. .. ........ .. . 5 
RF .............. ... .......... .. .. ........ ..... .. .. .. ...... .. ... .. .. ... . 7 
DK ....... .... ...... .... ... ... ........................ .. .... ..... ...... 8 
More than 24 . . . . . . . . . . . . . . . . . . . .. . . . . . . . .. . . . . . . . . . . 1 
12-23 ......................... ....... .................... 2 
6-11 ... .... .. .. .... .. ........ ... .... .. .......... ...... ... . 3 
3-5 ............................... ........ ....... .... ... .............. 4 
1-2 .......................... ......... ........ .. ... .................. 5 
RF ... ........... .......... .... .... ............ ........ ..... ............ 7 
DK ....... ...... ... .............. ... .. .... .. .. ......... ................ 8 
YES ...... ... ............... : ... ..... .. ...... .. ....... .... ............ l 
NO (GO TO SECTION L) .... .... ... .................. ... . 2 
RF(GOTOSECTIONL) .. ... .. ......... .... .... ......... 7 
DK (GO TO SECTION L) ... ... .. ... ........... .. .... .... 8 
K7a. During the seventh, eighth. and ninth months of your 
pregnancy, how often did you usually drink alcohol? 
Was it... 
K7b. On the days you drank alcohol during the seventh. 
eighth. and ninth months your pregnancy, how many 
drinks did you usually have? Was it .. . 
K7c. During the seventh, eighth and ninth months of your 
pregnancy, what was the greatest number of drinks 
that you had in one 24-hour period? Was it ... 
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Every day or most days ...... .. ...... 0 . 0 • • • • • • • • 1 
3-4 times per week ... .. .... .. .. .... ........ ... ... 2 
1-2 times per week ....... .. .. .. ........ .... ....... 3 
1-3 times per month ............ .. .. ... ......... .. 4 
Less than once per month ........... .. .. .. ..... 5 
RF .......................................................... :o .. ....... 7 
DK .................................................. o ••••• ••••• • o ... . . 8 
8 or more per day ...... .. ......... .. .... .. ......... 1 
5-7 per day ............ .. .... .. ........................ 2 
3-4 per day .............. .. ..... ...... ................. 3 
l-2 per day .. .... .. ...... .. ........ ..... ........ .. ..... 4 
Less than 1 per day .. .. .......... .. .... .. .... ..... 5 
RF ....................................... ... .. o .. .. . ................... 7 
DK ..... ......... ...... ........ ... .. ... o······ ·o··········-·· ·· ······· ·8 
More than 24 ........... ... ................ .. ........ 1 
12-23 ................ .. ........................... .. .... . 2 
6-11 ....... .. .......... ............ .. ........ .. ........... 3 
3-5 ..... .. ......... ... .. .. .... ............... .. .......... ............. 4 
l-2 ......... .. .............. .......... ... ....... ...... .. ... ... ....... 5 
RF ..... · ...................... : .... o o . ... . .. ............. .. ....... . ... .. 7 
DK ...................... ..... ......................... o ••• • ••••••••••• 8 
L. OCCUPATIONAL HISTORY 
Now I'd like to ask you about any jobs you may have had during the one-year period before 
(CHIT-D'S NAME was born! your pregnancy ended), that includes the three months before you became 
pregnant thru the time you delivered. Please include any part-time or full-time jobs you had at home, 
on a farm or outside your home: If you had more than one job or changed jobs but were with the 
same employer, I'll ask about each one separately. 
Ll. Did you have any part-time or full-time YES ............... .......................... ....... .. : ......... ................... I 
jobs, either inside or outside of your NO (GO TO SECI10N M) .......................... ...... ... ....... ... 2 
home, during the year before (CHilD'S 
NAME was born/ your pregnancy 
ended)? 
I'll begin with the job you had earliest in this period and end with the job you had just before 
(CHILD'S NAME was born! your pregnancy ended). 
L2a. What was the name of your employer 
(EXACT NAME) or were you self-
employed? 
L2b. What kind of business or industry was 
this (for example, manufacturing, retail, I I I I education, restaurant, work at home or 
on a farm)? 
L2c. What kind of work did you do or what 
was your job title? (for example, 
homemaker, farmer, engineer, office I I I I 
assistant, waitress, manager, teacher?) 
L2d. What were your most frequent activities I I I I or duties (for example, typing, keeping 1. 
account books, helping customers, I I I I supervising employees, caring for 2. 
children, teaching)? 
3. I I I I· 
L2e. During the year before (CHilD'S NAME 
was born! your pregnancy ended), 
HOURS PER WEEK w 
approximately how many hours per 
week did you work at this job? 
L2f. When did you begip working at this uJ I I I I I job? MONTH YEAR 
L2g. When did you stop working at this job? 
MONTII w I I I I I IF STILL WORKING AT THIS JOB, ENTER YEAR CURRENT DATE. 
L3 . Did you have any other full-time or YES ................ .. .. : ... ...... .............. ........... .. ... .... .. ...... .... .. I 
part-time jobs either inside or outside of NO (GO TO SECTION M) ...... ................................. .. ... 2 
your home during the year before 
(CHILD'S NAME was born/your 
pregnancy ended)? 
L3a. What was the name of your employer 
(EXACf NAME) or were you self-
employed? 
L3b. What kind of business or industry was 
this (for example, manufacturing, retail, I I I I 
education, restaurant, work at home or 
on a farm)? 
t-· --
L3c. What kind of work did you do or what 
was your job title? (for example, I I I I homemaker, farmer, engineer, office 
assistant, waitress, manager, teacher?) 
L3d. What were your most frequent activities I I I I or duties (for example, typing, keeping 1. 
account books, helping customers, I I I I supervising employees, caring for 1. 
children, teaching)? I I I I 3. 
L3e. During the year before {CHILD' S NAME 
was born/ your pregnancy ended), 
HOURS PER WEEK w approximately how many hours per 
week did you work at this job? 
L3f When did you begin working at this LU I I I I I job? MONTII YEAR 
L3g. When did you stop working at this job? LU I I I I I IF STILL WORKING AT TillS JOB, ENTER MONTI:! YEAR 
CURRENT DATE. 
L4. Did you have any other full-time or YES .. .......... .. ..... .... .......... ~ .............. ... ....... ...... .............. l 
part-time jobs either inside or outside of NO (GO TO SECTION M) ....... .................. ... ................ 2 
your home during the year before 
(CHILD'S NAME was born/ your 
pregnancy ended)? 
L4a. What was the name of your employer 
(EXACT NAME) <;>r were you self-
employed? 
L4b. What kind of business or industry was 
this (for example, manufacturing, retail, I I I I 
education, restaurant, work at home or 
on a farm)? 
L4c. What kind of work did you do or what 
was your job title? (for example, I I I I homemaker, farmer, engineer, office 
assistant, waitress, manager, teacher?) 
L4d. What were your most frequent activities I I I I or duties (for example, typing, keeping l. 
account books, helping customers, I I I I supervising employees, caring for 1. 
children, teaching)? I I I I 3. 
L4e. During the year before (CHILD'S NAME 
was born/ your pregnancy ended), 
HOURS PER WEEK w 
approximately how many hours per 
week did you work at this job? 
L4f When did you begin working at this 
MONTH LJ.j I I I I I job? YEAR 
L4g. When did you stop working at this job? 
MONTH LJ.J YEAR I I I I I IF STILL WORKING AT TillS JOB, ENTER 
CURRENT DATE. 
M. INCOME 
Now I'd like to ask you about your income. Please be assured that like everything else in this 
interview, all of this information will be kept strictly contidentlaL ' 
MI . In the year before you became pregnant 
· (with CHILD'S NAME), what was your 
total household income? This would 
have been from (DATE I year before 
conception) to (DATE of conception) 
Was it less than ten thousand dollars, 
more than fifty thousand dollars or 
somewhere in between? 
M2. Would you say it was .... ? 
M3 . 
{IF RESPONSE IS $20,000, ROUND UP TO 
THE HIGH RANGE,. $20-30,000; DO THE 
SAME FOR $30 - $40,000) 
How many people were supported by 
this income, including both adults and 
children? 
Less than $IO,OOO {GOTO M3) ..... ........ .. ............... I 
More than $50,000 (GO TO M3) .............................. 2 
In between ............................ .. ...................... ... ... ........ 3 
RF (GO TO M3) ........................ .. .... ; ....................... .. .. .. 7 
OK (GO TO M3) ...... .. ........................ .. ............. .. .. .. ....... 8 
$I0-20;000 .. ...................... .................. ... .. ..... .. .... ....... I 
$20-30,000 .................... .. .. .. .... .......... ... .... .. .. .... ... ....... 2 
$30-40,000 or .......... .. ................................ ................. 3 
$40~50,000 ... ............ ........... ..... .. .. .......... ... .. .... ..... ... ... 4 
RF ........ .................. ..... .. .......... .... ... ...... .. ..... ... ..... .. .. ... .... 7 
DK .......... ..... ....... ............ ......... ............ ....... ...... ............. 8 
#OFPEOPLE w DK=98 
/ 
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N. CLOSING AND FUTURE CONTACT INFORMATION 
That completes the interview. Thanks very much for doing this with me today. Your contribution to 
this study will help us greatly in our efforts to better understand the causes and prevention of cleft lip 
and cleft palate. 
Nl. In case we need to get in touch with you YES ......... .... ... .... ... ..... ... ...... ... .. ............ .... .... .... 1 
in the future, would you be willing to RF (GO TO N2) .... ...... ........ ........... ... .... ..... ....... .. .... ....... 7 
give me the name and address of DK(GOTON2) .......... ............. ..... ..... ...... .. ... ....... ......... 8 
someone who does not live with you 
who should always know where you 
will be? This information will be kept 
separate from your questionnaire. It 
will be locked except when needed by 
the research team. 
Nla. PRINT LEGffiL Y Nlb. PRINTLEGffiLY 
FIRST NAME: FIRST NAME: 
LAST NAME: LAST NAME: 
RELATIONSIDP TO RESPONDENT: RELATIONSHIP TO RESPONDENT: 
STREET ADDRESS: STREET ADDRESS: 
CITY, STATE: CITY, STATE: 
ZIP CODE: ZIP CODE: 
(AREA CODE) TELEPHONE NUMBER: (AREA CODE) TELEPHONE NUMBER 
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APPENDIX B: Statistical Notes 
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Figures 1-4: Graphs showing the non-linear relationships between the variables parity, 
hemoglobin and BMI and risk of clefts and the linear relationship between clefting and 
mother's age. 
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Table 1: Table showing the chi squared p-values for categorical variables- investigating 
the relationships between possible model covariates in order to avoid multi-colinearity 
problems during modeling. 
Edu Ethnic Income Alcohol Religion Marital Folate Gender 
Education 
Ethnicity .0001 
Income .0001 .0001 
Alcohol .0001 .0615 .0172 
Religion .0001 .0001 .0001 .0001 
Marital .0001 .0001 .0001 .0001 .0001 
Folate .1897 .6389 .9325 .9421 .0433 .2746 
Gender .5011 .3621 .6882 .7383 .1581 .7164 .8137 
Parity .0656 .8822 .0001 .0111 .2760 .0035 .0562 .0015 
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Figures 5-6: Histogram and normal quantile plot showing the distribution of mother's 
age. 
Note: Transformations did not appear to normalize the distribution of mother's age as 
evidenced by histograms, normal quantile plots and formal tests for normality, which 
were all highly significant even after transformation. 
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